<?xml version="1.0" encoding="UTF-8"?>
<PAPER>

<BODY>
<DIV><P>
</P>
<P>[0001] GOSMETIC COMPOSITIONS COMPRISING <ne id="WO2007039057.HC.class-names.248" epochem-id="EPOCHEM:NEW:CLASS:309" name="HYDROXYFATTY ACIDS" comment="" chebi-id="WO2007039057:339141" relevant="false" type="CLASS">HYDROXYFATTY ACIDS</ne>
The present invention is concerned with novel cosmetic or pharmaceutical compositions. More particularly, the invention is concerned with novel cosmetic or pharmaceutical compositions for treating or preventing any symptoms caused by negative developments of the physiological homeostasis of healthy skin, as well as for the promotion of hair growth and protection from hair loss.
Thus, in one aspect, the present invention is concerned with cosmetic or pharmaceutical compositions comprising a <ne id="WO2007039057.HC.class-names.292" epochem-id="EPOCHEM:NEW:CLASS:319" name="fatty acid" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acid</ne> containing 6 to 18 <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.1" epochem-id="EPOCHEM:COMPOUND:6728" name="carbon" comment="" chebi-id="CHEBI:27594" relevant="false">carbon</ne> atoms, which carries one or two <ne type="LIGAND" id="WO2007039057.HC.ligand-names.1" epochem-id="EPOCHEM:NEW:LIGAND:1" name="hydroxyl" comment="" chebi-id="CHEBI:29191" relevant="false">hydroxyl</ne>, <ne type="LIGAND" id="WO2007039057.HC.ligand-names.2" epochem-id="EPOCHEM:NEW:LIGAND:2" name="alkoxy" comment="" chebi-id="CHEBI:22338" relevant="false">alkoxy</ne>, preferably <ne type="LIGAND" id="WO2007039057.HC.ligand-names.332" epochem-id="EPOCHEM:NEW:LIGAND:94" name="methoxy" comment="" chebi-id="WO2007039057:259368" relevant="false">methoxy</ne> or <ne type="LIGAND" id="WO2007039057.HC.ligand-names.8" epochem-id="EPOCHEM:NEW:LIGAND:4" name="ethoxy" comment="" chebi-id="CHEBI:42241" relevant="false">ethoxy</ne>, <ne type="LIGAND" id="WO2007039057.HC.ligand-names.12" epochem-id="EPOCHEM:NEW:LIGAND:5" name="C2-C4-acyl" comment="" chebi-id="WO2007039057:437489" relevant="false">C2-C4-acyl</ne> protected <ne type="LIGAND" id="WO2007039057.HC.ligand-names.13" epochem-id="EPOCHEM:NEW:LIGAND:6" name="amino" comment="" chebi-id="CHEBI:46882" relevant="false">amino</ne>, preferably C2, or <ne type="LIGAND" id="WO2007039057.HC.ligand-names.24" epochem-id="EPOCHEM:NEW:LIGAND:8" name="oxo" comment="" chebi-id="CHEBI:46629" relevant="false">oxo</ne> group, preferably between the positions C6 and C12; or a salt, <ne id="WO2007039057.HC.class-names.330" epochem-id="EPOCHEM:NEW:CLASS:185" name="ester" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">ester</ne> or <ne id="WO2007039057.HC.class-names.266" epochem-id="EPOCHEM:NEW:CLASS:138" name="amide" comment="" chebi-id="CHEBI:29337" relevant="false" type="CLASS">amide</ne> of such <ne id="WO2007039057.HC.class-names.222" epochem-id="EPOCHEM:NEW:CLASS:85" name="acids" comment="" chebi-id="CHEBI:37527" relevant="false" type="CLASS">acids</ne> or a mixture of these <ne id="WO2007039057.HC.class-names.223" epochem-id="EPOCHEM:NEW:CLASS:85" name="acids" comment="" chebi-id="CHEBI:37527" relevant="false" type="CLASS">acids</ne>; and a carrier conventionally used in cosmetic or pharmaceutical compositions.
The <ne id="WO2007039057.HC.class-names.331" epochem-id="EPOCHEM:NEW:CLASS:185" name="ester" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">ester</ne> or <ne id="WO2007039057.HC.class-names.267" epochem-id="EPOCHEM:NEW:CLASS:138" name="amide" comment="" chebi-id="CHEBI:29337" relevant="false" type="CLASS">amide</ne> are, preferably, an <ne id="WO2007039057.HC.class-names.264" epochem-id="EPOCHEM:NEW:CLASS:315" name="alkyl ester" comment="" chebi-id="WO2007039057:324797" relevant="false" type="CLASS">alkyl ester</ne> or <ne id="WO2007039057.HC.class-names.265" epochem-id="EPOCHEM:NEW:CLASS:316" name="alkyl amide" comment="" chebi-id="WO2007039057:762825" relevant="false" type="CLASS">alkyl amide</ne>, wherein the term "<ne type="LIGAND" id="WO2007039057.HC.ligand-names.337" epochem-id="EPOCHEM:NEW:LIGAND:543" name="Alkyl" comment="" chebi-id="WO2007039057:275769" relevant="false">alkyl</ne>" encompasses straight chain as well as branched <ne type="LIGAND" id="WO2007039057.HC.ligand-names.338" epochem-id="EPOCHEM:NEW:LIGAND:543" name="Alkyl" comment="" chebi-id="WO2007039057:275769" relevant="false">alkyl</ne> groups, i.e. that "<ne type="LIGAND" id="WO2007039057.HC.ligand-names.104" epochem-id="EPOCHEM:NEW:LIGAND:23" name="C^-alkyl" comment="" chebi-id="WO2007039057:793858" relevant="false">C^-alkyl</ne>" encompasses straight chain <ne type="LIGAND" id="WO2007039057.HC.ligand-names.105" epochem-id="EPOCHEM:NEW:LIGAND:24" name="Ci-4-alkyl" comment="" chebi-id="WO2007039057:118586" relevant="false">Ci-4-alkyl</ne> (<ne type="LIGAND" id="WO2007039057.HC.ligand-names.88" epochem-id="EPOCHEM:NEW:LIGAND:13" name="methyl" comment="" chebi-id="CHEBI:29309" relevant="false">methyl</ne>, <ne type="LIGAND" id="WO2007039057.HC.ligand-names.317" epochem-id="EPOCHEM:NEW:LIGAND:125" name="ethyl" comment="" chebi-id="CHEBI:37807" relevant="false">ethyl</ne>, <ne type="LIGAND" id="WO2007039057.HC.ligand-names.96" epochem-id="EPOCHEM:NEW:LIGAND:15" name="n-propyl" comment="" chebi-id="CHEBI:26308" relevant="false">n-propyl</ne><ne type="LIGAND" id="WO2007039057.HC.ligand-names.97" epochem-id="EPOCHEM:NEW:LIGAND:16" name=",n-butyl" comment="" chebi-id="WO2007039057:98409" relevant="false">, n-butyl</ne>) as well as branched <ne type="LIGAND" id="WO2007039057.HC.ligand-names.98" epochem-id="EPOCHEM:NEW:LIGAND:17" name="C3-4-alkyl" comment="" chebi-id="WO2007039057:328183" relevant="false">C3-4-alkyl</ne> (<ne type="LIGAND" id="WO2007039057.HC.ligand-names.99" epochem-id="EPOCHEM:NEW:LIGAND:18" name="iso-propyl" comment="" chebi-id="WO2007039057:522409" relevant="false">iso-propyl</ne>, <ne type="LIGAND" id="WO2007039057.HC.ligand-names.100" epochem-id="EPOCHEM:NEW:LIGAND:19" name="iso-butyl" comment="" chebi-id="WO2007039057:952868" relevant="false">iso-butyl</ne>, <ne type="LIGAND" id="WO2007039057.HC.ligand-names.101" epochem-id="EPOCHEM:NEW:LIGAND:20" name="tert-butyl" comment="" chebi-id="CHEBI:30355" relevant="false">tert-butyl</ne>).
The salt may by formed by any cosmetically acceptable cation which means any <ne id="WO2007039057.HC.class-names.435" epochem-id="EPOCHEM:NEW:CLASS:971" name="metal cation" comment="" chebi-id="WO2007039057:793936" relevant="false" type="CLASS">metal cation</ne> as well as any organic cation that is not toxic to the skin and/or does not cause allergic reactions. Examples of such cations are <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.402" epochem-id="EPOCHEM:COMPOUND:4221" name="ammonium" comment="" chebi-id="CHEBI:28938" relevant="false">ammonium</ne> salts and <ne id="WO2007039057.HC.class-names.290" epochem-id="EPOCHEM:NEW:CLASS:317" name="alkyl ammonium" comment="" chebi-id="WO2007039057:746937" relevant="false" type="CLASS">alkyl ammonium</ne> salts, <ne id="WO2007039057.HC.class-names.382" epochem-id="EPOCHEM:NEW:CLASS:336" name="alkali" comment="" chebi-id="WO2007039057:241445" relevant="false" type="CLASS">alkali</ne> cations such as <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.887" epochem-id="EPOCHEM:COMPOUND:7085" name="sodium" comment="" chebi-id="CHEBI:26708" relevant="false">sodium</ne> and <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.406" epochem-id="EPOCHEM:COMPOUND:7084" name="potassium" comment="" chebi-id="CHEBI:26216" relevant="false">potassium</ne> ions and <ne id="WO2007039057.HC.class-names.291" epochem-id="EPOCHEM:NEW:CLASS:318" name="alkaline earth metal cations" comment="" chebi-id="WO2007039057:30891" relevant="false" type="CLASS">alkaline earth metal cations</ne> such as <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.768" epochem-id="EPOCHEM:COMPOUND:7090" name="calcium" comment="" chebi-id="CHEBI:22984" relevant="false">calcium</ne> und <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.358" epochem-id="EPOCHEM:COMPOUND:7091" name="magnesium" comment="" chebi-id="CHEBI:25107" relevant="false">magnesium</ne> ions.
In one embodiment of the present invention the <ne id="WO2007039057.HC.class-names.249" epochem-id="EPOCHEM:NEW:CLASS:310" name="aliphatic fatty acid" comment="" chebi-id="WO2007039057:762442" relevant="false" type="CLASS">aliphatic fatty acid</ne> is a <ne id="WO2007039057.HC.class-names.252" epochem-id="EPOCHEM:NEW:CLASS:311" name="saturated straight- chain fatty acid" comment="" chebi-id="WO2007039057:324836" relevant="false" type="CLASS">saturated straight- chain fatty acid</ne> or <ne id="WO2007039057.HC.class-names.254" epochem-id="EPOCHEM:NEW:CLASS:312" name="[omega] - branched-chain fatty acid" comment="" chebi-id="WO2007039057:687913" relevant="false" type="CLASS">[omega] - branched-chain fatty acid</ne> which preferably has 6 to 18 <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.2" epochem-id="EPOCHEM:COMPOUND:6728" name="carbon" comment="" chebi-id="CHEBI:27594" relevant="false">carbon</ne> atoms. In another embodiment the <ne id="WO2007039057.HC.class-names.250" epochem-id="EPOCHEM:NEW:CLASS:310" name="aliphatic fatty acid" comment="" chebi-id="WO2007039057:762442" relevant="false" type="CLASS">aliphatic fatty acid</ne> is a saturated straight-chain or <ne id="WO2007039057.HC.class-names.256" epochem-id="EPOCHEM:NEW:CLASS:313" name="[omega]- branched chain fatty acid" comment="" chebi-id="WO2007039057:772281" relevant="false" type="CLASS">[omega]- branched chain fatty acid</ne> which has 6 to 18 <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.3" epochem-id="EPOCHEM:COMPOUND:6728" name="carbon" comment="" chebi-id="CHEBI:27594" relevant="false">carbon</ne> atoms and is substituted, preferably by <ne type="LIGAND" id="WO2007039057.HC.ligand-names.249" epochem-id="EPOCHEM:NEW:LIGAND:68" name="hydroxy" comment="" chebi-id="CHEBI:43176" relevant="false">hydroxy</ne>, between the positions C6 and C12. A particularly preferred <ne id="WO2007039057.HC.class-names.298" epochem-id="EPOCHEM:NEW:CLASS:319" name="fatty acid" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acid</ne> is <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.265" epochem-id="EPOCHEM:NEW:COMPOUND:132" name="9- hydroxy stearic acid" comment="" chebi-id="WO2007039057:377465" relevant="false">9- hydroxy stearic acid</ne>. In a further aspect, the invention is concerned with cosmetic or pharmaceutical compositions comprising a <ne id="WO2007039057.HC.class-names.299" epochem-id="EPOCHEM:NEW:CLASS:319" name="fatty acid" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acid</ne> or a salt, <ne id="WO2007039057.HC.class-names.333" epochem-id="EPOCHEM:NEW:CLASS:185" name="ester" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">ester</ne> or <ne id="WO2007039057.HC.class-names.269" epochem-id="EPOCHEM:NEW:CLASS:138" name="amide" comment="" chebi-id="CHEBI:29337" relevant="false" type="CLASS">amide</ne> with the definitions and preferences as given above, and a <ne id="WO2007039057.HC.class-names.45" epochem-id="EPOCHEM:NEW:CLASS:24" name="retinoid" comment="" chebi-id="CHEBI:26537" relevant="true" type="CLASS">retinoid</ne>.
<ne id="WO2007039057.HC.class-names.39" epochem-id="EPOCHEM:NEW:CLASS:22" name="Retinoids" comment="" chebi-id="CHEBI:26537" relevant="false" type="CLASS">Retinoids</ne> for use in the invention are, e.g., <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.10" epochem-id="EPOCHEM:COMPOUND:881" name="retinoic acid" comment="" chebi-id="CHEBI:15367" relevant="true">retinoic acid</ne> or <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.741" epochem-id="EPOCHEM:NEW:COMPOUND:281" name="Retinol" comment="" chebi-id="WO2007039057:845039" relevant="false">retinol</ne> and isomers, e.g. 9-, 11- or 13-cis isomers thereof, and derivatives thereof which comprise <ne id="WO2007039057.HC.class-names.261" epochem-id="EPOCHEM:NEW:CLASS:23" name="retinyl esters" comment="" chebi-id="WO2007039057:519812" relevant="false" type="CLASS">retinyl esters</ne> such as the <ne type="LIGAND" id="WO2007039057.HC.ligand-names.302" epochem-id="EPOCHEM:NEW:LIGAND:327" name="acetate" comment="" chebi-id="CHEBI:30089" relevant="false">acetate</ne>, <ne type="LIGAND" id="WO2007039057.HC.ligand-names.303" epochem-id="EPOCHEM:NEW:LIGAND:328" name="phenylbutyrate" comment="" chebi-id="WO2007039057:770216" relevant="false">phenylbutyrate</ne>, <ne type="LIGAND" id="WO2007039057.HC.ligand-names.304" epochem-id="EPOCHEM:NEW:LIGAND:329" name="propanoate" comment="" chebi-id="CHEBI:17272" relevant="false">propanoate</ne>, <ne type="LIGAND" id="WO2007039057.HC.ligand-names.305" epochem-id="EPOCHEM:NEW:LIGAND:330" name="laurate" comment="" chebi-id="CHEBI:18262" relevant="false">laurate</ne>, <ne type="LIGAND" id="WO2007039057.HC.ligand-names.306" epochem-id="EPOCHEM:NEW:LIGAND:331" name="palmitate" comment="" chebi-id="CHEBI:29889" relevant="false">palmitate</ne>, <ne type="LIGAND" id="WO2007039057.HC.ligand-names.307" epochem-id="EPOCHEM:NEW:LIGAND:332" name="oleate" comment="" chebi-id="CHEBI:30823" relevant="false">oleate</ne>, <ne type="LIGAND" id="WO2007039057.HC.ligand-names.308" epochem-id="EPOCHEM:NEW:LIGAND:333" name="linoleate" comment="" chebi-id="CHEBI:30245" relevant="false">linoleate</ne>; or <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.763" epochem-id="EPOCHEM:NEW:COMPOUND:274" name="retinyl alkyl carbonate" comment="" chebi-id="WO2007039057:762347" relevant="false">retinyl alkyl carbonate</ne>; or <ne id="WO2007039057.HC.class-names.355" epochem-id="EPOCHEM:NEW:CLASS:183" name="ethers" comment="" chebi-id="CHEBI:25698" relevant="false" type="CLASS">ethers</ne> such as <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.37" epochem-id="EPOCHEM:NEW:COMPOUND:30" name="retinoxytrimethylsilane" comment="" chebi-id="WO2007039057:901675" relevant="true">retinoxytrimethylsilane</ne>; or <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.766" epochem-id="EPOCHEM:NEW:COMPOUND:1341" name="(all trans)-retinal" comment="" chebi-id="WO2007039057:847024" relevant="false">(all trans)-retinal</ne> or its <ne id="WO2007039057.HC.class-names.262" epochem-id="EPOCHEM:NEW:CLASS:314" name="acetals" comment="" chebi-id="WO2007039057:950244" relevant="false" type="CLASS">acetals</ne>; or <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.11" epochem-id="EPOCHEM:COMPOUND:881" name="retinoic acid" comment="" chebi-id="CHEBI:15367" relevant="true">retinoic acid</ne> or amides thereof such as <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.39" epochem-id="EPOCHEM:NEW:COMPOUND:31" name="methoxy PEG-12 retinamide" comment="" chebi-id="WO2007039057:287069" relevant="true">methoxy PEG-12 retinamide</ne> ("<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.698" epochem-id="EPOCHEM:NEW:COMPOUND:273" name="PEG-12" comment="" chebi-id="WO2007039057:527469" relevant="false">PEG-12</ne>" = -<ne type="FORMULA" id="WO2007039057.HC.formula-names.1" epochem-id="EPOCHEM:NEW:FORMULA:3" name="(CH2-CH2-O-)12" comment="" chebi-id="WO2007039057:663585" relevant="false">(CH2-CH2-O-)12</ne>).
More specifically, the invention is concerned with cosmetic or pharmaceutical compositions comprising at least one <ne id="WO2007039057.HC.class-names.300" epochem-id="EPOCHEM:NEW:CLASS:319" name="fatty acid" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acid</ne> or a salt, <ne id="WO2007039057.HC.class-names.334" epochem-id="EPOCHEM:NEW:CLASS:185" name="ester" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">ester</ne> or <ne id="WO2007039057.HC.class-names.270" epochem-id="EPOCHEM:NEW:CLASS:138" name="amide" comment="" chebi-id="CHEBI:29337" relevant="false" type="CLASS">amide</ne> with the definitions and preferences as given above, and optionally one <ne id="WO2007039057.HC.class-names.46" epochem-id="EPOCHEM:NEW:CLASS:24" name="retinoid" comment="" chebi-id="CHEBI:26537" relevant="true" type="CLASS">retinoid</ne>, for the treatment or prevention of symptoms caused by negative developments of the physiological homeostasis of healthy skin, as well as for the promotion of hair growth and protection from hair loss.
Treatment or prevention of symptoms caused by negative developments of the physiological homeostasis of healthy skin comprises treatment or prevention of wrinkles or dry skin or sensitive skin, thickening of the epidermis, inhibition of senescence of skin cells, prevention or treatment of photodamage, prevention or treatment of oxidative stress phenomena, prevention or treatment of cellulite, prevention and treatment of disturbances in ceramide and lipid synthesis, prevention of excess sebum production, reduction of activities of matrix metallo proteases or other proteases in the skin, treatment and prevention of inflammatory skin conditions including acne (= anti-acne), atopic eczema, polymorphic light eruption, psoriasis and vertiligo.
In still another aspect, the invention is concerned with a method of treatment or prevention of symptoms caused by negative developments of the physiological homeostasis of healthy skin as well as treatment or prevention of itchy or irritated skin and of promotion of hair growth and of protection from hair loss which method provides topically administering to a person in need of such treatment or prevention an effective amount of a <ne id="WO2007039057.HC.class-names.301" epochem-id="EPOCHEM:NEW:CLASS:319" name="fatty acid" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acid</ne> or a salt, <ne id="WO2007039057.HC.class-names.335" epochem-id="EPOCHEM:NEW:CLASS:185" name="ester" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">ester</ne> or <ne id="WO2007039057.HC.class-names.271" epochem-id="EPOCHEM:NEW:CLASS:138" name="amide" comment="" chebi-id="CHEBI:29337" relevant="false" type="CLASS">amide</ne> with the definitions and preferences as given above, optionally and preferably in combination with a <ne id="WO2007039057.HC.class-names.47" epochem-id="EPOCHEM:NEW:CLASS:24" name="retinoid" comment="" chebi-id="CHEBI:26537" relevant="true" type="CLASS">retinoid</ne> and preferably in the form of a cosmetic or pharmaceutical composition according to the invention.
A preferred embodiment of the present invention is a method of treating or preventing wrinkles or human dry skin or sensitive skin, of promoting hair growth, of protecting from hair loss and of thickening the epidermis, which method comprises the step of topically administering to a person in need of such treatment or prevention an effective amount of a <ne id="WO2007039057.HC.class-names.302" epochem-id="EPOCHEM:NEW:CLASS:319" name="fatty acid" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acid</ne> or a salt, <ne id="WO2007039057.HC.class-names.336" epochem-id="EPOCHEM:NEW:CLASS:185" name="ester" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">ester</ne> or <ne id="WO2007039057.HC.class-names.272" epochem-id="EPOCHEM:NEW:CLASS:138" name="amide" comment="" chebi-id="CHEBI:29337" relevant="false" type="CLASS">amide</ne> with the definitions and preferences as given above, optionally and preferably in combination with a <ne id="WO2007039057.HC.class-names.48" epochem-id="EPOCHEM:NEW:CLASS:24" name="retinoid" comment="" chebi-id="CHEBI:26537" relevant="true" type="CLASS">retinoid</ne>.
A further object of the present invention is a method for the prevention or treatment of pigmentation disorders and/or for providing an even skin tone, which method comprises the step of topically administering to a person in need of such prevention or treatment an effective amount of a composition according to the present invention as defined above, wherein the composition contains a <ne id="WO2007039057.HC.class-names.49" epochem-id="EPOCHEM:NEW:CLASS:24" name="retinoid" comment="" chebi-id="CHEBI:26537" relevant="true" type="CLASS">retinoid</ne>.
Another object of the present invention is a method for fortifying the pigmentation which method comprises the step of topically administering to a person in need of such fortification an effective amount of a composition according to the present invention as defined above and topically administering a tanning active, wherein the tanning active may be administered before, after or simultaneously with the administration of the effective amount of the composition according to the present invention, and wherein any <ne id="WO2007039057.HC.class-names.50" epochem-id="EPOCHEM:NEW:CLASS:24" name="retinoid" comment="" chebi-id="CHEBI:26537" relevant="true" type="CLASS">retinoid</ne> is essentially absent in such a composition.
The term 'an effective amount' refers to an amount necessary to obtain a physiological effect. The physiological effect may be achieved by one application dose or by repeated applications.
The dosage administered may, of course, vary depending upon known factors, such as the physiological characteristics of the particular composition comprising the <ne id="WO2007039057.HC.class-names.303" epochem-id="EPOCHEM:NEW:CLASS:319" name="fatty acid" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acid</ne> or a salt, <ne id="WO2007039057.HC.class-names.337" epochem-id="EPOCHEM:NEW:CLASS:185" name="ester" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">ester</ne> or <ne id="WO2007039057.HC.class-names.273" epochem-id="EPOCHEM:NEW:CLASS:138" name="amide" comment="" chebi-id="CHEBI:29337" relevant="false" type="CLASS">amide</ne> with the definitions and preferences as given above, optionally in combination with a <ne id="WO2007039057.HC.class-names.51" epochem-id="EPOCHEM:NEW:CLASS:24" name="retinoid" comment="" chebi-id="CHEBI:26537" relevant="true" type="CLASS">retinoid</ne> and its mode and route of administration; the age, health and weight of the recipient; the nature and extent of the symptoms; the kind of concurrent treatment; the frequency of treatment; and the effect desired and can be adjusted by a person skilled in the art. In another embodiment, the compositions according to the present invention can be used for the treatment or prevention of symptoms caused by negative developments of the physiological homeostasis of healthy skin as defined above, as well as for the promotion of hair growth and protection from hair loss. The compositions according to the present invention can further be used for the treatment or prevention of itchy or irritated skin or for fortifying the pigmentation (the latter, however, only, if no <ne id="WO2007039057.HC.class-names.52" epochem-id="EPOCHEM:NEW:CLASS:24" name="retinoid" comment="" chebi-id="CHEBI:26537" relevant="true" type="CLASS">retinoid</ne> but a tanning active is present.). If <ne id="WO2007039057.HC.class-names.53" epochem-id="EPOCHEM:NEW:CLASS:24" name="retinoid" comment="" chebi-id="CHEBI:26537" relevant="true" type="CLASS">retinoid</ne> is, however, present in the composition of this invention the composition can be used for the prevention or treatment of pigmentation disorders and/or for providing an even skin tone, since the boosting of <ne id="WO2007039057.HC.class-names.40" epochem-id="EPOCHEM:NEW:CLASS:22" name="Retinoids" comment="" chebi-id="CHEBI:26537" relevant="false" type="CLASS">retinoids</ne> by the <ne id="WO2007039057.HC.class-names.78" epochem-id="EPOCHEM:NEW:CLASS:25" name="fatty acids" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acids</ne> or a salt, <ne id="WO2007039057.HC.class-names.338" epochem-id="EPOCHEM:NEW:CLASS:185" name="ester" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">ester</ne> or <ne id="WO2007039057.HC.class-names.274" epochem-id="EPOCHEM:NEW:CLASS:138" name="amide" comment="" chebi-id="CHEBI:29337" relevant="false" type="CLASS">amide</ne> thereof as defined above may lead to a depigmentation.
Preverably the compositions of the present invention are used for the treatment or prevention of wrinkles or dry skin or sensitive skin, for the promotion of hair growth, for the protection from hair loss, for thickening the epidermis, (if <ne id="WO2007039057.HC.class-names.54" epochem-id="EPOCHEM:NEW:CLASS:24" name="retinoid" comment="" chebi-id="CHEBI:26537" relevant="true" type="CLASS">retinoid</ne> is present) for the prevention or treatment of pigmentation disorders and/or for providing an even skin tone, and/or (if <ne id="WO2007039057.HC.class-names.55" epochem-id="EPOCHEM:NEW:CLASS:24" name="retinoid" comment="" chebi-id="CHEBI:26537" relevant="true" type="CLASS">retinoid</ne> is absent and a tanning active is present) for fortifying the pigmentation.
Thus the composition according to the present invention, i.e. the <ne id="WO2007039057.HC.class-names.79" epochem-id="EPOCHEM:NEW:CLASS:25" name="fatty acids" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acids</ne> or a salt, <ne id="WO2007039057.HC.class-names.339" epochem-id="EPOCHEM:NEW:CLASS:185" name="ester" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">ester</ne> or <ne id="WO2007039057.HC.class-names.275" epochem-id="EPOCHEM:NEW:CLASS:138" name="amide" comment="" chebi-id="CHEBI:29337" relevant="false" type="CLASS">amide</ne> thereof with the definitions and preferences as defined above may fortify the pigmentation by enhancing the effect of a tanning active.
While, typically, the cosmetic or pharmaceutical compositions according to the present invention contain one of the <ne id="WO2007039057.HC.class-names.80" epochem-id="EPOCHEM:NEW:CLASS:25" name="fatty acids" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acids</ne> as defined above, the invention is not limited to that particular aspect and two or more <ne id="WO2007039057.HC.class-names.81" epochem-id="EPOCHEM:NEW:CLASS:25" name="fatty acids" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acids</ne> or a salt, <ne id="WO2007039057.HC.class-names.340" epochem-id="EPOCHEM:NEW:CLASS:185" name="ester" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">ester</ne> or <ne id="WO2007039057.HC.class-names.276" epochem-id="EPOCHEM:NEW:CLASS:138" name="amide" comment="" chebi-id="CHEBI:29337" relevant="false" type="CLASS">amide</ne> thereof as defined above may be present.
As stated above, a <ne id="WO2007039057.HC.class-names.56" epochem-id="EPOCHEM:NEW:CLASS:24" name="retinoid" comment="" chebi-id="CHEBI:26537" relevant="true" type="CLASS">retinoid</ne> may be additionally present, providing an additive or synergistic cosmetic effect, i.e. an improvement or prevention of symptoms caused by negative developments of the physiological homeostasis of healthy skin, as well as promotion of hair growth and protection from hair loss. Again, two or more <ne id="WO2007039057.HC.class-names.41" epochem-id="EPOCHEM:NEW:CLASS:22" name="Retinoids" comment="" chebi-id="CHEBI:26537" relevant="false" type="CLASS">retinoids</ne> may be present. If a <ne id="WO2007039057.HC.class-names.57" epochem-id="EPOCHEM:NEW:CLASS:24" name="retinoid" comment="" chebi-id="CHEBI:26537" relevant="true" type="CLASS">retinoid</ne> is present in the compositions of the present invention, the ratio of the <ne id="WO2007039057.HC.class-names.304" epochem-id="EPOCHEM:NEW:CLASS:319" name="fatty acid" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acid</ne> or a salt, <ne id="WO2007039057.HC.class-names.341" epochem-id="EPOCHEM:NEW:CLASS:185" name="ester" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">ester</ne> or <ne id="WO2007039057.HC.class-names.277" epochem-id="EPOCHEM:NEW:CLASS:138" name="amide" comment="" chebi-id="CHEBI:29337" relevant="false" type="CLASS">amide</ne> with the definitions and preferences as given above) to the <ne id="WO2007039057.HC.class-names.58" epochem-id="EPOCHEM:NEW:CLASS:24" name="retinoid" comment="" chebi-id="CHEBI:26537" relevant="true" type="CLASS">retinoid</ne> is suitably from about 1000:1 to 1 :1000, more preferably from about 100:1 to 1 :100 and in particular from about 30:1 to 1 :30 by weight. The <ne id="WO2007039057.HC.class-names.82" epochem-id="EPOCHEM:NEW:CLASS:25" name="fatty acids" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acids</ne> or a salt, <ne id="WO2007039057.HC.class-names.342" epochem-id="EPOCHEM:NEW:CLASS:185" name="ester" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">ester</ne> or <ne id="WO2007039057.HC.class-names.278" epochem-id="EPOCHEM:NEW:CLASS:138" name="amide" comment="" chebi-id="CHEBI:29337" relevant="false" type="CLASS">amide</ne> thereof as defined above show also an additive or synergistic effect with <ne id="WO2007039057.HC.class-names.42" epochem-id="EPOCHEM:NEW:CLASS:22" name="Retinoids" comment="" chebi-id="CHEBI:26537" relevant="false" type="CLASS">retinoids</ne> which are already present in the human skin.
In the compositions provided by the present invention, the amount of the <ne id="WO2007039057.HC.class-names.305" epochem-id="EPOCHEM:NEW:CLASS:319" name="fatty acid" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acid</ne> or a salt, <ne id="WO2007039057.HC.class-names.343" epochem-id="EPOCHEM:NEW:CLASS:185" name="ester" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">ester</ne> or <ne id="WO2007039057.HC.class-names.279" epochem-id="EPOCHEM:NEW:CLASS:138" name="amide" comment="" chebi-id="CHEBI:29337" relevant="false" type="CLASS">amide</ne> with the definitions and preferences as given above is suitably from about 0.0001 to about 50 %, preferably from about 0.001 to about 20 % by weight of the total composition. More preferably, the <ne id="WO2007039057.HC.class-names.306" epochem-id="EPOCHEM:NEW:CLASS:319" name="fatty acid" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acid</ne> as defined above are contained in the composition in an amount of about 0.01 % by weight to about 1 % by weight, most preferably in an amount of about 0.5 % by weight. If a <ne id="WO2007039057.HC.class-names.59" epochem-id="EPOCHEM:NEW:CLASS:24" name="retinoid" comment="" chebi-id="CHEBI:26537" relevant="true" type="CLASS">retinoid</ne> or derivative thereof is present, the amount of the latter is suitably from about 0.0001 to about 50 % by weight, preferably from about 0.001 to about 20 % by weight, most preferably in an amount of about 0.01 to about 1 weight%, in particular in an amount of about 0.1 % by weight, based on the total amount of the composition. Preferred according to the invention is a composition comprising the <ne id="WO2007039057.HC.class-names.307" epochem-id="EPOCHEM:NEW:CLASS:319" name="fatty acid" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acid</ne> or a salt, <ne id="WO2007039057.HC.class-names.344" epochem-id="EPOCHEM:NEW:CLASS:185" name="ester" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">ester</ne> or <ne id="WO2007039057.HC.class-names.280" epochem-id="EPOCHEM:NEW:CLASS:138" name="amide" comment="" chebi-id="CHEBI:29337" relevant="false" type="CLASS">amide</ne> with the definitions and preferences as given above in an amount of about 0.5 % by weight and a <ne id="WO2007039057.HC.class-names.60" epochem-id="EPOCHEM:NEW:CLASS:24" name="retinoid" comment="" chebi-id="CHEBI:26537" relevant="true" type="CLASS">retinoid</ne> or derivative thereof in an amount of about 0.1 % by weight, based on the total amount of the composition.
The term "cosmetic composition" as used herein e.g. refers to topical compositions for care of the human skin, see also the heading "Kosmetika" in Rompp Lexikon Chemie, 10th edition 1997, Georg Thieme Verlag Stuttgart, New York.
Regarding the kind of the topical (cosmetic or pharmaceutical) compositions and the preparation of the topical compositions as well as for further suitable additives, it can be referred to the pertinent literature, e.g. to Novak G.A., Die kosmetischen Praparate - Band 2, Die kosmetischen Praparate - Rezeptur, Rohstoffe, wissenschaftliche Grundlagen (Verlag fur Chem. Industrie H. Ziolkowski KG, Augsburg).
The amount of the cosmetic or pharmaceutical composition according to the invention, which is to be applied to the skin depends on the concentration of the active ingredients in the compositions and the desired cosmetic or pharmaceutical effect. For example, application can be such that a creme is applied to the skin. A creme is usually applied in an amount of 2 mg creme/cm&lt;2&gt; skin. The amount of the composition which is applied to the skin is, however, not critical, and if with a certain amount of applied composition the desired effect cannot be achieved, a higher concentration of the active ingredients can be used e.g. by applying more of the composition or by applying compositions which contain more active ingredient.
The cosmetic or pharmaceutical composition according to the invention is preferably applied at least once per day, e.g. twice or three times a day. Usually it takes at least two weeks until the desired effect is achieved. However, it can take several weeks or even months until the desired effect is fully maximized.
The compositions of the present invention contain the <ne id="WO2007039057.HC.class-names.83" epochem-id="EPOCHEM:NEW:CLASS:25" name="fatty acids" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acids</ne> or a salt, <ne id="WO2007039057.HC.class-names.345" epochem-id="EPOCHEM:NEW:CLASS:185" name="ester" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">ester</ne> or <ne id="WO2007039057.HC.class-names.281" epochem-id="EPOCHEM:NEW:CLASS:138" name="amide" comment="" chebi-id="CHEBI:29337" relevant="false" type="CLASS">amide</ne> thereof with the definitions and preferences as defined above with cosmetically or pharmaceutically acceptable excipients or diluents. If nothing else is stated, the excipients, additives, diluents, etc. mentioned in the following are suitable for cosmetic compositions.
If nothing else is stated, in this application parts and percentages are per weight and are based on the total weight of the composition.
Preferably, the cosmetic or pharmaceutical compositions of the present invention are topical compositions in the form of a suspension or dispersion in solvents or fatty substances, or alternatively in the form of an emulsion or micro emulsion (in particular of O/W or VWO type, 0/W/O or W/O/W-type), PET-emulsions, multiple emulsions, bickering emulsions, hydrogels, alcoholic gels, lipogels, one or multiphase solutions or a vesicular dispersion and other usual compositions, which can also be applied by pens, as masks or as sprays. The emulsions can also contain anionic, nonionic, cationic or amphoteric <ne type="ONT" id="WO2007039057.HC.class-names.431" epochem-id="EPOCHEM:NEW:CLASS:800" name="surfactant" comment="" chebi-id="CHEBI:35195" relevant="false">surfactant</ne>(s).
Preferred compositions according to the invention are skin care preparations, hair-care preparations, decorative preparations, light protection preparations and functional preparations.
Examples of skin care preparations are, in particular, body oils, body lotions, body gels, treatment creams, skin protection ointments, shaving preparations, such as shaving foams or gels, skin powders such as baby powder, moisturizing gels, moisturizing sprays, revitalizing body sprays, cellulite gels, anti acne preparations and peeling preparations.
Examples of hair care preparations are, for example, hair-washing preparations in the form of shampoos, hair conditioners, hair-care preparations, e. g. treatment preparations, pre-treatment preparations, hair tonics, styling creams, styling gels, pomades, hair rinses, treatment packs, intensive hair treatments, hair-straightening preparations, liquid hair- setting preparations, hair foams and hairsprays and lacquers, perming agents, hair gels, hair fixatives and hair dying or bleaching agents.
Examples of decorative preparations are in particular lipstick, eye shadow, mascaras, dry and moist make-up, rouge, powders, and suntan lotions.
Examples of functional preparations are cosmetic or pharmaceutical compositions containing active ingredients such as hormone preparations, vitamin preparations, vegetable extract preparations, anti-ageing preparations, and antimicrobial (antibacterial or antifungal) preparations without being limited thereto.
Cosmetic compositions in accordance with the invention can be in the form of a liquid, a lotion, a thickened lotion, a gel, a cream, a milk, an ointment, a paste, a powder, a makeup, or a solid tube stick and can be optionally be packaged as an aerosol and can be provided in the form of a mousse such as a aerosol mousse, a foam or a spray foams, sprays, sticks, a gel, a plaster, a powder, a cleanser, a soap or aerosols or wipes.
The compositions of the invention can also contain usual cosmetic or pharmaceutical adjuvants and additives, such as preservatives/ <ne type="ONT" id="WO2007039057.HC.class-names.91" epochem-id="EPOCHEM:NEW:CLASS:26" name="antioxidants" comment="" chebi-id="CHEBI:22586" relevant="false">antioxidants</ne>, fatty substances/ oils, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.790" epochem-id="EPOCHEM:NEW:COMPOUND:9" name="Water" comment="" chebi-id="CHEBI:15377" relevant="false">water</ne>, <ne type="ONT" id="WO2007039057.HC.class-names.436" epochem-id="EPOCHEM:NEW:CLASS:1133" name="organic solvents" comment="" chebi-id="WO2007039057:236512" relevant="false">organic solvents</ne>, <ne id="WO2007039057.HC.class-names.433" epochem-id="EPOCHEM:NEW:CLASS:492" name="silicones" comment="" chebi-id="CHEBI:48140" relevant="false" type="CLASS">silicones</ne>, thickeners, softeners, emulsifiers, sunscreens, antifoaming agents, moisturizers, fragrances, surfactants, fillers, sequestering agents, anionic, cationic, nonionic or amphoteric polymers or mixtures thereof, propellents, acidifying or basifying agents, <ne type="ONT" id="WO2007039057.HC.class-names.432" epochem-id="EPOCHEM:NEW:CLASS:970" name="dyes" comment="" chebi-id="WO2007039057:200125" relevant="false">dyes</ne>, colorants, <ne type="ONT" id="WO2007039057.HC.class-names.423" epochem-id="EPOCHEM:NEW:CLASS:913" name="pigments" comment="" chebi-id="CHEBI:26130" relevant="false">pigments</ne> or nanopigments, e.g. those suited for providing a photoprotective effect by physically blocking out ultraviolet radiation, or any other ingredients usually formulated into cosmetics or medicaments.
An additional amount of <ne type="ONT" id="WO2007039057.HC.class-names.92" epochem-id="EPOCHEM:NEW:CLASS:26" name="antioxidants" comment="" chebi-id="CHEBI:22586" relevant="false">antioxidants</ne>/ preservatives is generally preferred. Based on the invention all known <ne type="ONT" id="WO2007039057.HC.class-names.93" epochem-id="EPOCHEM:NEW:CLASS:26" name="antioxidants" comment="" chebi-id="CHEBI:22586" relevant="false">antioxidants</ne> usually formulated into cosmetics or medicaments can be used.
Especially preferred are <ne type="ONT" id="WO2007039057.HC.class-names.94" epochem-id="EPOCHEM:NEW:CLASS:26" name="antioxidants" comment="" chebi-id="CHEBI:22586" relevant="false">antioxidants</ne> chosen from the group consisting of <ne id="WO2007039057.HC.class-names.260" epochem-id="EPOCHEM:NEW:CLASS:3" name="amino acids" comment="" chebi-id="CHEBI:33709" relevant="false" type="CLASS">amino acids</ne> (e.g. <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.47" epochem-id="EPOCHEM:COMPOUND:1017" name="glycine" comment="" chebi-id="CHEBI:15428" relevant="false">glycine</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.48" epochem-id="EPOCHEM:COMPOUND:1026" name="histidine" comment="" chebi-id="CHEBI:27570" relevant="false">histidine</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.49" epochem-id="EPOCHEM:COMPOUND:1047" name="tyrosine" comment="" chebi-id="CHEBI:18186" relevant="false">tyrosine</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.50" epochem-id="EPOCHEM:NEW:COMPOUND:33" name="tryptophane" comment="" chebi-id="WO2007039057:63024" relevant="false">tryptophane</ne>) and their derivatives, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.51" epochem-id="EPOCHEM:COMPOUND:5827" name="imidazole" comment="" chebi-id="CHEBI:16069" relevant="false">imidazole</ne> (e.g. <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.53" epochem-id="EPOCHEM:COMPOUND:915" name="urocanic acid" comment="" chebi-id="CHEBI:27248" relevant="false">urocanic acid</ne>) and derivatives, <ne id="WO2007039057.HC.class-names.102" epochem-id="EPOCHEM:NEW:CLASS:31" name="peptides" comment="" chebi-id="CHEBI:16670" relevant="false" type="CLASS">peptides</ne> such as <ne type="CHEMICAL" id="WO2007039057.HC.substance-names.31" epochem-id="EPOCHEM:NEW:SUBSTANCE:121" name="D,L-carnosine" comment="" chebi-id="WO2007039057:329903" relevant="false">D,L-carnosine</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.56" epochem-id="EPOCHEM:NEW:COMPOUND:35" name="D- carnosine" comment="" chebi-id="WO2007039057:338738" relevant="false">D- carnosine</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.55" epochem-id="EPOCHEM:NEW:COMPOUND:34" name="L-carnosine" comment="" chebi-id="WO2007039057:169021" relevant="false">L-carnosine</ne> and derivatives (e.g. <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.57" epochem-id="EPOCHEM:COMPOUND:3714" name="anserine" comment="" chebi-id="CHEBI:18323" relevant="false">anserine</ne>), <ne id="WO2007039057.HC.class-names.98" epochem-id="EPOCHEM:NEW:CLASS:27" name="carotenoids" comment="" chebi-id="CHEBI:23044" relevant="false" type="CLASS">carotenoids</ne>, <ne id="WO2007039057.HC.class-names.99" epochem-id="EPOCHEM:NEW:CLASS:28" name="carotenes" comment="" chebi-id="CHEBI:23042" relevant="false" type="CLASS">carotenes</ne> (e.g. <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.58" epochem-id="EPOCHEM:NEW:COMPOUND:36" name="[alpha]- carotene" comment="" chebi-id="WO2007039057:751025" relevant="false">[alpha]- carotene</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.59" epochem-id="EPOCHEM:NEW:COMPOUND:37" name="[beta]-carotene" comment="" chebi-id="WO2007039057:203216" relevant="false">[beta]-carotene</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.60" epochem-id="EPOCHEM:COMPOUND:3577" name="lycopene" comment="" chebi-id="CHEBI:15948" relevant="false">lycopene</ne>) and derivatives, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.61" epochem-id="EPOCHEM:COMPOUND:3793" name="chlorogenic acid" comment="" chebi-id="CHEBI:16112" relevant="false">chlorogenic acid</ne> and derivatives, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.62" epochem-id="EPOCHEM:COMPOUND:683" name="lipoic acid" comment="" chebi-id="CHEBI:16494" relevant="false">lipoic acid</ne> and derivatives (e.g. <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.64" epochem-id="EPOCHEM:COMPOUND:685" name="dihydrolipoic acid" comment="" chebi-id="CHEBI:18047" relevant="false">dihydrolipoic acid</ne>), <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.65" epochem-id="EPOCHEM:NEW:COMPOUND:38" name="aurothioglucose" comment="" chebi-id="WO2007039057:117868" relevant="false">aurothioglucose</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.78" epochem-id="EPOCHEM:NEW:COMPOUND:43" name="propylthiouracil" comment="" chebi-id="CHEBI:8502" relevant="false">propylthiouracil</ne> and other <ne id="WO2007039057.HC.class-names.437" epochem-id="EPOCHEM:NEW:CLASS:526" name="thiols" comment="" chebi-id="CHEBI:29256" relevant="false" type="CLASS">thiols</ne> (e.g. <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.66" epochem-id="EPOCHEM:NEW:COMPOUND:39" name="thioredoxine" comment="" chebi-id="WO2007039057:181476" relevant="false">thioredoxine</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.67" epochem-id="EPOCHEM:COMPOUND:3727" name="glutathione" comment="" chebi-id="CHEBI:16856" relevant="false">glutathione</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.68" epochem-id="EPOCHEM:COMPOUND:984" name="cysteine" comment="" chebi-id="CHEBI:15356" relevant="false">cysteine</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.69" epochem-id="EPOCHEM:COMPOUND:3835" name="cystine" comment="" chebi-id="CHEBI:17376" relevant="false">cystine</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.70" epochem-id="EPOCHEM:NEW:COMPOUND:40" name="cystamine" comment="" chebi-id="WO2007039057:153559" relevant="false">cystamine</ne> and its <ne type="LIGAND" id="WO2007039057.HC.ligand-names.106" epochem-id="EPOCHEM:NEW:LIGAND:25" name="glycosyl" comment="" chebi-id="WO2007039057:768990" relevant="false">glycosyl</ne>-, <ne type="LIGAND" id="WO2007039057.HC.ligand-names.107" epochem-id="EPOCHEM:NEW:LIGAND:26" name="N- acetyl" comment="" chebi-id="WO2007039057:754700" relevant="false">N- acetyl</ne>-, <ne type="LIGAND" id="WO2007039057.HC.ligand-names.89" epochem-id="EPOCHEM:NEW:LIGAND:13" name="methyl" comment="" chebi-id="CHEBI:29309" relevant="false">methyl</ne>-, <ne type="LIGAND" id="WO2007039057.HC.ligand-names.318" epochem-id="EPOCHEM:NEW:LIGAND:125" name="ethyl" comment="" chebi-id="CHEBI:37807" relevant="false">ethyl</ne>-, <ne type="LIGAND" id="WO2007039057.HC.ligand-names.110" epochem-id="EPOCHEM:NEW:LIGAND:27" name="propyl" comment="" chebi-id="CHEBI:26308" relevant="false">propyl</ne>-, <ne type="LIGAND" id="WO2007039057.HC.ligand-names.111" epochem-id="EPOCHEM:NEW:LIGAND:28" name="amyl" comment="" chebi-id="WO2007039057:46996" relevant="false">amyl</ne>-, <ne type="LIGAND" id="WO2007039057.HC.ligand-names.322" epochem-id="EPOCHEM:NEW:LIGAND:131" name="butyl" comment="" chebi-id="CHEBI:41264" relevant="false">butyl</ne>- and <ne type="LIGAND" id="WO2007039057.HC.ligand-names.121" epochem-id="EPOCHEM:NEW:LIGAND:30" name="lauryl" comment="" chebi-id="CHEBI:23870" relevant="false">lauryl</ne>-, <ne type="LIGAND" id="WO2007039057.HC.ligand-names.122" epochem-id="EPOCHEM:NEW:LIGAND:31" name="palmitoyl" comment="" chebi-id="CHEBI:45021" relevant="false">palmitoyl</ne>-; <ne type="LIGAND" id="WO2007039057.HC.ligand-names.124" epochem-id="EPOCHEM:NEW:LIGAND:32" name="oleyl" comment="" chebi-id="WO2007039057:468128" relevant="false">oleyl</ne>-, y-<ne type="LIGAND" id="WO2007039057.HC.ligand-names.125" epochem-id="EPOCHEM:NEW:LIGAND:33" name="linoleyl" comment="" chebi-id="WO2007039057:467284" relevant="false">linoleyl</ne>-, <ne type="LIGAND" id="WO2007039057.HC.ligand-names.126" epochem-id="EPOCHEM:NEW:LIGAND:34" name="cholesteryl" comment="" chebi-id="WO2007039057:983831" relevant="false">cholesteryl</ne>- and <ne id="WO2007039057.HC.class-names.362" epochem-id="EPOCHEM:NEW:CLASS:320" name="glycerylester" comment="" chebi-id="WO2007039057:810191" relevant="false" type="CLASS">glycerylester</ne>) and the salts thereof, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.79" epochem-id="EPOCHEM:NEW:COMPOUND:44" name="dilaurylthiodipropionate" comment="" chebi-id="WO2007039057:827984" relevant="false">dilaurylthiodipropionate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.80" epochem-id="EPOCHEM:NEW:COMPOUND:45" name="distearylthiodipropionate" comment="" chebi-id="WO2007039057:249586" relevant="false">distearylthiodipropionate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.81" epochem-id="EPOCHEM:NEW:COMPOUND:46" name="thiodipropionic acid" comment="" chebi-id="WO2007039057:544855" relevant="false">thiodipropionic acid</ne> and its derivatives (<ne id="WO2007039057.HC.class-names.346" epochem-id="EPOCHEM:NEW:CLASS:185" name="ester" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">ester</ne>, <ne id="WO2007039057.HC.class-names.363" epochem-id="EPOCHEM:NEW:CLASS:321" name="ether" comment="" chebi-id="CHEBI:25698" relevant="false" type="CLASS">ether</ne>, <ne id="WO2007039057.HC.class-names.103" epochem-id="EPOCHEM:NEW:CLASS:31" name="peptides" comment="" chebi-id="CHEBI:16670" relevant="false" type="CLASS">peptides</ne>, <ne id="WO2007039057.HC.class-names.364" epochem-id="EPOCHEM:NEW:CLASS:322" name="lipids" comment="" chebi-id="CHEBI:18059" relevant="false" type="CLASS">lipids</ne>, <ne id="WO2007039057.HC.class-names.366" epochem-id="EPOCHEM:NEW:CLASS:323" name="nucleotides" comment="" chebi-id="CHEBI:36976" relevant="false" type="CLASS">nucleotides</ne>, <ne id="WO2007039057.HC.class-names.368" epochem-id="EPOCHEM:NEW:CLASS:324" name="nucleosides" comment="" chebi-id="CHEBI:33838" relevant="false" type="CLASS">nucleosides</ne> and salts) as well as <ne id="WO2007039057.HC.class-names.107" epochem-id="EPOCHEM:NEW:CLASS:32" name="sulfoximine" comment="" chebi-id="WO2007039057:858091" relevant="false" type="CLASS">sulfoximine</ne> compounds (such as <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.82" epochem-id="EPOCHEM:NEW:COMPOUND:47" name="buthioninsulfoximine" comment="" chebi-id="WO2007039057:503777" relevant="false">buthioninsulfoximine</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.83" epochem-id="EPOCHEM:NEW:COMPOUND:48" name="homocysteinsulfoximine" comment="" chebi-id="WO2007039057:793697" relevant="false">homocysteinsulfoximine</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.84" epochem-id="EPOCHEM:NEW:COMPOUND:49" name="buthioninsulfone" comment="" chebi-id="WO2007039057:367722" relevant="false">buthioninsulfone</ne>, <ne type="LIGAND" id="WO2007039057.HC.ligand-names.127" epochem-id="EPOCHEM:NEW:LIGAND:35" name="penta" comment="" chebi-id="WO2007039057:896515" relevant="false">penta</ne>-, <ne type="LIGAND" id="WO2007039057.HC.ligand-names.128" epochem-id="EPOCHEM:NEW:LIGAND:36" name="hexa" comment="" chebi-id="WO2007039057:443728" relevant="false">hexa</ne>-, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.86" epochem-id="EPOCHEM:NEW:COMPOUND:50" name="heptathioninsulfoximine" comment="" chebi-id="WO2007039057:3045" relevant="false">heptathioninsulfoximine</ne>) in very low compatible doses (e.g. pmol to [mu]mol/kg), additionally <ne id="WO2007039057.HC.class-names.370" epochem-id="EPOCHEM:NEW:CLASS:325" name="(metal)-chelators" comment="" chebi-id="WO2007039057:20656" relevant="false" type="CLASS">(metal)-chelators</ne> (such as <ne id="WO2007039057.HC.class-names.101" epochem-id="EPOCHEM:NEW:CLASS:30" name="[alpha]-hydroxyfatty acids" comment="" chebi-id="WO2007039057:357456" relevant="false" type="CLASS">[alpha]-hydroxyfatty acids</ne>, <ne type="LIGAND" id="WO2007039057.HC.ligand-names.129" epochem-id="EPOCHEM:NEW:LIGAND:37" name="palmic" comment="" chebi-id="WO2007039057:583048" relevant="false">palmic</ne>-, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.77" epochem-id="EPOCHEM:NEW:COMPOUND:42" name="phytinic acid" comment="" chebi-id="WO2007039057:617054" relevant="false">phytinic acid</ne>, lactoferrin), <ne id="WO2007039057.HC.class-names.100" epochem-id="EPOCHEM:NEW:CLASS:29" name="[beta]-hydroxyacids" comment="" chebi-id="WO2007039057:323627" relevant="false" type="CLASS">[beta]-hydroxyacids</ne> (such as <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.74" epochem-id="EPOCHEM:COMPOUND:963" name="citric acid" comment="" chebi-id="CHEBI:30769" relevant="false">citric acid</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.75" epochem-id="EPOCHEM:COMPOUND:496" name="lactic acid" comment="" chebi-id="CHEBI:28358" relevant="false">lactic acid</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.73" epochem-id="EPOCHEM:COMPOUND:391" name="malic acid" comment="" chebi-id="CHEBI:6650" relevant="false">malic acid</ne>), <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.71" epochem-id="EPOCHEM:NEW:COMPOUND:41" name="huminic acid" comment="" chebi-id="WO2007039057:49865" relevant="false">huminic acid</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.72" epochem-id="EPOCHEM:COMPOUND:762" name="gallic acid" comment="" chebi-id="CHEBI:30778" relevant="false">gallic acid</ne>, gallic extracts, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.141" epochem-id="EPOCHEM:COMPOUND:6489" name="bilirubin" comment="" chebi-id="CHEBI:16990" relevant="false">bilirubin</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.142" epochem-id="EPOCHEM:COMPOUND:6474" name="biliverdin" comment="" chebi-id="CHEBI:17033" relevant="false">biliverdin</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.770" epochem-id="EPOCHEM:NEW:COMPOUND:2" name="EDTA" comment="" chebi-id="WO2007039057:295625" relevant="false">EDTA</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.154" epochem-id="EPOCHEM:NEW:COMPOUND:76" name="EGTA" comment="" chebi-id="WO2007039057:947466" relevant="false">EGTA</ne> and its derivatives, unsaturated <ne id="WO2007039057.HC.class-names.84" epochem-id="EPOCHEM:NEW:CLASS:25" name="fatty acids" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acids</ne> and their derivatives (such as <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.87" epochem-id="EPOCHEM:NEW:COMPOUND:51" name="[gamma]-linoleic acid" comment="in real : [gamma]-linoleNIC acid" chebi-id="WO2007039057:627394" relevant="false">[gamma]-linoleic acid</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.88" epochem-id="EPOCHEM:NEW:COMPOUND:52" name="linolic acid" comment="" chebi-id="WO2007039057:519053" relevant="false">linolic acid</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.89" epochem-id="EPOCHEM:COMPOUND:700" name="oleic acid" comment="" chebi-id="CHEBI:16196" relevant="false">oleic acid</ne>), <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.90" epochem-id="EPOCHEM:COMPOUND:5186" name="folic acid" comment="" chebi-id="CHEBI:27470" relevant="false">folic acid</ne> and its derivatives, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.92" epochem-id="EPOCHEM:NEW:COMPOUND:53" name="ubiquinone" comment="" chebi-id="CHEBI:16389" relevant="false">ubiquinone</ne> and <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.93" epochem-id="EPOCHEM:NEW:COMPOUND:54" name="ubiquinol" comment="" chebi-id="CHEBI:17976" relevant="false">ubiquinol</ne> and their derivatives, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.94" epochem-id="EPOCHEM:NEW:COMPOUND:55" name="vitamin C" comment="" chebi-id="WO2007039057:680303" relevant="false">vitamin C</ne> and derivatives (such as <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.96" epochem-id="EPOCHEM:NEW:COMPOUND:56" name="ascorbylpalmitate" comment="" chebi-id="WO2007039057:666640" relevant="false">ascorbylpalmitate</ne> and <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.97" epochem-id="EPOCHEM:NEW:COMPOUND:57" name="ascorbyltetraisopalmitate" comment="" chebi-id="WO2007039057:3717" relevant="false">ascorbyltetraisopalmitate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.98" epochem-id="EPOCHEM:NEW:COMPOUND:58" name="Mg- ascorbylphosphate" comment="" chebi-id="WO2007039057:712927" relevant="false">Mg- ascorbylphosphate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.99" epochem-id="EPOCHEM:NEW:COMPOUND:59" name="Na-ascorbylphosphate" comment="" chebi-id="WO2007039057:972035" relevant="false">Na-ascorbylphosphate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.100" epochem-id="EPOCHEM:NEW:COMPOUND:60" name="Na-ascorbylacetate" comment="" chebi-id="WO2007039057:92921" relevant="false">Na-ascorbylacetate</ne>), <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.102" epochem-id="EPOCHEM:NEW:COMPOUND:10" name="tocopherol" comment="" chebi-id="CHEBI:27013" relevant="false">tocopherol</ne> and derivatives (such as <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.101" epochem-id="EPOCHEM:NEW:COMPOUND:61" name="vitamin-E-acetate" comment="" chebi-id="WO2007039057:465594" relevant="false">vitamin-E-acetate</ne>), mixtures of natural or synthetic <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.106" epochem-id="EPOCHEM:NEW:COMPOUND:4" name="vitamin E" comment="" chebi-id="CHEBI:33234" relevant="false">vitamin E</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.110" epochem-id="EPOCHEM:NEW:COMPOUND:62" name="vitamin A" comment="" chebi-id="CHEBI:17336" relevant="false">vitamin A</ne> and derivatives (<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.781" epochem-id="EPOCHEM:NEW:COMPOUND:1342" name="vitamin-A-palmitate" comment="" chebi-id="WO2007039057:125287" relevant="false">vitamin-A-palmitate</ne> and -<ne type="LIGAND" id="WO2007039057.HC.ligand-names.323" epochem-id="EPOCHEM:NEW:LIGAND:327" name="acetate" comment="" chebi-id="CHEBI:30089" relevant="false">acetate</ne>) as well as <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.113" epochem-id="EPOCHEM:NEW:COMPOUND:64" name="coniferylbenzoat" comment="" chebi-id="WO2007039057:430712" relevant="false">coniferylbenzoat</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.114" epochem-id="EPOCHEM:NEW:COMPOUND:65" name="rutinic acid" comment="" chebi-id="WO2007039057:438662" relevant="false">rutinic acid</ne> and derivatives, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.115" epochem-id="EPOCHEM:NEW:COMPOUND:66" name="[alpha]-glycosylrutin" comment="" chebi-id="WO2007039057:393734" relevant="false">[alpha]-glycosylrutin</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.116" epochem-id="EPOCHEM:COMPOUND:4984" name="ferulic acid" comment="" chebi-id="CHEBI:17620" relevant="false">ferulic acid</ne>,
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.117" epochem-id="EPOCHEM:NEW:COMPOUND:67" name="furfurylidenglucitol" comment="" chebi-id="WO2007039057:312148" relevant="false">furfurylidenglucitol</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.121" epochem-id="EPOCHEM:COMPOUND:3945" name="carnosine" comment="" chebi-id="CHEBI:15727" relevant="false">carnosine</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.123" epochem-id="EPOCHEM:NEW:COMPOUND:68" name="butylhydroxytoluene" comment="" chebi-id="CHEBI:34247" relevant="false">butylhydroxytoluene</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.124" epochem-id="EPOCHEM:NEW:COMPOUND:69" name="butylhydroxyanisole" comment="" chebi-id="WO2007039057:14290" relevant="false">butylhydroxyanisole</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.125" epochem-id="EPOCHEM:NEW:COMPOUND:70" name="trihydroxybutyrophenone" comment="" chebi-id="WO2007039057:271383" relevant="false">trihydroxybutyrophenone</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.126" epochem-id="EPOCHEM:COMPOUND:5985" name="urea" comment="" chebi-id="CHEBI:16199" relevant="false">urea</ne> and its derivatives, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.129" epochem-id="EPOCHEM:NEW:COMPOUND:71" name="mannose" comment="" chebi-id="CHEBI:37684" relevant="false">mannose</ne> and derivatives, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.881" epochem-id="EPOCHEM:COMPOUND:7669" name="zinc" comment="" chebi-id="CHEBI:27363" relevant="false">zinc</ne> and derivatives (e.g. <ne type="FORMULA" id="WO2007039057.HC.formula-names.2" epochem-id="EPOCHEM:NEW:FORMULA:1" name="ZnO" comment="" chebi-id="CHEBI:36560" relevant="false">ZnO</ne>, <ne type="FORMULA" id="WO2007039057.HC.formula-names.3" epochem-id="EPOCHEM:NEW:FORMULA:4" name="ZnSO4" comment="" chebi-id="CHEBI:35176" relevant="false">ZnSO4</ne>), <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.136" epochem-id="EPOCHEM:NEW:COMPOUND:72" name="selenium" comment="" chebi-id="CHEBI:27568" relevant="false">selenium</ne> and derivatives (e.g. <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.137" epochem-id="EPOCHEM:NEW:COMPOUND:73" name="selenomethionin" comment="" chebi-id="WO2007039057:155321" relevant="false">selenomethionin</ne>), <ne id="WO2007039057.HC.class-names.109" epochem-id="EPOCHEM:NEW:CLASS:34" name="stilbenes" comment="" chebi-id="WO2007039057:846876" relevant="false" type="CLASS">stilbenes</ne> and derivatives (such as <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.138" epochem-id="EPOCHEM:NEW:COMPOUND:74" name="stilbenoxide" comment="" chebi-id="WO2007039057:502736" relevant="false">stilbenoxide</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.140" epochem-id="EPOCHEM:NEW:COMPOUND:75" name="trans-stilbenoxide" comment="" chebi-id="WO2007039057:346371" relevant="false">trans-stilbenoxide</ne>) and suitable derivatives (salts, <ne id="WO2007039057.HC.class-names.389" epochem-id="EPOCHEM:NEW:CLASS:338" name="esters" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">esters</ne>, <ne id="WO2007039057.HC.class-names.356" epochem-id="EPOCHEM:NEW:CLASS:183" name="ethers" comment="" chebi-id="CHEBI:25698" relevant="false" type="CLASS">ethers</ne>, sugars, <ne id="WO2007039057.HC.class-names.367" epochem-id="EPOCHEM:NEW:CLASS:323" name="nucleotides" comment="" chebi-id="CHEBI:36976" relevant="false" type="CLASS">nucleotides</ne>, <ne id="WO2007039057.HC.class-names.369" epochem-id="EPOCHEM:NEW:CLASS:324" name="nucleosides" comment="" chebi-id="CHEBI:33838" relevant="false" type="CLASS">nucleosides</ne>, <ne id="WO2007039057.HC.class-names.104" epochem-id="EPOCHEM:NEW:CLASS:31" name="peptides" comment="" chebi-id="CHEBI:16670" relevant="false" type="CLASS">peptides</ne> and <ne id="WO2007039057.HC.class-names.365" epochem-id="EPOCHEM:NEW:CLASS:322" name="lipids" comment="" chebi-id="CHEBI:18059" relevant="false" type="CLASS">lipids</ne>) of the named active ingredients. One or more pre- servatives/<ne type="ONT" id="WO2007039057.HC.class-names.95" epochem-id="EPOCHEM:NEW:CLASS:26" name="antioxidants" comment="" chebi-id="CHEBI:22586" relevant="false">antioxidants</ne> may be present in an amount about 0.01 weight% to about 10 weight% of the total weight of the composition of the present invention. Preferably, one or more preservatives/<ne type="ONT" id="WO2007039057.HC.class-names.96" epochem-id="EPOCHEM:NEW:CLASS:26" name="antioxidants" comment="" chebi-id="CHEBI:22586" relevant="false">antioxidants</ne> are present in an amount about 0.1 weight% to about 1 weight%.
Typically topical formulations also contain surface active ingredients like emulsifiers, solubilizers and the like.
An emulsifier enables two or more immiscible components to be combined homogeneously. Moreover, the emulsifier acts to stabilize the composition. Emulsifiers that may be used in the present invention in order to form O/W, W/O, 0/W/O or W/O/W emulsions/ microemulsions include <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.155" epochem-id="EPOCHEM:NEW:COMPOUND:77" name="sorbitan oleate" comment="" chebi-id="WO2007039057:682073" relevant="false">sorbitan oleate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.156" epochem-id="EPOCHEM:NEW:COMPOUND:78" name="sorbitan sesquioleate" comment="" chebi-id="WO2007039057:282529" relevant="false">sorbitan sesquioleate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.157" epochem-id="EPOCHEM:NEW:COMPOUND:79" name="sorbitan isostearate" comment="" chebi-id="WO2007039057:54748" relevant="false">sorbitan isostearate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.161" epochem-id="EPOCHEM:NEW:COMPOUND:80" name="sorbitan trioleate" comment="" chebi-id="WO2007039057:131781" relevant="false">sorbitan trioleate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.162" epochem-id="EPOCHEM:NEW:COMPOUND:81" name="polyglyceryl-3-diisostearate" comment="" chebi-id="WO2007039057:383669" relevant="false">polyglyceryl-3-diisostearate</ne>, <ne id="WO2007039057.HC.class-names.110" epochem-id="EPOCHEM:NEW:CLASS:35" name="polyglycerol esters" comment="" chebi-id="WO2007039057:27075" relevant="false" type="CLASS">polyglycerol esters</ne> of <ne type="LIGAND" id="WO2007039057.HC.ligand-names.157" epochem-id="EPOCHEM:NEW:LIGAND:40" name="oleic" comment="" chebi-id="CHEBI:25667" relevant="false">oleic</ne>/<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.163" epochem-id="EPOCHEM:NEW:COMPOUND:82" name="isostearicacid" comment="" chebi-id="WO2007039057:848026" relevant="false">isostearic acid</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.substance-names.1" epochem-id="EPOCHEM:NEW:SUBSTANCE:14" name="polyglyceryl-6 hexaricinolate" comment="" chebi-id="WO2007039057:500831" relevant="false">polyglyceryl-6 hexaricinolate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.substance-names.2" epochem-id="EPOCHEM:NEW:SUBSTANCE:15" name="polyglyceryl-4-oleate" comment="" chebi-id="WO2007039057:972853" relevant="false">polyglyceryl-4-oleate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.substance-names.3" epochem-id="EPOCHEM:NEW:SUBSTANCE:16" name="polyglyceryl- 4 oleate" comment="" chebi-id="WO2007039057:539966" relevant="false">polyglyceryl- 4 oleate</ne>/<ne type="CHEMICAL" id="WO2007039057.HC.substance-names.4" epochem-id="EPOCHEM:NEW:SUBSTANCE:17" name="PEG-8propyleneglycol cocoate" comment="" chebi-id="WO2007039057:967322" relevant="false">PEG-8 propylene glycol cocoate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.substance-names.9" epochem-id="EPOCHEM:NEW:SUBSTANCE:21" name="oleamide DEA" comment="" chebi-id="WO2007039057:896957" relevant="false">oleamide DEA</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.substance-names.7" epochem-id="EPOCHEM:NEW:SUBSTANCE:19" name="TEA myristate" comment="" chebi-id="WO2007039057:363293" relevant="false">TEA myristate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.substance-names.8" epochem-id="EPOCHEM:NEW:SUBSTANCE:20" name="TEA stearate" comment="" chebi-id="WO2007039057:790302" relevant="false">TEA stearate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.311" epochem-id="EPOCHEM:NEW:COMPOUND:85" name="magnesium stearate" comment="" chebi-id="CHEBI:9254" relevant="false">magnesium stearate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.165" epochem-id="EPOCHEM:NEW:COMPOUND:84" name="sodium stearate" comment="" chebi-id="WO2007039057:190337" relevant="false">sodium stearate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.167" epochem-id="EPOCHEM:NEW:COMPOUND:86" name="potassium laurate" comment="" chebi-id="WO2007039057:80134" relevant="false">potassium laurate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.164" epochem-id="EPOCHEM:NEW:COMPOUND:83" name="potassium ricinoleate" comment="" chebi-id="WO2007039057:282999" relevant="false">potassium ricinoleate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.168" epochem-id="EPOCHEM:NEW:COMPOUND:87" name="sodium cocoate" comment="" chebi-id="WO2007039057:50742" relevant="false">sodium cocoate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.169" epochem-id="EPOCHEM:NEW:COMPOUND:88" name="sodium tallowate" comment="" chebi-id="WO2007039057:527972" relevant="false">sodium tallowate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.170" epochem-id="EPOCHEM:NEW:COMPOUND:89" name="potassium castorate" comment="" chebi-id="WO2007039057:696623" relevant="false">potassium castorate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.171" epochem-id="EPOCHEM:NEW:COMPOUND:90" name="sodium oleate" comment="" chebi-id="WO2007039057:771737" relevant="false">sodium oleate</ne>, and mixtures thereof. Further suitable emulsifiers are <ne id="WO2007039057.HC.class-names.111" epochem-id="EPOCHEM:NEW:CLASS:36" name="phosphate esters" comment="" chebi-id="WO2007039057:896427" relevant="false" type="CLASS">phosphate esters</ne> and the salts thereof such as <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.185" epochem-id="EPOCHEM:NEW:COMPOUND:94" name="cetyl phosphate" comment="" chebi-id="WO2007039057:312882" relevant="false">cetyl phosphate</ne> (<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.314" epochem-id="EPOCHEM:NEW:COMPOUND:153" name="Amphisol&lt;(R)&gt;A" comment="" chebi-id="WO2007039057:207813" relevant="false">Amphisol&lt;(R)&gt; A</ne>), <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.180" epochem-id="EPOCHEM:NEW:COMPOUND:91" name="diethanolamine cetyl phosphate" comment="" chebi-id="WO2007039057:456257" relevant="false">diethanolamine cetyl phosphate</ne> (<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.325" epochem-id="EPOCHEM:NEW:COMPOUND:155" name="Amphisol&lt;(R)&gt;" comment="" chebi-id="WO2007039057:361754" relevant="false">Amphisol&lt;(R)&gt;</ne>), <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.182" epochem-id="EPOCHEM:NEW:COMPOUND:92" name="potassium cetyl phosphate" comment="" chebi-id="WO2007039057:813559" relevant="false">potassium cetyl phosphate</ne> (<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.322" epochem-id="EPOCHEM:NEW:COMPOUND:154" name="Amphisol&lt;(R)&gt;K" comment="" chebi-id="WO2007039057:484089" relevant="false">Amphisol&lt;(R)&gt; K</ne>), <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.184" epochem-id="EPOCHEM:NEW:COMPOUND:93" name="sodium glyceryl oleate phosphate" comment="" chebi-id="WO2007039057:699722" relevant="false">sodium glyceryl oleate phosphate</ne>, hydrogenated vegetable <ne id="WO2007039057.HC.class-names.112" epochem-id="EPOCHEM:NEW:CLASS:37" name="glyceride phosphates" comment="" chebi-id="WO2007039057:257428" relevant="false" type="CLASS">glyceride phosphates</ne> and mixtures thereof. Furthermore, one or more synthetic polymers may be used as an emulsifier. For example, <ne type="CHEMICAL" id="WO2007039057.HC.substance-names.35" epochem-id="EPOCHEM:NEW:SUBSTANCE:125" name="PVP eicosene" comment="" chebi-id="WO2007039057:64087" relevant="false">PVP eicosene</ne> copolymer, <ne id="WO2007039057.HC.class-names.120" epochem-id="EPOCHEM:NEW:CLASS:39" name="acrylates" comment="" chebi-id="WO2007039057:571807" relevant="false" type="CLASS">acrylates</ne>/<ne id="WO2007039057.HC.class-names.371" epochem-id="EPOCHEM:NEW:CLASS:326" name="C1O-3oalkylacrylate" comment="" chebi-id="WO2007039057:29036" relevant="false" type="CLASS">C1O-3o alkyl acrylate</ne> crosspolymer, <ne id="WO2007039057.HC.class-names.121" epochem-id="EPOCHEM:NEW:CLASS:39" name="acrylates" comment="" chebi-id="WO2007039057:571807" relevant="false" type="CLASS">acrylates</ne>/<ne type="CHEMICAL" id="WO2007039057.HC.substance-names.32" epochem-id="EPOCHEM:NEW:SUBSTANCE:122" name="steareth-20methacrylate" comment="" chebi-id="WO2007039057:615320" relevant="false">steareth-20 methacrylate</ne> copolymer, <ne type="CHEMICAL" id="WO2007039057.HC.substance-names.33" epochem-id="EPOCHEM:NEW:SUBSTANCE:123" name="PEG-22/dodecyl glycol" comment="" chebi-id="WO2007039057:86393" relevant="false">PEG-22/dodecyl glycol</ne> copolymer, <ne type="CHEMICAL" id="WO2007039057.HC.substance-names.34" epochem-id="EPOCHEM:NEW:SUBSTANCE:124" name="PEG-45/dodecyl glycol" comment="" chebi-id="WO2007039057:432228" relevant="false">PEG-45/dodecyl glycol</ne> copolymer, and mixtures thereof. The preferred emulsifiers are <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.188" epochem-id="EPOCHEM:NEW:COMPOUND:94" name="cetyl phosphate" comment="" chebi-id="WO2007039057:312882" relevant="false">cetyl phosphate</ne> (<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.315" epochem-id="EPOCHEM:NEW:COMPOUND:153" name="Amphisol&lt;(R)&gt;A" comment="" chebi-id="WO2007039057:207813" relevant="false">Amphisol&lt;(R)&gt; A</ne>), <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.181" epochem-id="EPOCHEM:NEW:COMPOUND:91" name="diethanolamine cetyl phosphate" comment="" chebi-id="WO2007039057:456257" relevant="false">diethanolamine cetyl phosphate</ne> (<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.328" epochem-id="EPOCHEM:NEW:COMPOUND:155" name="Amphisol&lt;(R)&gt;" comment="" chebi-id="WO2007039057:361754" relevant="false">Amphisol&lt;(R)&gt;</ne>), <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.183" epochem-id="EPOCHEM:NEW:COMPOUND:92" name="potassium cetyl phosphate" comment="" chebi-id="WO2007039057:813559" relevant="false">potassium cetyl phosphate</ne> (<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.323" epochem-id="EPOCHEM:NEW:COMPOUND:154" name="Amphisol&lt;(R)&gt;K" comment="" chebi-id="WO2007039057:484089" relevant="false">Amphisol&lt;(R)&gt; K</ne>), <ne type="CHEMICAL" id="WO2007039057.HC.substance-names.36" epochem-id="EPOCHEM:NEW:SUBSTANCE:125" name="PVP eicosene" comment="" chebi-id="WO2007039057:64087" relevant="false">PVP Eicosene</ne> copolymer, <ne id="WO2007039057.HC.class-names.122" epochem-id="EPOCHEM:NEW:CLASS:39" name="acrylates" comment="" chebi-id="WO2007039057:571807" relevant="false" type="CLASS">acrylates</ne>/<ne id="WO2007039057.HC.class-names.372" epochem-id="EPOCHEM:NEW:CLASS:327" name="CiO-3o-alkylacrylate" comment="" chebi-id="WO2007039057:260099" relevant="false" type="CLASS">CiO-3o-alkyl acrylate</ne> crosspolymer, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.313" epochem-id="EPOCHEM:NEW:COMPOUND:152" name="PEG-20 sorbitan isostearate" comment="" chebi-id="WO2007039057:541478" relevant="false">PEG-20 sorbitan isostearate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.159" epochem-id="EPOCHEM:NEW:COMPOUND:79" name="sorbitan isostearate" comment="" chebi-id="WO2007039057:54748" relevant="false">sorbitan isostearate</ne>, and mixtures thereof. The one or more emulsifiers are present in a total amount about 0.01 weight% to about 20 weight% of the total weight of the composition of the present invention. Preferably, about 0.1 weight% to about 10 weight% of emulsifiers is used.
The lipid phase of the topical compositions can advantageously be chosen from: mineral oils and mineral <ne type="CHEMICAL" id="WO2007039057.HC.substance-names.39" epochem-id="EPOCHEM:NEW:SUBSTANCE:280" name="waxes" comment="" chebi-id="WO2007039057:676708" relevant="false">waxes</ne>; oils such as <ne id="WO2007039057.HC.class-names.142" epochem-id="EPOCHEM:NEW:CLASS:43" name="triglycerides" comment="" chebi-id="CHEBI:17855" relevant="false" type="CLASS">triglycerides</ne> of <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.200" epochem-id="EPOCHEM:NEW:COMPOUND:95" name="caprinic acid" comment="" chebi-id="CHEBI:30813" relevant="false">caprinic acid</ne> or <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.201" epochem-id="EPOCHEM:NEW:COMPOUND:96" name="caprylic acid" comment="" chebi-id="CHEBI:28837" relevant="false">caprylic acid</ne> and castor oil;
oils or <ne type="CHEMICAL" id="WO2007039057.HC.substance-names.40" epochem-id="EPOCHEM:NEW:SUBSTANCE:280" name="waxes" comment="" chebi-id="WO2007039057:676708" relevant="false">waxes</ne> and other natural or synthetic oils, in a preferred embodiment <ne id="WO2007039057.HC.class-names.392" epochem-id="EPOCHEM:NEW:CLASS:338" name="esters" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">esters</ne> of <ne id="WO2007039057.HC.class-names.85" epochem-id="EPOCHEM:NEW:CLASS:25" name="fatty acids" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acids</ne> with <ne id="WO2007039057.HC.class-names.131" epochem-id="EPOCHEM:NEW:CLASS:40" name="alcohols" comment="" chebi-id="CHEBI:30879" relevant="false" type="CLASS">alcohols</ne> e.g. <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.202" epochem-id="EPOCHEM:NEW:COMPOUND:97" name="isopropanol" comment="" chebi-id="CHEBI:17824" relevant="false">isopropanol</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.204" epochem-id="EPOCHEM:NEW:COMPOUND:25" name="propylene glycol" comment="" chebi-id="CHEBI:16997" relevant="false">propylene glycol</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.217" epochem-id="EPOCHEM:NEW:COMPOUND:98" name="glycerin" comment="" chebi-id="CHEBI:17754" relevant="false">glycerin</ne> or <ne id="WO2007039057.HC.class-names.393" epochem-id="EPOCHEM:NEW:CLASS:338" name="esters" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">esters</ne> of fatty <ne id="WO2007039057.HC.class-names.132" epochem-id="EPOCHEM:NEW:CLASS:40" name="fatty alcohols" comment="" chebi-id="CHEBI:24026" relevant="false" type="CLASS">alcohols</ne> with <ne id="WO2007039057.HC.class-names.128" epochem-id="EPOCHEM:NEW:CLASS:2" name="carboxylic acids" comment="" chebi-id="CHEBI:33575" relevant="false" type="CLASS">carboxylic acids</ne> or <ne id="WO2007039057.HC.class-names.86" epochem-id="EPOCHEM:NEW:CLASS:25" name="fatty acids" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acids</ne>; <ne id="WO2007039057.HC.class-names.139" epochem-id="EPOCHEM:NEW:CLASS:41" name="alkylbenzoates" comment="" chebi-id="WO2007039057:13224" relevant="false" type="CLASS">alkylbenzoates</ne>; and/or silicone oils such as <ne type="CHEMICAL" id="WO2007039057.HC.substance-names.10" epochem-id="EPOCHEM:NEW:SUBSTANCE:22" name="dimethylpolysiloxane" comment="" chebi-id="CHEBI:31498" relevant="false">dimethylpolysiloxane</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.substance-names.11" epochem-id="EPOCHEM:NEW:SUBSTANCE:23" name="diethylpolysiloxane" comment="" chebi-id="WO2007039057:190005" relevant="false">diethylpolysiloxane</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.substance-names.12" epochem-id="EPOCHEM:NEW:SUBSTANCE:24" name="diphenylpolysiloxane" comment="" chebi-id="WO2007039057:18574" relevant="false">diphenylpolysiloxane</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.substance-names.13" epochem-id="EPOCHEM:NEW:SUBSTANCE:25" name="cyclomethicones" comment="" chebi-id="WO2007039057:459113" relevant="false">cyclomethicones</ne> and mixtures thereof.
Exemplary fatty substances which can be incorporated in the oil phase of the emulsion, microemulsion, oleo gel, hydrodispersion or lipodispersion of the present invention are advantageously chosen from <ne id="WO2007039057.HC.class-names.394" epochem-id="EPOCHEM:NEW:CLASS:338" name="esters" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">esters</ne> of saturated and/or unsaturated, linear or branched <ne type="LIGAND" id="WO2007039057.HC.ligand-names.342" epochem-id="EPOCHEM:NEW:LIGAND:543" name="Alkyl" comment="" chebi-id="WO2007039057:275769" relevant="false">alkyl</ne> <ne id="WO2007039057.HC.class-names.129" epochem-id="EPOCHEM:NEW:CLASS:2" name="carboxylic acids" comment="" chebi-id="CHEBI:33575" relevant="false" type="CLASS">carboxylic acids</ne> with 3 to 30 <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.4" epochem-id="EPOCHEM:COMPOUND:6728" name="carbon" comment="" chebi-id="CHEBI:27594" relevant="false">carbon</ne> atoms, and saturated and/or unsaturated, linear and/or branched <ne id="WO2007039057.HC.class-names.133" epochem-id="EPOCHEM:NEW:CLASS:40" name="alcohols" comment="" chebi-id="CHEBI:30879" relevant="false" type="CLASS">alcohols</ne> with 3 to 30 <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.5" epochem-id="EPOCHEM:COMPOUND:6728" name="carbon" comment="" chebi-id="CHEBI:27594" relevant="false">carbon</ne> atoms as well as <ne id="WO2007039057.HC.class-names.395" epochem-id="EPOCHEM:NEW:CLASS:338" name="esters" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">esters</ne> of aromatic <ne id="WO2007039057.HC.class-names.130" epochem-id="EPOCHEM:NEW:CLASS:2" name="carboxylic acids" comment="" chebi-id="CHEBI:33575" relevant="false" type="CLASS">carboxylic acids</ne> and of saturated and/or unsaturated, linear or branched <ne id="WO2007039057.HC.class-names.134" epochem-id="EPOCHEM:NEW:CLASS:40" name="alcohols" comment="" chebi-id="CHEBI:30879" relevant="false" type="CLASS">alcohols</ne> of 3- 30 <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.6" epochem-id="EPOCHEM:COMPOUND:6728" name="carbon" comment="" chebi-id="CHEBI:27594" relevant="false">carbon</ne> atoms.
Such <ne id="WO2007039057.HC.class-names.396" epochem-id="EPOCHEM:NEW:CLASS:338" name="esters" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">esters</ne> can advantageously be selected from <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.226" epochem-id="EPOCHEM:NEW:COMPOUND:99" name="octylpalmitate" comment="" chebi-id="WO2007039057:133532" relevant="false">octylpalmitate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.substance-names.23" epochem-id="EPOCHEM:NEW:SUBSTANCE:31" name="octylcocoate" comment="" chebi-id="WO2007039057:614744" relevant="false">octylcocoate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.227" epochem-id="EPOCHEM:NEW:COMPOUND:100" name="octylisostearate" comment="" chebi-id="WO2007039057:579959" relevant="false">octylisostearate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.228" epochem-id="EPOCHEM:NEW:COMPOUND:101" name="octyldodecylmyristate" comment="" chebi-id="WO2007039057:46286" relevant="false">octyldodecylmyristate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.229" epochem-id="EPOCHEM:NEW:COMPOUND:102" name="cetearylisononanoate" comment="" chebi-id="WO2007039057:517877" relevant="false">cetearylisononanoate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.230" epochem-id="EPOCHEM:NEW:COMPOUND:103" name="isopropylmyristate" comment="" chebi-id="WO2007039057:835769" relevant="false">isopropylmyristate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.231" epochem-id="EPOCHEM:NEW:COMPOUND:104" name="isopropylpalmitate" comment="" chebi-id="WO2007039057:246668" relevant="false">isopropylpalmitate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.232" epochem-id="EPOCHEM:NEW:COMPOUND:105" name="isopropylstearate" comment="" chebi-id="WO2007039057:459929" relevant="false">isopropylstearate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.233" epochem-id="EPOCHEM:NEW:COMPOUND:106" name="isopropyloleate" comment="" chebi-id="WO2007039057:427785" relevant="false">isopropyloleate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.234" epochem-id="EPOCHEM:NEW:COMPOUND:107" name="n- butylstearate" comment="" chebi-id="WO2007039057:970656" relevant="false">n- butylstearate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.235" epochem-id="EPOCHEM:NEW:COMPOUND:108" name="n-hexyllaureate" comment="" chebi-id="WO2007039057:141164" relevant="false">n-hexyllaureate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.236" epochem-id="EPOCHEM:NEW:COMPOUND:109" name="n-decyloleat" comment="n-decyloleate" chebi-id="WO2007039057:356448" relevant="false">n-decyloleat</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.237" epochem-id="EPOCHEM:NEW:COMPOUND:110" name="isooctylstearate" comment="" chebi-id="WO2007039057:991938" relevant="false">isooctylstearate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.238" epochem-id="EPOCHEM:NEW:COMPOUND:111" name="isononylstearate" comment="" chebi-id="WO2007039057:536038" relevant="false">isononylstearate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.239" epochem-id="EPOCHEM:NEW:COMPOUND:112" name="isononylisononanoate" comment="" chebi-id="WO2007039057:333727" relevant="false">isononylisononanoate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.240" epochem-id="EPOCHEM:NEW:COMPOUND:113" name="2- ethyl hexylpalmitate" comment="" chebi-id="WO2007039057:405140" relevant="false">2- ethyl hexylpalmitate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.241" epochem-id="EPOCHEM:NEW:COMPOUND:114" name="2-ethylhexyllaurate" comment="" chebi-id="WO2007039057:485089" relevant="false">2-ethylhexyllaurate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.242" epochem-id="EPOCHEM:NEW:COMPOUND:115" name="2- hexyldecylstearate" comment="" chebi-id="WO2007039057:71158" relevant="false">2- hexyldecylstearate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.243" epochem-id="EPOCHEM:NEW:COMPOUND:116" name="2-octyldodecylpalmitate" comment="" chebi-id="WO2007039057:191410" relevant="false">2-octyldodecylpalmitate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.244" epochem-id="EPOCHEM:NEW:COMPOUND:117" name="stearylheptanoate" comment="" chebi-id="WO2007039057:902355" relevant="false">stearylheptanoate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.245" epochem-id="EPOCHEM:NEW:COMPOUND:118" name="oleyloleate" comment="" chebi-id="WO2007039057:375144" relevant="false">oleyloleate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.246" epochem-id="EPOCHEM:NEW:COMPOUND:119" name="oleylerucate" comment="" chebi-id="WO2007039057:112822" relevant="false">oleylerucate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.247" epochem-id="EPOCHEM:NEW:COMPOUND:120" name="erucyloleate" comment="" chebi-id="WO2007039057:867324" relevant="false">erucyloleate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.248" epochem-id="EPOCHEM:NEW:COMPOUND:121" name="erucylerucate" comment="erucyl erucate " chebi-id="WO2007039057:281312" relevant="false">erucylerucate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.249" epochem-id="EPOCHEM:NEW:COMPOUND:122" name="tridecylstearate" comment="" chebi-id="WO2007039057:156737" relevant="false">tridecylstearate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.250" epochem-id="EPOCHEM:NEW:COMPOUND:123" name="tridecyltrimellitate" comment="" chebi-id="WO2007039057:194980" relevant="false">tridecyltrimellitate</ne>, as well as synthetic, half-synthetic or natural mixtures of such <ne id="WO2007039057.HC.class-names.397" epochem-id="EPOCHEM:NEW:CLASS:338" name="esters" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">esters</ne> e.g. jojoba oil.
Other fatty components suitable for use in the topical compositions of the present invention include polar oils such as <ne id="WO2007039057.HC.class-names.140" epochem-id="EPOCHEM:NEW:CLASS:42" name="lecithines" comment="" chebi-id="WO2007039057:314903" relevant="false" type="CLASS">lecithines</ne> and <ne id="WO2007039057.HC.class-names.308" epochem-id="EPOCHEM:NEW:CLASS:319" name="fatty acid" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acid</ne> <ne id="WO2007039057.HC.class-names.143" epochem-id="EPOCHEM:NEW:CLASS:43" name="triglycerides" comment="" chebi-id="CHEBI:17855" relevant="false" type="CLASS">triglycerides</ne>, namely <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.251" epochem-id="EPOCHEM:NEW:COMPOUND:124" name="tri- glycerol" comment="" chebi-id="WO2007039057:31427" relevant="false">tri- glycerol</ne> <ne id="WO2007039057.HC.class-names.398" epochem-id="EPOCHEM:NEW:CLASS:338" name="esters" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">esters</ne> of saturated and/or unsaturated, straight or branched <ne id="WO2007039057.HC.class-names.415" epochem-id="EPOCHEM:NEW:CLASS:551" name="carboxylic acid" comment="" chebi-id="CHEBI:33575" relevant="false" type="CLASS">carboxylic acid</ne> with 8 to 24 <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.7" epochem-id="EPOCHEM:COMPOUND:6728" name="carbon" comment="" chebi-id="CHEBI:27594" relevant="false">carbon</ne> atoms, preferably of 12 to 18 <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.8" epochem-id="EPOCHEM:COMPOUND:6728" name="carbon" comment="" chebi-id="CHEBI:27594" relevant="false">carbon</ne>-atoms whereas the <ne id="WO2007039057.HC.class-names.309" epochem-id="EPOCHEM:NEW:CLASS:319" name="fatty acid" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acid</ne> <ne id="WO2007039057.HC.class-names.144" epochem-id="EPOCHEM:NEW:CLASS:43" name="triglycerides" comment="" chebi-id="CHEBI:17855" relevant="false" type="CLASS">triglycerides</ne> are preferably chosen from synthetic, half synthetic or natural oils (e.g. cocoglyceride, olive oil, sun flower oil, soybean oil, peanut oil, rape seed oil, sweet almond oil, palm oil, coconut oil, castor oil, hydrogenated castor oil, wheat oil, grape seed oil, macadamia nut oil and others); apolar oils such as linear and/ or branched <ne id="WO2007039057.HC.class-names.161" epochem-id="EPOCHEM:NEW:CLASS:45" name="hydrocarbons" comment="" chebi-id="CHEBI:24632" relevant="false" type="CLASS">hydrocarbons</ne> and <ne type="CHEMICAL" id="WO2007039057.HC.substance-names.41" epochem-id="EPOCHEM:NEW:SUBSTANCE:280" name="waxes" comment="" chebi-id="WO2007039057:676708" relevant="false">waxes</ne> e.g. mineral oils, vaseline (petrolatum); paraffins, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.843" epochem-id="EPOCHEM:NEW:COMPOUND:2011" name="squalane" comment="" chebi-id="WO2007039057:290529" relevant="false">squalane</ne> and <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.842" epochem-id="EPOCHEM:COMPOUND:3609" name="squalene" comment="" chebi-id="CHEBI:15440" relevant="false">squalene</ne>, <ne id="WO2007039057.HC.class-names.166" epochem-id="EPOCHEM:NEW:CLASS:50" name="polyolefines" comment="" chebi-id="WO2007039057:693671" relevant="false" type="CLASS">polyolefines</ne>, hydrogenated <ne id="WO2007039057.HC.class-names.164" epochem-id="EPOCHEM:NEW:CLASS:48" name="polyisobutenes" comment="" chebi-id="WO2007039057:490105" relevant="false" type="CLASS">polyisobutenes</ne> and <ne id="WO2007039057.HC.class-names.163" epochem-id="EPOCHEM:NEW:CLASS:47" name="isohexadecanes" comment="" chebi-id="WO2007039057:125688" relevant="false" type="CLASS">isohexadecanes</ne>, favored <ne id="WO2007039057.HC.class-names.167" epochem-id="EPOCHEM:NEW:CLASS:50" name="polyolefines" comment="" chebi-id="WO2007039057:693671" relevant="false" type="CLASS">polyolefines</ne> are <ne id="WO2007039057.HC.class-names.165" epochem-id="EPOCHEM:NEW:CLASS:49" name="polydecenes" comment="" chebi-id="WO2007039057:783639" relevant="false" type="CLASS">polydecenes</ne>; <ne id="WO2007039057.HC.class-names.162" epochem-id="EPOCHEM:NEW:CLASS:46" name="dialkyl ethers" comment="" chebi-id="WO2007039057:133987" relevant="false" type="CLASS">dialkyl ethers</ne> such as <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.252" epochem-id="EPOCHEM:NEW:COMPOUND:125" name="dicaprylylether" comment="" chebi-id="WO2007039057:316782" relevant="false">dicaprylylether</ne>; linear or <ne id="WO2007039057.HC.class-names.373" epochem-id="EPOCHEM:NEW:CLASS:328" name="cyclic silicone" comment="" chebi-id="WO2007039057:923048" relevant="false" type="CLASS">cyclic silicone</ne> oils such as preferably <ne type="CHEMICAL" id="WO2007039057.HC.substance-names.14" epochem-id="EPOCHEM:NEW:SUBSTANCE:25" name="cyclomethicones" comment="" chebi-id="WO2007039057:459113" relevant="false">cyclomethicones</ne> (<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.253" epochem-id="EPOCHEM:COMPOUND:7249" name="octamethylcyclotetrasiloxane" comment="" chebi-id="CHEBI:25640" relevant="false">octamethylcyclotetrasiloxane</ne>; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.254" epochem-id="EPOCHEM:NEW:COMPOUND:126" name="cetyldimethicone" comment="" chebi-id="WO2007039057:509957" relevant="false">cetyldimethicone</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.255" epochem-id="EPOCHEM:NEW:COMPOUND:127" name="hexamethylcyclotrisiloxane" comment="" chebi-id="WO2007039057:773588" relevant="false">hexamethylcyclotrisiloxane</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.substance-names.15" epochem-id="EPOCHEM:NEW:SUBSTANCE:26" name="polydimethylsiloxane" comment="" chebi-id="CHEBI:48137" relevant="false">polydimethylsiloxane</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.substance-names.16" epochem-id="EPOCHEM:NEW:SUBSTANCE:27" name="poly(methylphenylsiloxane)" comment="" chebi-id="WO2007039057:834329" relevant="false">poly(methylphenylsiloxane)</ne> and mixtures thereof.
Still other fatty components which can advantageously be incorporated in topical com- positions of the present invention are <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.256" epochem-id="EPOCHEM:NEW:COMPOUND:128" name="isoeikosane" comment="" chebi-id="WO2007039057:386965" relevant="false">isoeikosane</ne>; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.257" epochem-id="EPOCHEM:NEW:COMPOUND:129" name="neopentylglykoldiheptanoate" comment="" chebi-id="WO2007039057:527699" relevant="false">neopentylglykoldiheptanoate</ne>; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.258" epochem-id="EPOCHEM:NEW:COMPOUND:130" name="pro- pyleneglykoldicaprylate" comment="" chebi-id="WO2007039057:477402" relevant="false">pro- pyleneglykoldicaprylate</ne>/ <ne type="LIGAND" id="WO2007039057.HC.ligand-names.208" epochem-id="EPOCHEM:NEW:LIGAND:51" name="dicaprate" comment="" chebi-id="WO2007039057:164747" relevant="false">dicaprate</ne>; <ne type="LIGAND" id="WO2007039057.HC.ligand-names.181" epochem-id="EPOCHEM:NEW:LIGAND:44" name="caprylic" comment="" chebi-id="WO2007039057:766489" relevant="false">caprylic</ne>/ <ne type="LIGAND" id="WO2007039057.HC.ligand-names.192" epochem-id="EPOCHEM:NEW:LIGAND:45" name="capric" comment="" chebi-id="WO2007039057:811964" relevant="false">capric</ne>/ <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.279" epochem-id="EPOCHEM:NEW:COMPOUND:133" name="diglycerylsuccinate" comment="" chebi-id="WO2007039057:464104" relevant="false">diglycerylsuccinate</ne>; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.789" epochem-id="EPOCHEM:NEW:COMPOUND:1345" name="butyleneglycol caprylat" comment="" chebi-id="WO2007039057:144820" relevant="false">butyleneglycol caprylat</ne>/<ne type="LIGAND" id="WO2007039057.HC.ligand-names.204" epochem-id="EPOCHEM:NEW:LIGAND:47" name="caprat" comment="" chebi-id="WO2007039057:386276" relevant="false">caprat</ne>; <ne id="WO2007039057.HC.class-names.374" epochem-id="EPOCHEM:NEW:CLASS:329" name="Ci2-i3-alkyllactate" comment="C12-13-alkyl lactate" chebi-id="WO2007039057:557789" relevant="false" type="CLASS">Ci2-i3-alkyllactate</ne>; <ne id="WO2007039057.HC.class-names.375" epochem-id="EPOCHEM:NEW:CLASS:330" name="di-C12.-3 alkyltartrate" comment="di-C12-13 alkyl tartrate" chebi-id="WO2007039057:625818" relevant="false" type="CLASS">di-C12.-3 alkyltartrate</ne>; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.281" epochem-id="EPOCHEM:NEW:COMPOUND:135" name="triisostearin" comment="" chebi-id="WO2007039057:147581" relevant="false">triisostearin</ne>; <ne type="LIGAND" id="WO2007039057.HC.ligand-names.205" epochem-id="EPOCHEM:NEW:LIGAND:48" name="dipentaerythrityl" comment="" chebi-id="WO2007039057:15047" relevant="false">dipentaerythrityl</ne> <ne type="LIGAND" id="WO2007039057.HC.ligand-names.206" epochem-id="EPOCHEM:NEW:LIGAND:49" name="hexacaprylat" comment="" chebi-id="WO2007039057:15544" relevant="false">hexacaprylat</ne>/<ne type="LIGAND" id="WO2007039057.HC.ligand-names.207" epochem-id="EPOCHEM:NEW:LIGAND:50" name="hexacaprate" comment="" chebi-id="WO2007039057:664168" relevant="false">hexacaprate</ne>; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.282" epochem-id="EPOCHEM:NEW:COMPOUND:136" name="propylenglycolmonoisostearate" comment="" chebi-id="WO2007039057:236688" relevant="false">propylenglycolmonoisostearate</ne>; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.283" epochem-id="EPOCHEM:NEW:COMPOUND:137" name="tricaprylin" comment="" chebi-id="WO2007039057:480347" relevant="false">tricaprylin</ne>; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.284" epochem-id="EPOCHEM:NEW:COMPOUND:138" name="dimethylisosorbid" comment="" chebi-id="WO2007039057:818730" relevant="false">dimethylisosorbid</ne>. Especially beneficial is the use of mixtures <ne id="WO2007039057.HC.class-names.408" epochem-id="EPOCHEM:NEW:CLASS:342" name="C12-i5-alkylbenzoate" comment="C12-15-alkyl benzoate" chebi-id="WO2007039057:864997" relevant="false" type="CLASS">C12-i5-alkylbenzoate</ne> and <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.285" epochem-id="EPOCHEM:NEW:COMPOUND:139" name="2-ethylhexylisostearate" comment="" chebi-id="WO2007039057:502911" relevant="false">2-ethylhexylisostearate</ne>, mixtures <ne id="WO2007039057.HC.class-names.409" epochem-id="EPOCHEM:NEW:CLASS:342" name="C12-i5-alkylbenzoate" comment="C12-15-alkyl benzoate" chebi-id="WO2007039057:864997" relevant="false" type="CLASS">C12-i5-alkylbenzoate</ne> and <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.287" epochem-id="EPOCHEM:NEW:COMPOUND:140" name="isotridecylisononanoate" comment="" chebi-id="WO2007039057:179458" relevant="false">isotridecylisononanoate</ne> as well as mixtures of <ne id="WO2007039057.HC.class-names.410" epochem-id="EPOCHEM:NEW:CLASS:343" name="C12-15-alkylbenzoate" comment="" chebi-id="WO2007039057:639991" relevant="false" type="CLASS">C12-15-alkylbenzoate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.286" epochem-id="EPOCHEM:NEW:COMPOUND:139" name="2-ethylhexylisostearate" comment="" chebi-id="WO2007039057:502911" relevant="false">2-ethylhexylisostearate</ne> and <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.288" epochem-id="EPOCHEM:NEW:COMPOUND:140" name="isotridecylisononanoate" comment="" chebi-id="WO2007039057:179458" relevant="false">isotridecylisononanoate</ne>.
The oily phase of the compositions of the present invention can also contain natural vegetable or animal <ne type="CHEMICAL" id="WO2007039057.HC.substance-names.42" epochem-id="EPOCHEM:NEW:SUBSTANCE:280" name="waxes" comment="" chebi-id="WO2007039057:676708" relevant="false">waxes</ne> such as bee wax, china wax, bumblebee wax and other <ne type="CHEMICAL" id="WO2007039057.HC.substance-names.43" epochem-id="EPOCHEM:NEW:SUBSTANCE:280" name="waxes" comment="" chebi-id="WO2007039057:676708" relevant="false">waxes</ne> of insects as well as shea butter and cocoa butter.
A moisturizing agent may be incorporated into a topical composition of the present invention to maintain hydration or rehydrate the skin. Moisturizers that prevent <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.791" epochem-id="EPOCHEM:NEW:COMPOUND:9" name="Water" comment="" chebi-id="CHEBI:15377" relevant="false">water</ne> from evaporating from the skin by providing a protective coating are called emollients.
Additionally an emollient provides a softening or soothing effect on the skin surface and is generally considered safe for topical use. Preferred emollients include mineral oils, lanolin, petrolatum, <ne type="LIGAND" id="WO2007039057.HC.ligand-names.193" epochem-id="EPOCHEM:NEW:LIGAND:45" name="capric" comment="" chebi-id="WO2007039057:811964" relevant="false">capric</ne>/<ne id="WO2007039057.HC.class-names.376" epochem-id="EPOCHEM:NEW:CLASS:331" name="caprylictriglyceraldehydes" comment="" chebi-id="WO2007039057:963905" relevant="false" type="CLASS">caprylic triglyceraldehydes</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.289" epochem-id="EPOCHEM:COMPOUND:1785" name="cholesterol" comment="" chebi-id="CHEBI:16113" relevant="false">cholesterol</ne>, <ne id="WO2007039057.HC.class-names.434" epochem-id="EPOCHEM:NEW:CLASS:492" name="silicones" comment="" chebi-id="CHEBI:48140" relevant="false" type="CLASS">silicones</ne> such as <ne type="CHEMICAL" id="WO2007039057.HC.substance-names.17" epochem-id="EPOCHEM:NEW:SUBSTANCE:28" name="dimeticone" comment="" chebi-id="CHEBI:31498" relevant="false">dimeticone</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.substance-names.18" epochem-id="EPOCHEM:NEW:SUBSTANCE:29" name="cyclometicone" comment="" chebi-id="WO2007039057:766671" relevant="false">cyclometicone</ne>, almond oil, jojoba oil, avocado oil, castor oil, sesame oil, sunflower oil, coconut oil and grape seed oil, cocoa butter, olive oil aloe extracts, <ne id="WO2007039057.HC.class-names.87" epochem-id="EPOCHEM:NEW:CLASS:25" name="fatty acids" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acids</ne> such as <ne type="LIGAND" id="WO2007039057.HC.ligand-names.158" epochem-id="EPOCHEM:NEW:LIGAND:40" name="oleic" comment="" chebi-id="CHEBI:25667" relevant="false">oleic</ne> and <ne type="LIGAND" id="WO2007039057.HC.ligand-names.209" epochem-id="EPOCHEM:NEW:LIGAND:52" name="stearic" comment="" chebi-id="WO2007039057:275662" relevant="false">stearic</ne>, <ne id="WO2007039057.HC.class-names.404" epochem-id="EPOCHEM:NEW:CLASS:339" name="fatty alcohols" comment="" chebi-id="CHEBI:24026" relevant="false" type="CLASS">fatty alcohols</ne> such as <ne type="LIGAND" id="WO2007039057.HC.ligand-names.329" epochem-id="EPOCHEM:NEW:LIGAND:334" name="cetyl" comment="" chebi-id="WO2007039057:468434" relevant="false">cetyl</ne> and <ne type="LIGAND" id="WO2007039057.HC.ligand-names.221" epochem-id="EPOCHEM:NEW:LIGAND:54" name="hexadecyl" comment="" chebi-id="CHEBI:25842" relevant="false">hexadecyl</ne> (ENJAY), <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.290" epochem-id="EPOCHEM:NEW:COMPOUND:141" name="diisopropyl adipate" comment="" chebi-id="WO2007039057:378747" relevant="false">diisopropyl adipate</ne>, <ne id="WO2007039057.HC.class-names.377" epochem-id="EPOCHEM:NEW:CLASS:62" name="hydroxybenzoate esters" comment="" chebi-id="WO2007039057:260995" relevant="false" type="CLASS">hydroxybenzoate esters</ne>, <ne id="WO2007039057.HC.class-names.378" epochem-id="EPOCHEM:NEW:CLASS:332" name="benzoic acid esters of C9.i5" comment="" chebi-id="WO2007039057:370766" relevant="false" type="CLASS">benzoic acid esters of C9.i5</ne>-<ne id="WO2007039057.HC.class-names.136" epochem-id="EPOCHEM:NEW:CLASS:40" name="alcohols" comment="" chebi-id="CHEBI:30879" relevant="false" type="CLASS">alcohols</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.330" epochem-id="EPOCHEM:NEW:COMPOUND:156" name="isononyl iso-nonanoate" comment="" chebi-id="WO2007039057:858221" relevant="false">isononyl iso-nonanoate</ne>, <ne id="WO2007039057.HC.class-names.358" epochem-id="EPOCHEM:NEW:CLASS:183" name="ethers" comment="" chebi-id="CHEBI:25698" relevant="false" type="CLASS">ethers</ne> such as <ne id="WO2007039057.HC.class-names.184" epochem-id="EPOCHEM:NEW:CLASS:60" name="polyoxypropylene butyl ethers" comment="" chebi-id="WO2007039057:366620" relevant="false" type="CLASS">polyoxypropylene butyl ethers</ne> and <ne id="WO2007039057.HC.class-names.185" epochem-id="EPOCHEM:NEW:CLASS:61" name="polyoxypropylene cetyl ethers" comment="" chebi-id="WO2007039057:36167" relevant="false" type="CLASS">polyoxypropylene cetyl ethers</ne>, and <ne id="WO2007039057.HC.class-names.379" epochem-id="EPOCHEM:NEW:CLASS:333" name="C12-is-alkyl benzoates" comment="" chebi-id="WO2007039057:476558" relevant="false" type="CLASS">C12-is-alkyl benzoates</ne>, and mixtures thereof. The most preferred emollients are <ne id="WO2007039057.HC.class-names.188" epochem-id="EPOCHEM:NEW:CLASS:62" name="hydroxybenzoate esters" comment="" chebi-id="WO2007039057:260995" relevant="false" type="CLASS">hydroxybenzoate esters</ne>, aloe vera, <ne id="WO2007039057.HC.class-names.380" epochem-id="EPOCHEM:NEW:CLASS:334" name="C12.15-alkyl benzoates" comment="" chebi-id="WO2007039057:256173" relevant="false" type="CLASS">C12.15-alkyl benzoates</ne>, and mixtures thereof. An emollient is present in an amount of about 1 weight% to about 20 weight% of the total weight of the composition. The preferred amount of emollient is about 2 weight% to about 15 weight%, and most preferably about 4 weight% to about 10 weight%.
Moisturizers that bind <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.792" epochem-id="EPOCHEM:NEW:COMPOUND:9" name="Water" comment="" chebi-id="CHEBI:15377" relevant="false">water</ne>, thereby retaining it on the skin surface are called humectants. Suitable humectants can be incorporated into a topical composition of the present invention such as <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.218" epochem-id="EPOCHEM:NEW:COMPOUND:98" name="glycerin" comment="" chebi-id="CHEBI:17754" relevant="false">glycerin</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.substance-names.19" epochem-id="EPOCHEM:NEW:SUBSTANCE:30" name="polypropylene glycol" comment="" chebi-id="WO2007039057:142811" relevant="false">polypropylene glycol</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.substance-names.20" epochem-id="EPOCHEM:NEW:SUBSTANCE:2" name="polyethylene glycol" comment="" chebi-id="CHEBI:46793" relevant="false">polyethylene glycol</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.76" epochem-id="EPOCHEM:COMPOUND:496" name="lactic acid" comment="" chebi-id="CHEBI:28358" relevant="false">lactic acid</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.293" epochem-id="EPOCHEM:NEW:COMPOUND:142" name="pyrrolidon carboxylic acid" comment="" chebi-id="WO2007039057:620692" relevant="false">pyrrolidon carboxylic acid</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.127" epochem-id="EPOCHEM:COMPOUND:5985" name="urea" comment="" chebi-id="CHEBI:16199" relevant="false">urea</ne>, <ne id="WO2007039057.HC.class-names.168" epochem-id="EPOCHEM:NEW:CLASS:51" name="phopholipids" comment="" chebi-id="WO2007039057:545655" relevant="false" type="CLASS">phopholipids</ne>, collagen, elastin, <ne type="ONT" id="WO2007039057.HC.class-names.416" epochem-id="EPOCHEM:NEW:CLASS:530" name="ceramides" comment="" chebi-id="CHEBI:17761" relevant="false">ceramides</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.295" epochem-id="EPOCHEM:NEW:COMPOUND:144" name="lecithin sorbitol" comment="" chebi-id="WO2007039057:69900" relevant="false">lecithin sorbitol</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.294" epochem-id="EPOCHEM:NEW:COMPOUND:143" name="PEG-4" comment="" chebi-id="CHEBI:44920" relevant="false">PEG-4</ne>, and mixtures thereof. Additional suitable moisturizers are polymeric moisturizers of the family of <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.793" epochem-id="EPOCHEM:NEW:COMPOUND:9" name="Water" comment="" chebi-id="CHEBI:15377" relevant="false">water</ne> soluble and/ or swellable/ and/ or with <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.794" epochem-id="EPOCHEM:NEW:COMPOUND:9" name="Water" comment="" chebi-id="CHEBI:15377" relevant="false">water</ne> gelating <ne id="WO2007039057.HC.class-names.179" epochem-id="EPOCHEM:NEW:CLASS:57" name="polysaccharides" comment="" chebi-id="CHEBI:18154" relevant="false" type="CLASS">polysaccharides</ne> such as <ne type="CHEMICAL" id="WO2007039057.HC.substance-names.21" epochem-id="EPOCHEM:NEW:SUBSTANCE:7" name="hyaluronic acid" comment="" chebi-id="CHEBI:16336" relevant="false">hyaluronic acid</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.substance-names.22" epochem-id="EPOCHEM:NEW:SUBSTANCE:11" name="chitosan" comment="" chebi-id="WO2007039057:813407" relevant="false">chitosan</ne> and/or a <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.296" epochem-id="EPOCHEM:NEW:COMPOUND:145" name="fucose" comment="" chebi-id="CHEBI:33984" relevant="false">fucose</ne> rich polysaccharide which is e.g. available as Fucogel(R)1000 (<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.297" epochem-id="EPOCHEM:NEW:COMPOUND:146" name="CAS-Nr.178463 -23-5" comment="CAS NUMBER" chebi-id="WO2007039057:897057" relevant="false">CAS-Nr. 178463-23-5</ne>) by SOLABIA S. One or more humectants are optionally present at about 0.5 weight% to about 8 weight% in a composition of the present invention, preferably about 1 weight% to about 5 weight%.
The aqueous phase of the preferred topical compositions of the present invention can contain the usual cosmetic or pharmaceutical additives such as <ne id="WO2007039057.HC.class-names.137" epochem-id="EPOCHEM:NEW:CLASS:40" name="alcohols" comment="" chebi-id="CHEBI:30879" relevant="false" type="CLASS">alcohols</ne>, especially lower <ne id="WO2007039057.HC.class-names.138" epochem-id="EPOCHEM:NEW:CLASS:40" name="alcohols" comment="" chebi-id="CHEBI:30879" relevant="false" type="CLASS">alcohols</ne>, preferably <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.298" epochem-id="EPOCHEM:COMPOUND:4765" name="ethanol" comment="" chebi-id="CHEBI:16236" relevant="false">ethanol</ne> and/ or <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.203" epochem-id="EPOCHEM:NEW:COMPOUND:97" name="isopropanol" comment="" chebi-id="CHEBI:17824" relevant="false">isopropanol</ne>, low <ne id="WO2007039057.HC.class-names.180" epochem-id="EPOCHEM:NEW:CLASS:58" name="diols" comment="" chebi-id="CHEBI:23824" relevant="false" type="CLASS">diols</ne> or <ne id="WO2007039057.HC.class-names.181" epochem-id="EPOCHEM:NEW:CLASS:59" name="polyols" comment="" chebi-id="CHEBI:26191" relevant="false" type="CLASS">polyols</ne> and their <ne id="WO2007039057.HC.class-names.361" epochem-id="EPOCHEM:NEW:CLASS:183" name="ethers" comment="" chebi-id="CHEBI:25698" relevant="false" type="CLASS">ethers</ne>, preferably <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.303" epochem-id="EPOCHEM:NEW:COMPOUND:147" name="propyleneglycol" comment="" chebi-id="WO2007039057:947970" relevant="false">propyleneglycol</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.219" epochem-id="EPOCHEM:NEW:COMPOUND:98" name="glycerin" comment="" chebi-id="CHEBI:17754" relevant="false">glycerin</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.305" epochem-id="EPOCHEM:NEW:COMPOUND:148" name="ethyleneglycol" comment="" chebi-id="CHEBI:30742" relevant="false">ethyleneglycol</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.306" epochem-id="EPOCHEM:NEW:COMPOUND:148" name="ethyleneglycol" comment="" chebi-id="CHEBI:30742" relevant="false">ethyleneglycol</ne> <ne type="LIGAND" id="WO2007039057.HC.ligand-names.237" epochem-id="EPOCHEM:NEW:LIGAND:63" name="monoethyl" comment="" chebi-id="WO2007039057:16434" relevant="false">monoethyl</ne>- or <ne id="WO2007039057.HC.class-names.418" epochem-id="EPOCHEM:NEW:CLASS:966" name="monobutylether" comment="" chebi-id="WO2007039057:653784" relevant="false" type="CLASS">monobutylether</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.848" epochem-id="EPOCHEM:NEW:COMPOUND:147" name="propyleneglycol" comment="" chebi-id="WO2007039057:947970" relevant="false">propyleneglycol</ne> <ne type="LIGAND" id="WO2007039057.HC.ligand-names.336" epochem-id="EPOCHEM:NEW:LIGAND:542" name="monomethyl" comment="" chebi-id="WO2007039057:820398" relevant="false">monomethyl</ne>- or -<ne type="LIGAND" id="WO2007039057.HC.ligand-names.238" epochem-id="EPOCHEM:NEW:LIGAND:63" name="monoethyl" comment="" chebi-id="WO2007039057:16434" relevant="false">monoethyl</ne>- or-<ne id="WO2007039057.HC.class-names.419" epochem-id="EPOCHEM:NEW:CLASS:966" name="monobutylether" comment="" chebi-id="WO2007039057:653784" relevant="false" type="CLASS">monobutylether</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.309" epochem-id="EPOCHEM:NEW:COMPOUND:150" name="diethyleneglycol" comment="" chebi-id="WO2007039057:715061" relevant="false">diethyleneglycol</ne> <ne type="LIGAND" id="WO2007039057.HC.ligand-names.241" epochem-id="EPOCHEM:NEW:LIGAND:542" name="monomethyl" comment="" chebi-id="WO2007039057:820398" relevant="false">monomethyl</ne>-or <ne id="WO2007039057.HC.class-names.420" epochem-id="EPOCHEM:NEW:CLASS:967" name="monoethylether" comment="" chebi-id="WO2007039057:999348" relevant="false" type="CLASS">monoethylether</ne> and analogue products, polymers, foam stabilisators; electrolytes and especially one or more thickeners.
Thickeners that may be used in formulations of the present invention to assist in making the consistency of a product suitable include <ne id="WO2007039057.HC.class-names.191" epochem-id="EPOCHEM:NEW:CLASS:65" name="carbomer" comment="" chebi-id="WO2007039057:178753" relevant="false" type="CLASS">carbomer</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.906" epochem-id="EPOCHEM:NEW:COMPOUND:2115" name="siliciumdioxide" comment="" chebi-id="WO2007039057:52547" relevant="false">siliciumdioxide</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.360" epochem-id="EPOCHEM:COMPOUND:7091" name="magnesium" comment="" chebi-id="CHEBI:25107" relevant="false">magnesium</ne> and/ or <ne id="WO2007039057.HC.class-names.194" epochem-id="EPOCHEM:NEW:CLASS:67" name="aluminium silicates" comment="" chebi-id="WO2007039057:435304" relevant="false" type="CLASS">aluminium silicates</ne>, beeswax, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.332" epochem-id="EPOCHEM:COMPOUND:693" name="stearic acid" comment="" chebi-id="CHEBI:28842" relevant="false">stearic acid</ne>, <ne id="WO2007039057.HC.class-names.189" epochem-id="EPOCHEM:NEW:CLASS:63" name="stearyl alcohol polysaccharides" comment="" chebi-id="WO2007039057:950657" relevant="false" type="CLASS">stearyl alcohol polysaccharides</ne> and their derivatives such as <ne type="CHEMICAL" id="WO2007039057.HC.substance-names.25" epochem-id="EPOCHEM:NEW:SUBSTANCE:33" name="xanthan gum" comment="" chebi-id="WO2007039057:296261" relevant="false">xanthan gum</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.substance-names.24" epochem-id="EPOCHEM:NEW:SUBSTANCE:32" name="hydroxypropyl cellulose" comment="" chebi-id="WO2007039057:425209" relevant="false">hydroxypropyl cellulose</ne>, <ne id="WO2007039057.HC.class-names.190" epochem-id="EPOCHEM:NEW:CLASS:64" name="polyacrylamides" comment="" chebi-id="WO2007039057:475247" relevant="false" type="CLASS">polyacrylamides</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.195" epochem-id="EPOCHEM:COMPOUND:731" name="acrylate" comment="" chebi-id="CHEBI:37080" relevant="false">acrylate</ne> crosspolymers preferably a <ne id="WO2007039057.HC.class-names.192" epochem-id="EPOCHEM:NEW:CLASS:65" name="carbomer" comment="" chebi-id="WO2007039057:178753" relevant="false" type="CLASS">carbomer</ne>, such as carbopole&lt;(R)&gt; of type 980, 981 , 1382, 2984, 5984 alone or mixtures thereof.
Suitable neutralizing agents which may be included in the composition of the present invention to neutralize components such as e.g. an emulsifier or a foam builder/stabilizer include but are not limited to <ne id="WO2007039057.HC.class-names.193" epochem-id="EPOCHEM:NEW:CLASS:66" name="alkali hydroxides" comment="" chebi-id="WO2007039057:64970" relevant="false" type="CLASS">alkali hydroxides</ne> such as a <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.893" epochem-id="EPOCHEM:COMPOUND:7085" name="sodium" comment="" chebi-id="CHEBI:26708" relevant="false">sodium</ne> and <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.346" epochem-id="EPOCHEM:COMPOUND:7172" name="potassium hydroxide" comment="" chebi-id="CHEBI:32035" relevant="false">potassium hydroxide</ne>; <ne type="ONT" id="WO2007039057.HC.class-names.438" epochem-id="EPOCHEM:NEW:CLASS:1080" name="organic bases" comment="" chebi-id="WO2007039057:983514" relevant="false">organic bases</ne> such as <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.261" epochem-id="EPOCHEM:COMPOUND:4092" name="diethanolamine" comment="" chebi-id="CHEBI:28123" relevant="false">diethanolamine</ne> (<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.264" epochem-id="EPOCHEM:NEW:COMPOUND:131" name="DEA" comment="" chebi-id="WO2007039057:840022" relevant="true">DEA</ne>), <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.347" epochem-id="EPOCHEM:COMPOUND:4117" name="triethanolamine" comment="" chebi-id="CHEBI:28621" relevant="false">triethanolamine</ne> (<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.354" epochem-id="EPOCHEM:NEW:COMPOUND:157" name="TEA" comment="" chebi-id="WO2007039057:545795" relevant="false">TEA</ne>), <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.355" epochem-id="EPOCHEM:NEW:COMPOUND:158" name="aminomethyl propanol" comment="" chebi-id="WO2007039057:131011" relevant="false">aminomethyl propanol</ne>, and mixtures thereof; <ne id="WO2007039057.HC.class-names.411" epochem-id="EPOCHEM:NEW:CLASS:3" name="amino acids" comment="" chebi-id="CHEBI:33709" relevant="false" type="CLASS">amino acids</ne> such as <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.356" epochem-id="EPOCHEM:COMPOUND:1072" name="arginine" comment="" chebi-id="CHEBI:29016" relevant="false">arginine</ne> and <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.357" epochem-id="EPOCHEM:COMPOUND:1034" name="lysine" comment="" chebi-id="CHEBI:25094" relevant="false">lysine</ne> and any combination of any foregoing. The neutralizing agent can be present in an amount of about 0.01 weight% to about 8 weight% in the composition of the present invention, preferably, 1 weight% to about 5 weight%.
The addition of electrolytes into the composition of the present invention may be necessary to change the behavior of a hydrophobic emulsifier. Thus, the emulsions/ microemulsions of this invention may contain preferably electrolytes of one or several salts including anions such as <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.365" epochem-id="EPOCHEM:COMPOUND:3" name="chloride" comment="" chebi-id="CHEBI:17996" relevant="false">chloride</ne>, <ne id="WO2007039057.HC.class-names.195" epochem-id="EPOCHEM:NEW:CLASS:68" name="sulfates" comment="" chebi-id="CHEBI:26820" relevant="false" type="CLASS">sulfates</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.785" epochem-id="EPOCHEM:NEW:COMPOUND:1296" name="carbonate" comment="" chebi-id="CHEBI:41609" relevant="false">carbonate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.370" epochem-id="EPOCHEM:COMPOUND:1359" name="borate" comment="" chebi-id="CHEBI:22908" relevant="false">borate</ne> and <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.371" epochem-id="EPOCHEM:NEW:COMPOUND:160" name="aluminate" comment="" chebi-id="WO2007039057:179915" relevant="false">aluminate</ne>, without being limited thereto. Other suitable electrolytes can be on the basis of organic anions such as, but not limited to, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.372" epochem-id="EPOCHEM:COMPOUND:495" name="lactate" comment="" chebi-id="CHEBI:24996" relevant="false">lactate</ne>, <ne type="LIGAND" id="WO2007039057.HC.ligand-names.324" epochem-id="EPOCHEM:NEW:LIGAND:327" name="acetate" comment="" chebi-id="CHEBI:30089" relevant="false">acetate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.396" epochem-id="EPOCHEM:COMPOUND:741" name="benzoate" comment="" chebi-id="CHEBI:16150" relevant="false">benzoate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.397" epochem-id="EPOCHEM:COMPOUND:420" name="propionate" comment="" chebi-id="CHEBI:17272" relevant="false">propionate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.400" epochem-id="EPOCHEM:NEW:COMPOUND:161" name="tartrate" comment="" chebi-id="CHEBI:35396" relevant="false">tartrate</ne> and <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.401" epochem-id="EPOCHEM:NEW:COMPOUND:162" name="citrate" comment="" chebi-id="CHEBI:16947" relevant="false">citrate</ne>. As cations preferably <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.404" epochem-id="EPOCHEM:COMPOUND:4221" name="ammonium" comment="" chebi-id="CHEBI:28938" relevant="false">ammonium</ne>, <ne id="WO2007039057.HC.class-names.196" epochem-id="EPOCHEM:NEW:CLASS:69" name="alkylammonium" comment="" chebi-id="WO2007039057:439915" relevant="false" type="CLASS">alkylammonium</ne>, <ne id="WO2007039057.HC.class-names.384" epochem-id="EPOCHEM:NEW:CLASS:336" name="alkali" comment="" chebi-id="WO2007039057:241445" relevant="false" type="CLASS">alkali</ne>- or <ne id="WO2007039057.HC.class-names.381" epochem-id="EPOCHEM:NEW:CLASS:335" name="alkaline earth metals" comment="" chebi-id="CHEBI:22313" relevant="false" type="CLASS">alkaline earth metals</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.361" epochem-id="EPOCHEM:COMPOUND:7091" name="magnesium" comment="" chebi-id="CHEBI:25107" relevant="false">magnesium</ne>-, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.782" epochem-id="EPOCHEM:COMPOUND:7456" name="iron" comment="" chebi-id="CHEBI:18248" relevant="false">iron</ne>- or <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.882" epochem-id="EPOCHEM:COMPOUND:7669" name="zinc" comment="" chebi-id="CHEBI:27363" relevant="false">zinc</ne>-ions are selected. Especially preferred salts are <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.413" epochem-id="EPOCHEM:COMPOUND:7084" name="potassium" comment="" chebi-id="CHEBI:26216" relevant="false">potassium</ne> and <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.415" epochem-id="EPOCHEM:COMPOUND:6837" name="sodium chloride" comment="" chebi-id="CHEBI:26710" relevant="false">sodium chloride</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.363" epochem-id="EPOCHEM:COMPOUND:7189" name="magnesium sulfate" comment="" chebi-id="CHEBI:32599" relevant="false">magnesium sulfate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.364" epochem-id="EPOCHEM:COMPOUND:7364" name="zinc sulfate" comment="" chebi-id="CHEBI:35176" relevant="false">zinc sulfate</ne> and mixtures thereof. Electrolytes can be present in an amount of about 0.01 weight% to about 8 weight% in the composition of the present invention.
According to the invention for preparing the compositions of the invention the active ingredients can be used as such or in an encapsulated form, for example in a liposomal form. Liposomes are preferably formed with <ne id="WO2007039057.HC.class-names.197" epochem-id="EPOCHEM:NEW:CLASS:70" name="lecithins" comment="" chebi-id="CHEBI:16110" relevant="true" type="CLASS">lecithins</ne> with or without addition of sterols or <ne id="WO2007039057.HC.class-names.200" epochem-id="EPOCHEM:NEW:CLASS:73" name="phytosterols" comment="" chebi-id="CHEBI:26125" relevant="false" type="CLASS">phytosterols</ne>. The encapsulation of the active ingredients can be alone or together with other active ingredients. It is possible to encapsulate only the <ne id="WO2007039057.HC.class-names.310" epochem-id="EPOCHEM:NEW:CLASS:319" name="fatty acid" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acid</ne> or a salt, <ne id="WO2007039057.HC.class-names.347" epochem-id="EPOCHEM:NEW:CLASS:185" name="ester" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">ester</ne> or <ne id="WO2007039057.HC.class-names.282" epochem-id="EPOCHEM:NEW:CLASS:138" name="amide" comment="" chebi-id="CHEBI:29337" relevant="false" type="CLASS">amide</ne> thereof with the preferences and definitions as defined above or only the <ne id="WO2007039057.HC.class-names.61" epochem-id="EPOCHEM:NEW:CLASS:24" name="retinoid" comment="" chebi-id="CHEBI:26537" relevant="true" type="CLASS">retinoid</ne>, but it is also possible to encapsulate both ingredients either together or in separate capsules.
Other embodiments include solid or semisolid capsules aiming to protect the <ne id="WO2007039057.HC.class-names.62" epochem-id="EPOCHEM:NEW:CLASS:24" name="retinoid" comment="" chebi-id="CHEBI:26537" relevant="true" type="CLASS">retinoid</ne> from degradation or for controlled delivery. The capsule may contain the <ne id="WO2007039057.HC.class-names.63" epochem-id="EPOCHEM:NEW:CLASS:24" name="retinoid" comment="" chebi-id="CHEBI:26537" relevant="true" type="CLASS">retinoid</ne> alone or together with the <ne id="WO2007039057.HC.class-names.311" epochem-id="EPOCHEM:NEW:CLASS:319" name="fatty acid" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acid</ne> or a salt, <ne id="WO2007039057.HC.class-names.348" epochem-id="EPOCHEM:NEW:CLASS:185" name="ester" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">ester</ne> or <ne id="WO2007039057.HC.class-names.283" epochem-id="EPOCHEM:NEW:CLASS:138" name="amide" comment="" chebi-id="CHEBI:29337" relevant="false" type="CLASS">amide</ne> thereof with the preferences and definitions as defined above. Suitable encapsulation technologies are for example described in WO 0180823, WO 9903450, WO 9317784 or in Fragrance Journal (2001), 29(2), 83-90.
The composition of the present invention can also contain one or more additional pharmaceutically or cosmetically active ingredients, in particular for preventing or reducing acne, wrinkles, lines, atrophy, inflammation, as well as topical anesthetics, artificial tanning agents and accelerators, antimicrobial agents, antifungal agents and sun screening additives without being limited thereto.
Examples of such ingredients are <ne id="WO2007039057.HC.class-names.105" epochem-id="EPOCHEM:NEW:CLASS:31" name="peptides" comment="" chebi-id="CHEBI:16670" relevant="false" type="CLASS">peptides</ne> (e.g., Matrixyl(TM) [<ne id="WO2007039057.HC.class-names.412" epochem-id="EPOCHEM:NEW:CLASS:344" name="pentapeptide" comment="" chebi-id="WO2007039057:749349" relevant="false" type="CLASS">pentapeptide</ne> derivative]), <ne id="WO2007039057.HC.class-names.422" epochem-id="EPOCHEM:NEW:CLASS:968" name="oligopeptides" comment="" chebi-id="CHEBI:25676" relevant="false" type="CLASS">oligopeptides</ne>, wax-based synthetic <ne id="WO2007039057.HC.class-names.106" epochem-id="EPOCHEM:NEW:CLASS:31" name="peptides" comment="" chebi-id="CHEBI:16670" relevant="false" type="CLASS">peptides</ne> (e.g., <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.416" epochem-id="EPOCHEM:NEW:COMPOUND:163" name="octyl palmitate" comment="" chebi-id="WO2007039057:214322" relevant="false">octyl palmitate</ne> and <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.787" epochem-id="EPOCHEM:NEW:COMPOUND:1343" name="tribehenin" comment="" chebi-id="WO2007039057:378663" relevant="false">tribehenin</ne> and <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.160" epochem-id="EPOCHEM:NEW:COMPOUND:79" name="sorbitan isostearate" comment="" chebi-id="WO2007039057:54748" relevant="false">sorbitan isostearate</ne> and <ne id="WO2007039057.HC.class-names.386" epochem-id="EPOCHEM:NEW:CLASS:337" name="palmitoyl-oligopeptide" comment="" chebi-id="WO2007039057:606718" relevant="false" type="CLASS">palmitoyl-oligopeptide</ne>), <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.418" epochem-id="EPOCHEM:COMPOUND:1821" name="glycerol" comment="" chebi-id="CHEBI:17754" relevant="false">glycerol</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.128" epochem-id="EPOCHEM:COMPOUND:5985" name="urea" comment="" chebi-id="CHEBI:16199" relevant="false">urea</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.419" epochem-id="EPOCHEM:NEW:COMPOUND:164" name="guanidine" comment="" chebi-id="CHEBI:42820" relevant="false">guanidine</ne> (e.g. <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.788" epochem-id="EPOCHEM:NEW:COMPOUND:1344" name="amino guanidine" comment="" chebi-id="WO2007039057:125826" relevant="false">amino guanidine</ne>); <ne type="ONT" id="WO2007039057.HC.class-names.198" epochem-id="EPOCHEM:NEW:CLASS:71" name="vitamins" comment="" chebi-id="CHEBI:33229" relevant="true">vitamins</ne> and derivatives thereof such as <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.95" epochem-id="EPOCHEM:NEW:COMPOUND:55" name="vitamin C" comment="" chebi-id="WO2007039057:680303" relevant="false">vitamin C</ne> (<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.423" epochem-id="EPOCHEM:NEW:COMPOUND:166" name="ascorbicacid" comment="" chebi-id="WO2007039057:557744" relevant="false">ascorbic acid</ne>), <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.111" epochem-id="EPOCHEM:NEW:COMPOUND:62" name="vitamin A" comment="" chebi-id="CHEBI:17336" relevant="false">vitamin A</ne> (e.g., <ne id="WO2007039057.HC.class-names.64" epochem-id="EPOCHEM:NEW:CLASS:24" name="retinoid" comment="" chebi-id="CHEBI:26537" relevant="true" type="CLASS">retinoid</ne> derivatives such as <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.421" epochem-id="EPOCHEM:COMPOUND:3433" name="retinyl palmitate" comment="" chebi-id="CHEBI:17616" relevant="false">retinyl palmitate</ne> or <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.422" epochem-id="EPOCHEM:NEW:COMPOUND:165" name="retinyl propionate" comment="" chebi-id="WO2007039057:352444" relevant="false">retinyl propionate</ne>), <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.107" epochem-id="EPOCHEM:NEW:COMPOUND:4" name="vitamin E" comment="" chebi-id="CHEBI:33234" relevant="false">vitamin E</ne> (e.g., <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.829" epochem-id="EPOCHEM:NEW:COMPOUND:7" name="tocopherol acetate" comment="" chebi-id="WO2007039057:408844" relevant="false">tocopherol acetate</ne>), <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.424" epochem-id="EPOCHEM:NEW:COMPOUND:167" name="vitamin B3" comment="" chebi-id="WO2007039057:195119" relevant="false">vitamin B3</ne> (e.g. <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.425" epochem-id="EPOCHEM:NEW:COMPOUND:168" name="niacinamide" comment="" chebi-id="CHEBI:17154" relevant="false">niacinamide</ne>) and <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.426" epochem-id="EPOCHEM:NEW:COMPOUND:169" name="vitamin B5" comment="" chebi-id="CHEBI:46905" relevant="false">vitamin B5</ne> (e.g. <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.849" epochem-id="EPOCHEM:NEW:COMPOUND:8" name="panthenol" comment="" chebi-id="WO2007039057:777869" relevant="false">panthenol</ne>), <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.442" epochem-id="EPOCHEM:NEW:COMPOUND:170" name="vitamin B6" comment="" chebi-id="WO2007039057:503793" relevant="false">vitamin B6</ne> and <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.443" epochem-id="EPOCHEM:NEW:COMPOUND:171" name="vitamin B12" comment="" chebi-id="WO2007039057:62343" relevant="false">vitamin B12</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.864" epochem-id="EPOCHEM:COMPOUND:5166" name="biotin" comment="" chebi-id="CHEBI:15956" relevant="false">biotin</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.91" epochem-id="EPOCHEM:COMPOUND:5186" name="folic acid" comment="" chebi-id="CHEBI:27470" relevant="false">folic acid</ne>; anti-acne actives or medicaments (e.g. <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.445" epochem-id="EPOCHEM:COMPOUND:4708" name="resorcinol" comment="" chebi-id="CHEBI:27810" relevant="false">resorcinol</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.444" epochem-id="EPOCHEM:COMPOUND:750" name="salicylic acid" comment="" chebi-id="CHEBI:16914" relevant="false">salicylic acid</ne>, and the like); <ne type="ONT" id="WO2007039057.HC.class-names.97" epochem-id="EPOCHEM:NEW:CLASS:26" name="antioxidants" comment="" chebi-id="CHEBI:22586" relevant="false">antioxidants</ne> (e.g. <ne id="WO2007039057.HC.class-names.201" epochem-id="EPOCHEM:NEW:CLASS:73" name="phytosterols" comment="" chebi-id="CHEBI:26125" relevant="false" type="CLASS">phytosterols</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.63" epochem-id="EPOCHEM:COMPOUND:683" name="lipoic acid" comment="" chebi-id="CHEBI:16494" relevant="false">lipoic acid</ne>); <ne id="WO2007039057.HC.class-names.199" epochem-id="EPOCHEM:NEW:CLASS:72" name="flavonoids" comment="" chebi-id="CHEBI:24044" relevant="false" type="CLASS">flavonoids</ne> (e.g. <ne id="WO2007039057.HC.class-names.202" epochem-id="EPOCHEM:NEW:CLASS:74" name="isoflavones" comment="" chebi-id="CHEBI:38757" relevant="false" type="CLASS">isoflavones</ne>, <ne id="WO2007039057.HC.class-names.203" epochem-id="EPOCHEM:NEW:CLASS:75" name="phytoestrogens" comment="" chebi-id="WO2007039057:585707" relevant="false" type="CLASS">phytoestrogens</ne>); skin soothing and healing agents such as aloe vera extract, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.455" epochem-id="EPOCHEM:COMPOUND:6134" name="allantoin" comment="" chebi-id="CHEBI:15676" relevant="false">allantoin</ne> and the like;
agents suitable for aesthetic purposes such as essential oils, fragrances, skin sensates, opacifiers, aromatic compounds (e.g., clove oil, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.446" epochem-id="EPOCHEM:NEW:COMPOUND:172" name="menthol" comment="" chebi-id="WO2007039057:740779" relevant="false">menthol</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.818" epochem-id="EPOCHEM:COMPOUND:5335" name="camphor" comment="" chebi-id="CHEBI:36773" relevant="false">camphor</ne>, eucalyptus oil, and <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.447" epochem-id="EPOCHEM:COMPOUND:7908" name="eugenol" comment="" chebi-id="CHEBI:4917" relevant="false">eugenol</ne>), desquamatory actives, <ne id="WO2007039057.HC.class-names.204" epochem-id="EPOCHEM:NEW:CLASS:76" name="hydroxy acids" comment="" chebi-id="WO2007039057:303488" relevant="false" type="CLASS">hydroxy acids</ne> such as AHA <ne id="WO2007039057.HC.class-names.241" epochem-id="EPOCHEM:NEW:CLASS:85" name="acids" comment="" chebi-id="CHEBI:37527" relevant="false" type="CLASS">acids</ne>, radical scavengers, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.448" epochem-id="EPOCHEM:COMPOUND:3413" name="farnesol" comment="" chebi-id="CHEBI:28600" relevant="false">farnesol</ne>, antifungal actives in particular <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.449" epochem-id="EPOCHEM:NEW:COMPOUND:173" name="bisabolol" comment="" chebi-id="WO2007039057:768167" relevant="false">bisabolol</ne>, <ne id="WO2007039057.HC.class-names.421" epochem-id="EPOCHEM:NEW:CLASS:553" name="alkyldiols" comment="" chebi-id="WO2007039057:760322" relevant="false" type="CLASS">alkyldiols</ne> such as <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.450" epochem-id="EPOCHEM:NEW:COMPOUND:174" name="1 ,2-pentanediol" comment="" chebi-id="WO2007039057:961873" relevant="false">1 ,2-pentanediol</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.454" epochem-id="EPOCHEM:NEW:COMPOUND:177" name="hexanediol" comment="" chebi-id="WO2007039057:126764" relevant="false">hexanediol</ne> or <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.451" epochem-id="EPOCHEM:NEW:COMPOUND:175" name="1 ,2-octanediol" comment="" chebi-id="WO2007039057:45387" relevant="false">1 ,2-octanediol</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.452" epochem-id="EPOCHEM:COMPOUND:3167" name="phytol" comment="" chebi-id="CHEBI:17327" relevant="false">phytol</ne>, <ne id="WO2007039057.HC.class-names.182" epochem-id="EPOCHEM:NEW:CLASS:59" name="polyols" comment="" chebi-id="CHEBI:26191" relevant="false" type="CLASS">polyols</ne> such as <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.453" epochem-id="EPOCHEM:NEW:COMPOUND:176" name="phytanetriol" comment="" chebi-id="WO2007039057:346037" relevant="false">phytanetriol</ne>, <ne type="ONT" id="WO2007039057.HC.class-names.417" epochem-id="EPOCHEM:NEW:CLASS:530" name="ceramides" comment="" chebi-id="CHEBI:17761" relevant="false">ceramides</ne> and pseudoceramides, <ne id="WO2007039057.HC.class-names.387" epochem-id="EPOCHEM:NEW:CLASS:3" name="amino acids" comment="" chebi-id="CHEBI:33709" relevant="false" type="CLASS">amino acids</ne>, protein hydrolysates, polyunsaturated <ne id="WO2007039057.HC.class-names.88" epochem-id="EPOCHEM:NEW:CLASS:25" name="fatty acids" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acids</ne>, plant extracts like kinetin, DNA or RNA and their fragmentation products, <ne id="WO2007039057.HC.class-names.439" epochem-id="EPOCHEM:NEW:CLASS:1" name="carbohydrates" comment="" chebi-id="CHEBI:23008" relevant="false" type="CLASS">carbohydrates</ne>, conjugated <ne id="WO2007039057.HC.class-names.89" epochem-id="EPOCHEM:NEW:CLASS:25" name="fatty acids" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acids</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.907" epochem-id="EPOCHEM:NEW:COMPOUND:1621" name="carnitin" comment="" chebi-id="WO2007039057:940763" relevant="false">carnitin</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.122" epochem-id="EPOCHEM:COMPOUND:3945" name="carnosine" comment="" chebi-id="CHEBI:15727" relevant="false">carnosine</ne>, <ne id="WO2007039057.HC.class-names.440" epochem-id="EPOCHEM:NEW:CLASS:1134" name="biochinonen" comment="" chebi-id="WO2007039057:920065" relevant="false" type="CLASS">biochinonen</ne>, <ne id="WO2007039057.HC.class-names.441" epochem-id="EPOCHEM:NEW:CLASS:1135" name="phytofluen" comment="" chebi-id="WO2007039057:698556" relevant="false" type="CLASS">phytofluen</ne>, <ne id="WO2007039057.HC.class-names.442" epochem-id="EPOCHEM:NEW:CLASS:1136" name="phytoen" comment="" chebi-id="WO2007039057:648856" relevant="false" type="CLASS">phytoen</ne>, and their corresponding derivatives.
Additionally the cosmetic and pharmaceutical topical composition of the present invention may contain UV-screening agents (UV-filter).
The additional UV-screening agents are advantageously selected from IR, UV-A, UV-B, UV-C and/ or broadband filters. Examples of UV-B or broad spectrum screening agents, i.e. substances having absorption maximums between about 290 nm and 340 nm may be organic or inorganic compounds. Organic UV-B or broadband screening agents are e.g. <ne id="WO2007039057.HC.class-names.123" epochem-id="EPOCHEM:NEW:CLASS:39" name="acrylates" comment="" chebi-id="WO2007039057:571807" relevant="false" type="CLASS">acrylates</ne> such as <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.456" epochem-id="EPOCHEM:NEW:COMPOUND:178" name="2- ethylhexyl 2-cyano-3,3-diphenylacrylate" comment="" chebi-id="WO2007039057:450497" relevant="false">2- ethylhexyl 2-cyano-3,3-diphenylacrylate</ne> (<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.457" epochem-id="EPOCHEM:NEW:COMPOUND:179" name="octocrylene" comment="" chebi-id="WO2007039057:823558" relevant="false">octocrylene</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.458" epochem-id="EPOCHEM:NEW:COMPOUND:180" name="PARSOL&lt;(R)&gt; 340" comment="" chebi-id="WO2007039057:647928" relevant="false">PARSOL&lt;(R)&gt; 340</ne>), <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.459" epochem-id="EPOCHEM:NEW:COMPOUND:181" name="ethyl 2-cyano-3,3- diphenylacrylate" comment="" chebi-id="WO2007039057:317625" relevant="false">ethyl 2-cyano-3,3- diphenylacrylate</ne> and the like; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.819" epochem-id="EPOCHEM:COMPOUND:5335" name="camphor" comment="" chebi-id="CHEBI:36773" relevant="false">camphor</ne> derivatives such as <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.460" epochem-id="EPOCHEM:NEW:COMPOUND:182" name="4-methyl benzylidene camphor" comment="" chebi-id="WO2007039057:243863" relevant="false">4-methyl benzylidene camphor</ne> (<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.461" epochem-id="EPOCHEM:NEW:COMPOUND:183" name="PARSOL&lt;(R)&gt;5000" comment="" chebi-id="WO2007039057:716174" relevant="false">PARSOL&lt;(R)&gt; 5000</ne>), <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.462" epochem-id="EPOCHEM:NEW:COMPOUND:184" name="3-benzylidene camphor" comment="" chebi-id="WO2007039057:423684" relevant="false">3-benzylidene camphor</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.463" epochem-id="EPOCHEM:NEW:COMPOUND:185" name="camphor benzalkonium methosulfate" comment="" chebi-id="WO2007039057:811176" relevant="false">camphor benzalkonium methosulfate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.substance-names.26" epochem-id="EPOCHEM:NEW:SUBSTANCE:34" name="polyacrylamidomethyl benzylidene camphor" comment="" chebi-id="WO2007039057:16784" relevant="false">polyacrylamidomethyl benzylidene camphor</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.464" epochem-id="EPOCHEM:NEW:COMPOUND:186" name="sulfo benzylidene camphor" comment="" chebi-id="WO2007039057:812695" relevant="false">sulfo benzylidene camphor</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.465" epochem-id="EPOCHEM:NEW:COMPOUND:187" name="sulphomethyl benzylidene camphor" comment="" chebi-id="WO2007039057:177020" relevant="false">sulphomethyl benzylidene camphor</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.826" epochem-id="EPOCHEM:NEW:COMPOUND:1349" name="therephthalidene dicamphor sulfonic acid" comment="" chebi-id="WO2007039057:642180" relevant="false">therephthalidene dicamphor sulfonic acid</ne> and the like; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.827" epochem-id="EPOCHEM:NEW:COMPOUND:1350" name="Cinnamate" comment="" chebi-id="CHEBI:23248" relevant="false">Cinnamate</ne> derivatives such as <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.470" epochem-id="EPOCHEM:NEW:COMPOUND:192" name="ethylhexyl methoxycinnamate" comment="" chebi-id="WO2007039057:95968" relevant="false">ethylhexyl methoxycinnamate</ne> (<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.474" epochem-id="EPOCHEM:NEW:COMPOUND:193" name="PARSOL&lt;(R)&gt;MCX" comment="" chebi-id="WO2007039057:34433" relevant="false">PARSOL&lt;(R)&gt; MCX</ne>), <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.466" epochem-id="EPOCHEM:NEW:COMPOUND:188" name="ethoxyethyl methoxycinnamate" comment="" chebi-id="WO2007039057:985084" relevant="false">ethoxyethyl methoxycinnamate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.467" epochem-id="EPOCHEM:NEW:COMPOUND:189" name="diethanolamine methoxycinnamate" comment="" chebi-id="WO2007039057:618584" relevant="false">diethanolamine methoxycinnamate</ne> (<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.469" epochem-id="EPOCHEM:NEW:COMPOUND:191" name="PARSOL&lt;(R)&gt;Hydro" comment="" chebi-id="WO2007039057:709807" relevant="false">PARSOL&lt;(R)&gt; Hydro</ne>), <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.468" epochem-id="EPOCHEM:NEW:COMPOUND:190" name="isoamyl methoxycinnamate" comment="" chebi-id="WO2007039057:405917" relevant="false">isoamyl methoxycinnamate</ne> and the like as well as cinnamic acid derivatives bond to <ne id="WO2007039057.HC.class-names.413" epochem-id="EPOCHEM:NEW:CLASS:145" name="siloxanes" comment="" chebi-id="CHEBI:48138" relevant="false" type="CLASS">siloxanes</ne>; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.475" epochem-id="EPOCHEM:NEW:COMPOUND:194" name="p-aminobenzoic acid" comment="" chebi-id="CHEBI:30753" relevant="false">p- aminobenzoic acid</ne> derivatives, such as <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.476" epochem-id="EPOCHEM:NEW:COMPOUND:194" name="p-aminobenzoic acid" comment="" chebi-id="CHEBI:30753" relevant="false">p-aminobenzoic acid</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.477" epochem-id="EPOCHEM:NEW:COMPOUND:195" name="2-ethylhexyl p- dimethylaminobenzoate" comment="" chebi-id="WO2007039057:123442" relevant="false">2-ethylhexyl p- dimethylaminobenzoate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.478" epochem-id="EPOCHEM:NEW:COMPOUND:196" name="N-oxypropylenated ethyl p-aminobenzoate" comment="" chebi-id="WO2007039057:479799" relevant="false">N-oxypropylenated ethyl p-aminobenzoate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.479" epochem-id="EPOCHEM:NEW:COMPOUND:197" name="glyceryl p- aminobenzoate" comment="" chebi-id="WO2007039057:610438" relevant="false">glyceryl p- aminobenzoate</ne>; <ne id="WO2007039057.HC.class-names.206" epochem-id="EPOCHEM:NEW:CLASS:77" name="benzophenones" comment="" chebi-id="CHEBI:22726" relevant="false" type="CLASS">benzophenones</ne> such as <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.488" epochem-id="EPOCHEM:NEW:COMPOUND:205" name="benzophenone-3" comment="" chebi-id="WO2007039057:553040" relevant="false">benzophenone-3</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.489" epochem-id="EPOCHEM:NEW:COMPOUND:206" name="benzophenone-4" comment="" chebi-id="WO2007039057:859069" relevant="false">benzophenone-4</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.490" epochem-id="EPOCHEM:NEW:COMPOUND:207" name="2, 2', 4,4'- tetrahydroxy-benzophenone" comment="" chebi-id="WO2007039057:885882" relevant="false">2, 2', 4,4'- tetrahydroxy-benzophenone</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.483" epochem-id="EPOCHEM:NEW:COMPOUND:200" name="2,2'-dihydroxy-4,4'-dimethoxybenzophenone" comment="" chebi-id="WO2007039057:132449" relevant="false">2,2'-dihydroxy-4,4'-dimethoxybenzophenone</ne> and the like; <ne id="WO2007039057.HC.class-names.402" epochem-id="EPOCHEM:NEW:CLASS:338" name="esters" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">esters</ne> of <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.484" epochem-id="EPOCHEM:NEW:COMPOUND:201" name="benzalmalonic acid" comment="" chebi-id="WO2007039057:17604" relevant="false">benzalmalonic acid</ne> such as <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.485" epochem-id="EPOCHEM:NEW:COMPOUND:202" name="di-(2-ethylhexyl) 4-methoxybenzalmalonate" comment="" chebi-id="WO2007039057:128843" relevant="false">di-(2-ethylhexyl) 4-methoxybenzalmalonate</ne>; <ne id="WO2007039057.HC.class-names.403" epochem-id="EPOCHEM:NEW:CLASS:338" name="esters" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">esters</ne> of <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.486" epochem-id="EPOCHEM:NEW:COMPOUND:203" name="2-(4-ethoxy-anilinomethylene)propandioic acid" comment="" chebi-id="WO2007039057:57612" relevant="false">2-(4-ethoxy-anilinomethylene)propandioic acid</ne> such as <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.487" epochem-id="EPOCHEM:NEW:COMPOUND:204" name="2-(4-ethoxy anilinomethylene) propandioic acid diethyl ester" comment="" chebi-id="WO2007039057:274105" relevant="false">2-(4-ethoxy anilinomethylene) propandioic acid diethyl ester</ne> as described in the European Patent Publication EP 0895 776; <ne id="WO2007039057.HC.class-names.414" epochem-id="EPOCHEM:NEW:CLASS:345" name="organosiloxane" comment="" chebi-id="WO2007039057:182191" relevant="false" type="CLASS">organosiloxane</ne> compounds containing <ne type="LIGAND" id="WO2007039057.HC.ligand-names.334" epochem-id="EPOCHEM:NEW:LIGAND:541" name="benzmalonate groups" comment="" chebi-id="WO2007039057:105117" relevant="false">benzmalonate groups</ne> as described in the European Patent Publications EP 0358584 B1 , EP 0538431 B1 and EP 0709080 A1 such as PARSOL&lt;(R)&gt; SLX; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.491" epochem-id="EPOCHEM:NEW:COMPOUND:208" name="drometrizole trisiloxane" comment="" chebi-id="WO2007039057:976492" relevant="false">drometrizole trisiloxane</ne> (Mexoryl XL); <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.52" epochem-id="EPOCHEM:COMPOUND:5827" name="imidazole" comment="" chebi-id="CHEBI:16069" relevant="false">imidazole</ne> derivatives such as e.g. <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.492" epochem-id="EPOCHEM:NEW:COMPOUND:209" name="2-phenyl benzimidazole sulfonic acid" comment="" chebi-id="WO2007039057:744456" relevant="false">2-phenyl benzimidazole sulfonic acid</ne> and its salts (PARSOL&lt;(R)&gt;HS).
Salts of <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.493" epochem-id="EPOCHEM:NEW:COMPOUND:209" name="2-phenyl benzimidazole sulfonic acid" comment="" chebi-id="WO2007039057:744456" relevant="false">2-phenyl benzimidazole sulfonic acid</ne> are e.g. <ne id="WO2007039057.HC.class-names.385" epochem-id="EPOCHEM:NEW:CLASS:336" name="alkali" comment="" chebi-id="WO2007039057:241445" relevant="false" type="CLASS">alkali</ne> salts such as <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.895" epochem-id="EPOCHEM:COMPOUND:7085" name="sodium" comment="" chebi-id="CHEBI:26708" relevant="false">sodium</ne>- or <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.414" epochem-id="EPOCHEM:COMPOUND:7084" name="potassium" comment="" chebi-id="CHEBI:26216" relevant="false">potassium</ne> salts, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.405" epochem-id="EPOCHEM:COMPOUND:4221" name="ammonium" comment="" chebi-id="CHEBI:28938" relevant="false">ammonium</ne> salts, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.513" epochem-id="EPOCHEM:COMPOUND:5958" name="morpholine" comment="" chebi-id="CHEBI:34856" relevant="false">morpholine</ne> salts, salts of primary, sec. and tert. <ne id="WO2007039057.HC.class-names.443" epochem-id="EPOCHEM:NEW:CLASS:170" name="amines" comment="" chebi-id="CHEBI:32952" relevant="false" type="CLASS">amines</ne> like <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.514" epochem-id="EPOCHEM:NEW:COMPOUND:210" name="monoethanolamine" comment="" chebi-id="CHEBI:16000" relevant="false">monoethanolamine</ne> salts, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.263" epochem-id="EPOCHEM:COMPOUND:4092" name="diethanolamine" comment="" chebi-id="CHEBI:28123" relevant="false">diethanolamine</ne> salts and the like; salicylate derivatives such as <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.515" epochem-id="EPOCHEM:NEW:COMPOUND:211" name="isopropylbenzyl salicylate" comment="" chebi-id="WO2007039057:23494" relevant="false">isopropylbenzyl salicylate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.516" epochem-id="EPOCHEM:NEW:COMPOUND:212" name="benzyl salicylate" comment="" chebi-id="WO2007039057:686595" relevant="false">benzyl salicylate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.517" epochem-id="EPOCHEM:NEW:COMPOUND:213" name="butyl salicylate" comment="" chebi-id="WO2007039057:617504" relevant="false">butyl salicylate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.518" epochem-id="EPOCHEM:NEW:COMPOUND:214" name="ethylhexyl salicylate" comment="" chebi-id="WO2007039057:328507" relevant="false">ethylhexyl salicylate</ne> (PARSOL&lt;(R)&gt; EHS, Neo Heliopan OS), <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.521" epochem-id="EPOCHEM:NEW:COMPOUND:215" name="isooctyl salicylate" comment="" chebi-id="WO2007039057:225236" relevant="false">isooctyl salicylate</ne> or <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.522" epochem-id="EPOCHEM:NEW:COMPOUND:216" name="homomenthyl salicylate" comment="" chebi-id="WO2007039057:357811" relevant="false">homomenthyl salicylate</ne> (homosalate, PARSOL&lt;(R)&gt; HMS, Neo Heliopan HMS) and the like; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.523" epochem-id="EPOCHEM:NEW:COMPOUND:217" name="triazine" comment="" chebi-id="CHEBI:38056" relevant="false">triazine</ne> derivatives such as <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.525" epochem-id="EPOCHEM:NEW:COMPOUND:218" name="ethylhexyl triazone" comment="" chebi-id="WO2007039057:691716" relevant="false">ethylhexyl triazone</ne> (Uvinul T-150), <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.526" epochem-id="EPOCHEM:NEW:COMPOUND:219" name="diethylhexyl butamido triazone" comment="" chebi-id="WO2007039057:497496" relevant="false">diethylhexyl butamido triazone</ne> (Uvasorb HEB) and the like. Encapsulated UV-filters such as encapsulated <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.471" epochem-id="EPOCHEM:NEW:COMPOUND:192" name="ethylhexyl methoxycinnamate" comment="" chebi-id="WO2007039057:95968" relevant="false">ethylhexyl methoxycinnamate</ne> (Eusolex UV-pearls) or microcapsules loaded with UV-filters as e.g. dislosed in EP 1471995 and the like;
Examples of broad spectrum or UV A screening agents i.e. substances having absorption maximums between about 320 nm and 400 nm may be organic or inorganic compounds.
Organic broad spectrum or UV A screening agents include e.g. <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.527" epochem-id="EPOCHEM:NEW:COMPOUND:220" name="dibenzoylmethane" comment="" chebi-id="WO2007039057:694990" relevant="false">dibenzoylmethane</ne> derivatives such as <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.530" epochem-id="EPOCHEM:NEW:COMPOUND:221" name="4-tert.-butyl-4'-methoxydibenzoyl-methane" comment="text original" chebi-id="WO2007039057:918856" relevant="false">4-tert.-butyl-4'-methoxydibenzoyl-methane</ne> (PARSOL&lt;(R)&gt; 1789), <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.531" epochem-id="EPOCHEM:NEW:COMPOUND:222" name="dimethoxydibenzoylmethane" comment="" chebi-id="WO2007039057:567854" relevant="false">dimethoxydibenzoylmethane</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.532" epochem-id="EPOCHEM:NEW:COMPOUND:223" name="isopropyldibenzoylmethane" comment="" chebi-id="WO2007039057:960967" relevant="false">isopropyldibenzoylmethane</ne> and the like; <ne id="WO2007039057.HC.class-names.444" epochem-id="EPOCHEM:NEW:CLASS:1137" name="benzotriazole" comment="" chebi-id="WO2007039057:425065" relevant="false" type="CLASS">benzotriazole</ne> derivatives such as <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.533" epochem-id="EPOCHEM:NEW:COMPOUND:224" name="2,2'-methylene-bis-(6-(2H-benzotriazole-2-yl)-4-(1 , 1 ,3,3,- tetramethylbutyl)-phenol" comment="" chebi-id="WO2007039057:574954" relevant="false">2,2'-methylene-bis-(6-(2H-benzotriazole-2-yl)-4-(1 , 1 ,3,3,- tetramethylbutyl)-phenol</ne> (<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.534" epochem-id="EPOCHEM:NEW:COMPOUND:225" name="TinosorbM" comment="" chebi-id="WO2007039057:794140" relevant="false">Tinosorb M</ne>) and the like; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.535" epochem-id="EPOCHEM:NEW:COMPOUND:226" name="bis-ethylhexyloxyphenol methoxyphenyl triazine" comment="" chebi-id="WO2007039057:162416" relevant="false">bis-ethylhexyloxyphenol methoxyphenyl triazine</ne> (<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.536" epochem-id="EPOCHEM:NEW:COMPOUND:227" name="TinosorbS" comment="" chebi-id="WO2007039057:634438" relevant="false">Tinosorb S</ne>) and the like; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.537" epochem-id="EPOCHEM:NEW:COMPOUND:228" name="phenylene-1 ,4-bis-benzimidazolsulfonic acids" comment="" chebi-id="WO2007039057:472183" relevant="false">phenylene-1 ,4-bis-benzimidazolsulfonic acids</ne> or salts such as <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.538" epochem-id="EPOCHEM:NEW:COMPOUND:229" name="2,2-(1 ,4-phenylene)bis-(1 H-benzimidazol-4,6-disulfonic acid)" comment="" chebi-id="WO2007039057:314975" relevant="false">2,2-(1 ,4-phenylene)bis-(1 H-benzimidazol-4,6-disulfonic acid)</ne> (<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.539" epochem-id="EPOCHEM:NEW:COMPOUND:230" name="NeoheliopanAP" comment="" chebi-id="WO2007039057:984464" relevant="false">Neoheliopan AP</ne>); <ne type="LIGAND" id="WO2007039057.HC.ligand-names.18" epochem-id="EPOCHEM:NEW:LIGAND:6" name="amino" comment="" chebi-id="CHEBI:46882" relevant="false">amino</ne> substituted <ne id="WO2007039057.HC.class-names.207" epochem-id="EPOCHEM:NEW:CLASS:78" name="hydroxybenzophenones" comment="" chebi-id="CHEBI:24677" relevant="false" type="CLASS">hydroxybenzophenones</ne> such as <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.540" epochem-id="EPOCHEM:NEW:COMPOUND:231" name="2-(4-Diethylamino- 2-hydroxy-benzoyl)-benzoic acid hexylester" comment="" chebi-id="WO2007039057:167181" relevant="false">2-(4-Diethylamino- 2-hydroxy-benzoyl)-benzoic acid hexylester</ne> (<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.541" epochem-id="EPOCHEM:NEW:COMPOUND:232" name="UvinulA plus" comment="" chebi-id="WO2007039057:970376" relevant="false">Uvinul A plus</ne>) as described in the European Patent Publication EP 1046391 ; Ionic UV-A filters as described in the International Patent Publication WO2005080341 A1 ;
As <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.528" epochem-id="EPOCHEM:NEW:COMPOUND:220" name="dibenzoylmethane" comment="" chebi-id="WO2007039057:694990" relevant="false">dibenzoylmethane</ne> derivatives have limited photostability it may be desirable to photostabilize these UV-A screening agents. Thus, the term "conventional UV-A screening agent" also refers to <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.529" epochem-id="EPOCHEM:NEW:COMPOUND:220" name="dibenzoylmethane" comment="" chebi-id="WO2007039057:694990" relevant="false">dibenzoylmethane</ne> derivatives such as e.g. PARSOL&lt;(R)&gt; 1789 stabilized by, e.g. <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.544" epochem-id="EPOCHEM:NEW:COMPOUND:233" name="3,3-Diphenylacrylate" comment="" chebi-id="WO2007039057:657121" relevant="false">3,3-Diphenylacrylate</ne> derivatives as described in the European Patent Publications EP 0 514 491 B1 and EP 0 780 119 A1 ; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.549" epochem-id="EPOCHEM:NEW:COMPOUND:234" name="Benzylidene camphor" comment="" chebi-id="WO2007039057:990727" relevant="false">Benzylidene camphor</ne> derivatives as described in the US Patent No. 5,605,680; <ne id="WO2007039057.HC.class-names.208" epochem-id="EPOCHEM:NEW:CLASS:79" name="Organosiloxanes" comment="" chebi-id="CHEBI:48140" relevant="false" type="CLASS">Organosiloxanes</ne> containing <ne type="LIGAND" id="WO2007039057.HC.ligand-names.335" epochem-id="EPOCHEM:NEW:LIGAND:541" name="benzmalonate groups" comment="" chebi-id="WO2007039057:105117" relevant="false">benzmalonate groups</ne> as described in the European Patent Publications EP 0358584 B1 , EP 0538431 B1 and EP 0709080 A1. A good overview of UV-A- and UV-B screening agents which can be added to the compositions of the present invention can also be found in DE-A 103 27 432. All UV- screening agents disclosed in this document are also useful as components for the compositions of the present invention and are included herein by reference. Additionally the composition of the present invention may contain UV-A and UV-B filters. Further examples of UV- filters or screening agents are disclosed, e.g., in WO 04/000256, see especially pages 10-12 which are included herein by reference.
A safe and effective amount of the UV-screening agent is used, typically from about 1 wt. -% to about 20 wt.-%, more typically from about 2 wt.-% to about 10 wt.-% based on the total weight of the composition.
Other suitable UV-screening agents which may be incorporated into the cosmetic or pharmaceutical topical compositions of the present invention are inorganic <ne type="ONT" id="WO2007039057.HC.class-names.424" epochem-id="EPOCHEM:NEW:CLASS:913" name="pigments" comment="" chebi-id="CHEBI:26130" relevant="false">pigments</ne> such as microparticulated <ne id="WO2007039057.HC.class-names.209" epochem-id="EPOCHEM:NEW:CLASS:80" name="metal oxides" comment="" chebi-id="WO2007039057:615299" relevant="false" type="CLASS">metal oxides</ne> (e.g. PARSOL&lt;(R)&gt; TX).
Examples of such compounds include e.g. <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.550" epochem-id="EPOCHEM:COMPOUND:7651" name="titanium dioxide" comment="" chebi-id="CHEBI:32234" relevant="false">titanium dioxide</ne> having an average primary particle size of from about 15 nm to about 100 nm, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.551" epochem-id="EPOCHEM:COMPOUND:7673" name="zinc oxide" comment="" chebi-id="CHEBI:36560" relevant="false">zinc oxide</ne> having an average primary particle size of from about 15 nm to about 150 nm, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.552" epochem-id="EPOCHEM:NEW:COMPOUND:235" name="zirconium oxide" comment="" chebi-id="WO2007039057:385421" relevant="false">zirconium oxide</ne> having an average primary particle size of from about 15 nm to about 150 nm, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.553" epochem-id="EPOCHEM:NEW:COMPOUND:236" name="iron oxide" comment="" chebi-id="WO2007039057:768598" relevant="false">iron oxide</ne> having an average primary particle size of from about 15 nm to about 500 nm, and mixtures thereof. The <ne id="WO2007039057.HC.class-names.211" epochem-id="EPOCHEM:NEW:CLASS:81" name="metal oxide" comment="" chebi-id="WO2007039057:317597" relevant="false" type="CLASS">metal oxide</ne> particles may also be coated by <ne id="WO2007039057.HC.class-names.210" epochem-id="EPOCHEM:NEW:CLASS:80" name="metal oxides" comment="" chebi-id="WO2007039057:615299" relevant="false" type="CLASS">metal oxides</ne> such as e.g. <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.867" epochem-id="EPOCHEM:NEW:COMPOUND:2026" name="aluminum" comment="" chebi-id="CHEBI:28984" relevant="false">aluminum</ne> or <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.866" epochem-id="EPOCHEM:COMPOUND:7443" name="zirconium" comment="" chebi-id="CHEBI:33342" relevant="false">zirconium</ne> oxides or by organic coatings such as e.g. <ne id="WO2007039057.HC.class-names.183" epochem-id="EPOCHEM:NEW:CLASS:59" name="polyols" comment="" chebi-id="CHEBI:26191" relevant="false" type="CLASS">polyols</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.554" epochem-id="EPOCHEM:NEW:COMPOUND:237" name="methicone" comment="" chebi-id="WO2007039057:123966" relevant="false">methicone</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.555" epochem-id="EPOCHEM:NEW:COMPOUND:238" name="aluminum stearate" comment="" chebi-id="CHEBI:37867" relevant="false">aluminum stearate</ne>, <ne id="WO2007039057.HC.class-names.212" epochem-id="EPOCHEM:NEW:CLASS:82" name="alkyl silane" comment="" chebi-id="WO2007039057:957477" relevant="false" type="CLASS">alkyl silane</ne>. Such coatings are well known in the art. When used herein, the inorganic sunscreens are present in the amount of from about 0.1 wt.-% to about 20 wt.-%, preferably from about 0.5 wt.-% to about 10 wt.-%, more preferably from about 1wt.-% to about 5 wt.-% based on the total weight of the composition.
The <ne id="WO2007039057.HC.class-names.90" epochem-id="EPOCHEM:NEW:CLASS:25" name="fatty acids" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acids</ne> or a salt, <ne id="WO2007039057.HC.class-names.349" epochem-id="EPOCHEM:NEW:CLASS:185" name="ester" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">ester</ne> or <ne id="WO2007039057.HC.class-names.284" epochem-id="EPOCHEM:NEW:CLASS:138" name="amide" comment="" chebi-id="CHEBI:29337" relevant="false" type="CLASS">amide</ne> thereof with the preferences and definitions as given above are known or belong to a known class of compounds and as such can be prepared by known methods or in analogy thereto.
In another embodiment the invention relates to the use of a <ne id="WO2007039057.HC.class-names.312" epochem-id="EPOCHEM:NEW:CLASS:319" name="fatty acid" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acid</ne> or a salt, <ne id="WO2007039057.HC.class-names.350" epochem-id="EPOCHEM:NEW:CLASS:185" name="ester" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">ester</ne> or <ne id="WO2007039057.HC.class-names.285" epochem-id="EPOCHEM:NEW:CLASS:138" name="amide" comment="" chebi-id="CHEBI:29337" relevant="false" type="CLASS">amide</ne> with the definitions and preferences as given above for boosting the cosmetic effects of <ne id="WO2007039057.HC.class-names.43" epochem-id="EPOCHEM:NEW:CLASS:22" name="Retinoids" comment="" chebi-id="CHEBI:26537" relevant="false" type="CLASS">retinoids</ne> and/or tanning actives.
The efficacy of the compositions of the invention comprising <ne id="WO2007039057.HC.class-names.313" epochem-id="EPOCHEM:NEW:CLASS:319" name="fatty acid" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acid</ne> or a salt, <ne id="WO2007039057.HC.class-names.351" epochem-id="EPOCHEM:NEW:CLASS:185" name="ester" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">ester</ne> or <ne id="WO2007039057.HC.class-names.286" epochem-id="EPOCHEM:NEW:CLASS:138" name="amide" comment="" chebi-id="CHEBI:29337" relevant="false" type="CLASS">amide</ne> with the definitions and preferences as given above, optionally in combination with a <ne id="WO2007039057.HC.class-names.65" epochem-id="EPOCHEM:NEW:CLASS:24" name="retinoid" comment="" chebi-id="CHEBI:26537" relevant="true" type="CLASS">retinoid</ne> as well as the concept of a synergistic effect between a <ne id="WO2007039057.HC.class-names.66" epochem-id="EPOCHEM:NEW:CLASS:24" name="retinoid" comment="" chebi-id="CHEBI:26537" relevant="true" type="CLASS">retinoid</ne> and a <ne id="WO2007039057.HC.class-names.314" epochem-id="EPOCHEM:NEW:CLASS:319" name="fatty acid" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acid</ne> as defined above may be demonstrated in an in vitro test system using human primary keratinocytes as outlined below. The marker may be the enzyme Transglutaminase 1 , which is a well-known and common differentiation marker in human epidermal cells. Epidermal keratinocytes are isolated from human foreskin biopsies and cultured in keratinocyte serum free medium (KSFM, GIBCO) in a growth chamber with 37&lt;0&gt;C and 5% CO2. At the second passage, cells are transferred to 6 well plates and allowed to reach approximately 50% surface confluence.
The active ingredient(s) are solubilized in <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.299" epochem-id="EPOCHEM:COMPOUND:4765" name="ethanol" comment="" chebi-id="CHEBI:16236" relevant="false">ethanol</ne> or <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.300" epochem-id="EPOCHEM:COMPOUND:4765" name="ethanol" comment="" chebi-id="CHEBI:16236" relevant="false">ethanol</ne>/ <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.556" epochem-id="EPOCHEM:NEW:COMPOUND:239" name="tetrahydrofuran" comment="" chebi-id="CHEBI:26911" relevant="false">tetrahydrofuran</ne>. <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.12" epochem-id="EPOCHEM:COMPOUND:881" name="retinoic acid" comment="" chebi-id="CHEBI:15367" relevant="true">Retinoic acid</ne> solutions are handled under yellow light conditions only. When keratinocyte cultures reaches the appropriate confluence, the KSFM medium is supplemented with 1.3 mM <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.769" epochem-id="EPOCHEM:COMPOUND:7090" name="calcium" comment="" chebi-id="CHEBI:22984" relevant="false">calcium</ne>, in order to induce keratinocyte differentiation and thus also induce TG1 expression, and treatment is started by adding either a <ne id="WO2007039057.HC.class-names.67" epochem-id="EPOCHEM:NEW:CLASS:24" name="retinoid" comment="" chebi-id="CHEBI:26537" relevant="true" type="CLASS">retinoid</ne> such as <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.13" epochem-id="EPOCHEM:COMPOUND:881" name="retinoic acid" comment="" chebi-id="CHEBI:15367" relevant="true">retinoic acid</ne> or a <ne id="WO2007039057.HC.class-names.315" epochem-id="EPOCHEM:NEW:CLASS:319" name="fatty acid" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acid</ne> or a salt, <ne id="WO2007039057.HC.class-names.352" epochem-id="EPOCHEM:NEW:CLASS:185" name="ester" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">ester</ne> or <ne id="WO2007039057.HC.class-names.287" epochem-id="EPOCHEM:NEW:CLASS:138" name="amide" comment="" chebi-id="CHEBI:29337" relevant="false" type="CLASS">amide</ne> with the definitions and preferences as given above or both substances in combination. For every sample, medium and/or treatment substances are changed twice daily. Seventy-two hours after the beginning of the treatment, cells are harvested and the RNA extracted. RNA is reverse transcribed into cDNA. Relative quantification of TG1 mRNA transcript levels in control versus treatment cultures are determined using multiplexed real time PCR analysis.
The ability of the cosmetic or pharmaceutical compositions of the present invention to reduce skin wrinkles may be assessed by profilometric methods described in "Skin topography measurement by interference fringe projection: a technical validation". (Lagarde J M; Rouvrais C; Black D; Diridollou S; Gall Y, Skin research and technology: official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) (2001 May), 7(2), 112-21 or "Direct and non-direct measurement techniques for analysis of skin surface topography". Fischer T W; Wigger-Alberti W; Eisner P., Skin pharmacology and applied skin physiology (1999 Jan-Apr), 12(1-2), 1-11.
The ability of the compounds and compositions of the present invention to stimulate or protect hair growth may be determined with a mouse model described for example in WO 9817273. Instead of using <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.557" epochem-id="EPOCHEM:NEW:COMPOUND:240" name="Cyclophosphamide" comment="" chebi-id="CHEBI:4027" relevant="false">Cyclophosphamide</ne> (Neostar, Pharmacia) to damage hair follicle Mitomycin, or <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.558" epochem-id="EPOCHEM:NEW:COMPOUND:241" name="Methotrexate" comment="" chebi-id="CHEBI:44185" relevant="false">Methotrexate</ne> can be used. It is also possible to detect hair growth acceleration with newborn mice. They have a synchronized hair cycle and approximately after 3 weeks all hair follicles go into the telogen phase. Then the animals are treated and it is evaluated how fast and to what extend the hair is growing Similar tests using in vitro or in vivo setups can also be found in J. Invest. Dermato. symposium proceedings 3rd Int. Meeting of Hair Research Societies, 8/1 , p.39 - 45 (2003).
The following examples exemplify the invention, but they should not be construed as limiting the invention.
Example 1 An anti-aging formulation containing the ingredients indicated below can be prepared in a manner known per se.
Example formulation number 1
Ingredients % (w/w)
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.559" epochem-id="EPOCHEM:NEW:COMPOUND:242" name="Glyceryl Myristate" comment="" chebi-id="WO2007039057:385319" relevant="false">Glyceryl Myristate</ne> 4.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.568" epochem-id="EPOCHEM:NEW:COMPOUND:246" name="Cetyl Alcohol" comment="" chebi-id="CHEBI:16125" relevant="false">Cetyl Alcohol</ne> 2.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.565" epochem-id="EPOCHEM:NEW:COMPOUND:244" name="Steareth-2" comment="cas009005-00-9" chebi-id="WO2007039057:16308" relevant="false">Steareth-2</ne> 2.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.563" epochem-id="EPOCHEM:NEW:COMPOUND:243" name="Steareth-21" comment="CAS NO.: 9005-00-9 " chebi-id="WO2007039057:971757" relevant="false">Steareth-21</ne> 2.00 <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.650" epochem-id="EPOCHEM:NEW:COMPOUND:256" name="lsopropyl Myristate" comment="" chebi-id="WO2007039057:941951" relevant="false">lsopropyl Myristate</ne> 5.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.104" epochem-id="EPOCHEM:NEW:COMPOUND:10" name="tocopherol" comment="" chebi-id="CHEBI:27013" relevant="false">Tocopherol</ne> <ne type="LIGAND" id="WO2007039057.HC.ligand-names.326" epochem-id="EPOCHEM:NEW:LIGAND:327" name="acetate" comment="" chebi-id="CHEBI:30089" relevant="false">Acetate</ne> 0.50
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.472" epochem-id="EPOCHEM:NEW:COMPOUND:192" name="ethylhexyl methoxycinnamate" comment="" chebi-id="WO2007039057:95968" relevant="false">Ethylhexyl Methoxycinnamate</ne> 4.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.519" epochem-id="EPOCHEM:NEW:COMPOUND:214" name="ethylhexyl salicylate" comment="" chebi-id="WO2007039057:328507" relevant="false">Ethylhexyl Salicylate</ne> 2.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.567" epochem-id="EPOCHEM:NEW:COMPOUND:245" name="Butyl Methoxydibenzoylmethane" comment="" chebi-id="WO2007039057:20381" relevant="false">Butyl Methoxydibenzoylmethane</ne> 1.00
Almond Oil 2.00
BHT 0.05
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.569" epochem-id="EPOCHEM:NEW:COMPOUND:247" name="Phenoxyethanol" comment="" chebi-id="WO2007039057:872800" relevant="false">Phenoxyethanol</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.581" epochem-id="EPOCHEM:NEW:COMPOUND:248" name="Methylparaben" comment="" chebi-id="WO2007039057:179825" relevant="false">Methylparaben</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.593" epochem-id="EPOCHEM:NEW:COMPOUND:249" name="Ethylparaben" comment="" chebi-id="WO2007039057:489268" relevant="false">Ethylparaben</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.605" epochem-id="EPOCHEM:NEW:COMPOUND:250" name="Propylparaben" comment="" chebi-id="WO2007039057:368057" relevant="false">Propylparaben</ne> &amp; 0.80 <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.617" epochem-id="EPOCHEM:NEW:COMPOUND:251" name="Butylparaben" comment="" chebi-id="WO2007039057:697925" relevant="false">Butylparaben</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.629" epochem-id="EPOCHEM:NEW:COMPOUND:252" name="lsopropylparaben" comment="" chebi-id="WO2007039057:443642" relevant="false">lsopropylparaben</ne>
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.641" epochem-id="EPOCHEM:NEW:COMPOUND:253" name="Disodium EDTA" comment="" chebi-id="WO2007039057:514107" relevant="false">Disodium EDTA</ne> 0.10
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.642" epochem-id="EPOCHEM:NEW:COMPOUND:254" name="D-Panthenol" comment="" chebi-id="CHEBI:27373" relevant="false">D-Panthenol</ne> 0.30
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.205" epochem-id="EPOCHEM:NEW:COMPOUND:25" name="propylene glycol" comment="" chebi-id="CHEBI:16997" relevant="false">Propylene Glycol</ne> 4.00
<ne type="CHEMICAL" id="WO2007039057.HC.substance-names.27" epochem-id="EPOCHEM:NEW:SUBSTANCE:35" name="Polyacrylamide" comment="" chebi-id="WO2007039057:553195" relevant="false">Polyacrylamide</ne> &amp; <ne type="LIGAND" id="WO2007039057.HC.ligand-names.245" epochem-id="EPOCHEM:NEW:LIGAND:67" name="C13-14" comment="" chebi-id="WO2007039057:667116" relevant="false">C13-14</ne> <ne id="WO2007039057.HC.class-names.213" epochem-id="EPOCHEM:NEW:CLASS:83" name="lsoparaffin" comment="" chebi-id="WO2007039057:926810" relevant="false" type="CLASS">lsoparaffin</ne> &amp; <ne id="WO2007039057.HC.class-names.217" epochem-id="EPOCHEM:NEW:CLASS:84" name="Laureth" comment="" chebi-id="WO2007039057:192523" relevant="false" type="CLASS">Laureth</ne>-7 0.50
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.266" epochem-id="EPOCHEM:NEW:COMPOUND:132" name="9- hydroxy stearic acid" comment="" chebi-id="WO2007039057:377465" relevant="true">9-hydroxy stearic acid</ne> 0.50
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.742" epochem-id="EPOCHEM:NEW:COMPOUND:281" name="Retinol" comment="" chebi-id="WO2007039057:845039" relevant="false">Retinol</ne> 15D (<ne type="LIGAND" id="WO2007039057.HC.ligand-names.183" epochem-id="EPOCHEM:NEW:LIGAND:44" name="caprylic" comment="" chebi-id="WO2007039057:766489" relevant="false">Caprylic</ne>/<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.643" epochem-id="EPOCHEM:NEW:COMPOUND:255" name="CapricTriglyceride" comment="" chebi-id="WO2007039057:660099" relevant="false">Capric Triglyceride</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.743" epochem-id="EPOCHEM:NEW:COMPOUND:281" name="Retinol" comment="" chebi-id="WO2007039057:845039" relevant="false">Retinol</ne>) 0.50
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.795" epochem-id="EPOCHEM:NEW:COMPOUND:9" name="Water" comment="" chebi-id="CHEBI:15377" relevant="false">Water</ne> Ad 100
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.348" epochem-id="EPOCHEM:COMPOUND:4117" name="triethanolamine" comment="" chebi-id="CHEBI:28621" relevant="false">Triethanolamine</ne> q.s. Example 2
An anti-aging formulations containing the ingredients indicated below can be prepared in a manner known per se.
Example formulation number 2
Ingredients % (w/w)
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.560" epochem-id="EPOCHEM:NEW:COMPOUND:242" name="Glyceryl Myristate" comment="" chebi-id="WO2007039057:385319" relevant="false">Glyceryl Myristate</ne> 4.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.644" epochem-id="EPOCHEM:NEW:COMPOUND:246" name="Cetyl Alcohol" comment="" chebi-id="CHEBI:16125" relevant="false">Cetyl Alcohol</ne> 2.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.566" epochem-id="EPOCHEM:NEW:COMPOUND:244" name="Steareth-2" comment="cas009005-00-9" chebi-id="WO2007039057:16308" relevant="false">Steareth-2</ne> 2.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.564" epochem-id="EPOCHEM:NEW:COMPOUND:243" name="Steareth-21" comment="CAS NO.: 9005-00-9 " chebi-id="WO2007039057:971757" relevant="false">Steareth-21</ne> 2.00 <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.651" epochem-id="EPOCHEM:NEW:COMPOUND:256" name="lsopropyl Myristate" comment="" chebi-id="WO2007039057:941951" relevant="false">lsopropyl Myristate</ne> 5.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.654" epochem-id="EPOCHEM:NEW:COMPOUND:257" name="Tocopheryl Acetate" comment="" chebi-id="WO2007039057:992777" relevant="false">Tocopheryl Acetate</ne> 0.50
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.473" epochem-id="EPOCHEM:NEW:COMPOUND:192" name="ethylhexyl methoxycinnamate" comment="" chebi-id="WO2007039057:95968" relevant="false">Ethylhexyl Methoxycinnamate</ne> 4.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.520" epochem-id="EPOCHEM:NEW:COMPOUND:214" name="ethylhexyl salicylate" comment="" chebi-id="WO2007039057:328507" relevant="false">Ethylhexyl Salicylate</ne> 2.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.649" epochem-id="EPOCHEM:NEW:COMPOUND:245" name="Butyl Methoxydibenzoylmethane" comment="" chebi-id="WO2007039057:20381" relevant="false">Butyl Methoxydibenzoylmethane</ne> 1.00
Almond Oil 2.00
BHT 0.05 <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.570" epochem-id="EPOCHEM:NEW:COMPOUND:247" name="Phenoxyethanol" comment="" chebi-id="WO2007039057:872800" relevant="false">Phenoxyethanol</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.582" epochem-id="EPOCHEM:NEW:COMPOUND:248" name="Methylparaben" comment="" chebi-id="WO2007039057:179825" relevant="false">Methylparaben</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.594" epochem-id="EPOCHEM:NEW:COMPOUND:249" name="Ethylparaben" comment="" chebi-id="WO2007039057:489268" relevant="false">Ethylparaben</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.606" epochem-id="EPOCHEM:NEW:COMPOUND:250" name="Propylparaben" comment="" chebi-id="WO2007039057:368057" relevant="false">Propylparaben</ne> &amp; 0.80 <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.618" epochem-id="EPOCHEM:NEW:COMPOUND:251" name="Butylparaben" comment="" chebi-id="WO2007039057:697925" relevant="false">Butylparaben</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.630" epochem-id="EPOCHEM:NEW:COMPOUND:252" name="lsopropylparaben" comment="" chebi-id="WO2007039057:443642" relevant="false">lsopropylparaben</ne>
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.666" epochem-id="EPOCHEM:NEW:COMPOUND:260" name="Disodium EDTA" comment="" chebi-id="WO2007039057:514107" relevant="false">Disodium EDTA</ne> 0.10
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.660" epochem-id="EPOCHEM:NEW:COMPOUND:254" name="D-Panthenol" comment="" chebi-id="CHEBI:27373" relevant="false">D-Panthenol</ne> 0.30
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.206" epochem-id="EPOCHEM:NEW:COMPOUND:25" name="propylene glycol" comment="" chebi-id="CHEBI:16997" relevant="false">Propylene Glycol</ne> 4.00
<ne type="CHEMICAL" id="WO2007039057.HC.substance-names.28" epochem-id="EPOCHEM:NEW:SUBSTANCE:35" name="Polyacrylamide" comment="" chebi-id="WO2007039057:553195" relevant="false">Polyacrylamide</ne> &amp; <ne type="LIGAND" id="WO2007039057.HC.ligand-names.246" epochem-id="EPOCHEM:NEW:LIGAND:67" name="C13-14" comment="" chebi-id="WO2007039057:667116" relevant="false">C13-14</ne> <ne id="WO2007039057.HC.class-names.214" epochem-id="EPOCHEM:NEW:CLASS:83" name="lsoparaffin" comment="" chebi-id="WO2007039057:926810" relevant="false" type="CLASS">lsoparaffin</ne> &amp; <ne id="WO2007039057.HC.class-names.218" epochem-id="EPOCHEM:NEW:CLASS:84" name="Laureth" comment="" chebi-id="WO2007039057:192523" relevant="false" type="CLASS">Laureth</ne>-7 0.50
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.796" epochem-id="EPOCHEM:NEW:COMPOUND:9" name="Water" comment="" chebi-id="CHEBI:15377" relevant="false">Water</ne> Ad 100
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.674" epochem-id="EPOCHEM:NEW:COMPOUND:261" name="9-hydroxy-stearic acid" comment="" chebi-id="WO2007039057:254020" relevant="false">9-hydroxy-stearic acid</ne> 0.50
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.721" epochem-id="EPOCHEM:NEW:COMPOUND:275" name="Retinol Acetate" comment="" chebi-id="WO2007039057:401402" relevant="false">Retinol Acetate</ne> 2.8 Ml 0.10
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.349" epochem-id="EPOCHEM:COMPOUND:4117" name="triethanolamine" comment="" chebi-id="CHEBI:28621" relevant="false">Triethanolamine</ne> q.s.
Example 3
A facial treatment formulation containing the ingredients indicated below can be prepared in a manner known per se
Formulation No. 3
Inqredients % (w/w)
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.561" epochem-id="EPOCHEM:NEW:COMPOUND:242" name="Glyceryl Myristate" comment="" chebi-id="WO2007039057:385319" relevant="false">Glyceryl Myristate</ne> 5.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.645" epochem-id="EPOCHEM:NEW:COMPOUND:246" name="Cetyl Alcohol" comment="" chebi-id="CHEBI:16125" relevant="false">Cetyl Alcohol</ne> 2.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.191" epochem-id="EPOCHEM:NEW:COMPOUND:94" name="cetyl phosphate" comment="" chebi-id="WO2007039057:312882" relevant="false">Cetyl Phosphate</ne> 2.00 <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.652" epochem-id="EPOCHEM:NEW:COMPOUND:256" name="lsopropyl Myristate" comment="" chebi-id="WO2007039057:941951" relevant="false">lsopropyl Myristate</ne> 10.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.655" epochem-id="EPOCHEM:NEW:COMPOUND:257" name="Tocopheryl Acetate" comment="" chebi-id="WO2007039057:992777" relevant="false">Tocopheryl Acetate</ne> 0.30
Almond Oil 2.00
BHT 0.05
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.571" epochem-id="EPOCHEM:NEW:COMPOUND:247" name="Phenoxyethanol" comment="" chebi-id="WO2007039057:872800" relevant="false">Phenoxyethanol</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.583" epochem-id="EPOCHEM:NEW:COMPOUND:248" name="Methylparaben" comment="" chebi-id="WO2007039057:179825" relevant="false">Methylparaben</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.595" epochem-id="EPOCHEM:NEW:COMPOUND:249" name="Ethylparaben" comment="" chebi-id="WO2007039057:489268" relevant="false">Ethylparaben</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.607" epochem-id="EPOCHEM:NEW:COMPOUND:250" name="Propylparaben" comment="" chebi-id="WO2007039057:368057" relevant="false">Propylparaben</ne> &amp; 0.60
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.619" epochem-id="EPOCHEM:NEW:COMPOUND:251" name="Butylparaben" comment="" chebi-id="WO2007039057:697925" relevant="false">Butylparaben</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.631" epochem-id="EPOCHEM:NEW:COMPOUND:252" name="lsopropylparaben" comment="" chebi-id="WO2007039057:443642" relevant="false">lsopropylparaben</ne>
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.675" epochem-id="EPOCHEM:NEW:COMPOUND:262" name="Tromethamine" comment="" chebi-id="CHEBI:9754" relevant="false">Tromethamine</ne> 0.90
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.797" epochem-id="EPOCHEM:NEW:COMPOUND:9" name="Water" comment="" chebi-id="CHEBI:15377" relevant="false">Water</ne> Ad. 100
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.830" epochem-id="EPOCHEM:NEW:COMPOUND:2025" name="D-Panthenol" comment="" chebi-id="CHEBI:27373" relevant="false">D-Panthenol</ne> 0.20
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.661" epochem-id="EPOCHEM:NEW:COMPOUND:260" name="Disodium EDTA" comment="" chebi-id="WO2007039057:514107" relevant="false">Disodium EDTA</ne> 0.10
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.207" epochem-id="EPOCHEM:NEW:COMPOUND:25" name="propylene glycol" comment="" chebi-id="CHEBI:16997" relevant="false">Propylene Glycol</ne> 4.00
<ne type="CHEMICAL" id="WO2007039057.HC.substance-names.29" epochem-id="EPOCHEM:NEW:SUBSTANCE:35" name="Polyacrylamide" comment="" chebi-id="WO2007039057:553195" relevant="false">Polyacrylamide</ne> &amp; <ne type="LIGAND" id="WO2007039057.HC.ligand-names.247" epochem-id="EPOCHEM:NEW:LIGAND:67" name="C13-14" comment="" chebi-id="WO2007039057:667116" relevant="false">C13-14</ne> <ne id="WO2007039057.HC.class-names.215" epochem-id="EPOCHEM:NEW:CLASS:83" name="lsoparaffin" comment="" chebi-id="WO2007039057:926810" relevant="false" type="CLASS">lsoparaffin</ne> &amp; <ne id="WO2007039057.HC.class-names.219" epochem-id="EPOCHEM:NEW:CLASS:84" name="Laureth" comment="" chebi-id="WO2007039057:192523" relevant="false" type="CLASS">Laureth</ne>-7 2.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.267" epochem-id="EPOCHEM:NEW:COMPOUND:132" name="9- hydroxy stearic acid" comment="" chebi-id="WO2007039057:377465" relevant="true">9-hydroxy stearic acid</ne> 0.50
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.745" epochem-id="EPOCHEM:NEW:COMPOUND:281" name="Retinol" comment="" chebi-id="WO2007039057:845039" relevant="false">Retinol</ne> 15D (<ne type="LIGAND" id="WO2007039057.HC.ligand-names.184" epochem-id="EPOCHEM:NEW:LIGAND:44" name="caprylic" comment="" chebi-id="WO2007039057:766489" relevant="false">Caprylic</ne>/<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.828" epochem-id="EPOCHEM:NEW:COMPOUND:255" name="CapricTriglyceride" comment="" chebi-id="WO2007039057:660099" relevant="false">Capric Triglyceride</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.746" epochem-id="EPOCHEM:NEW:COMPOUND:281" name="Retinol" comment="" chebi-id="WO2007039057:845039" relevant="false">Retinol</ne>) 0.50
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.350" epochem-id="EPOCHEM:COMPOUND:4117" name="triethanolamine" comment="" chebi-id="CHEBI:28621" relevant="false">Triethanolamine</ne> q.s.
Example 4
A facial treatment formulation containing the ingredients indicated below can be prepared in a manner known per se
Formulation No. 4
Ingredients % (w/w)
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.562" epochem-id="EPOCHEM:NEW:COMPOUND:242" name="Glyceryl Myristate" comment="" chebi-id="WO2007039057:385319" relevant="false">Glyceryl Myristate</ne> 5.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.646" epochem-id="EPOCHEM:NEW:COMPOUND:246" name="Cetyl Alcohol" comment="" chebi-id="CHEBI:16125" relevant="false">Cetyl Alcohol</ne> 2.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.192" epochem-id="EPOCHEM:NEW:COMPOUND:94" name="cetyl phosphate" comment="" chebi-id="WO2007039057:312882" relevant="false">Cetyl Phosphate</ne> 2.00 <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.653" epochem-id="EPOCHEM:NEW:COMPOUND:256" name="lsopropyl Myristate" comment="" chebi-id="WO2007039057:941951" relevant="false">lsopropyl Myristate</ne> 10.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.656" epochem-id="EPOCHEM:NEW:COMPOUND:257" name="Tocopheryl Acetate" comment="" chebi-id="WO2007039057:992777" relevant="false">Tocopheryl Acetate</ne> 0.30
Almond Oil 2.00
BHT 0.05
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.572" epochem-id="EPOCHEM:NEW:COMPOUND:247" name="Phenoxyethanol" comment="" chebi-id="WO2007039057:872800" relevant="false">Phenoxyethanol</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.584" epochem-id="EPOCHEM:NEW:COMPOUND:248" name="Methylparaben" comment="" chebi-id="WO2007039057:179825" relevant="false">Methylparaben</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.596" epochem-id="EPOCHEM:NEW:COMPOUND:249" name="Ethylparaben" comment="" chebi-id="WO2007039057:489268" relevant="false">Ethylparaben</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.608" epochem-id="EPOCHEM:NEW:COMPOUND:250" name="Propylparaben" comment="" chebi-id="WO2007039057:368057" relevant="false">Propylparaben</ne> &amp; 0.60
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.620" epochem-id="EPOCHEM:NEW:COMPOUND:251" name="Butylparaben" comment="" chebi-id="WO2007039057:697925" relevant="false">Butylparaben</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.632" epochem-id="EPOCHEM:NEW:COMPOUND:252" name="lsopropylparaben" comment="" chebi-id="WO2007039057:443642" relevant="false">lsopropylparaben</ne>
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.676" epochem-id="EPOCHEM:NEW:COMPOUND:262" name="Tromethamine" comment="" chebi-id="CHEBI:9754" relevant="false">Tromethamine</ne> 0.90
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.798" epochem-id="EPOCHEM:NEW:COMPOUND:9" name="Water" comment="" chebi-id="CHEBI:15377" relevant="false">Water</ne> Ad. 100
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.831" epochem-id="EPOCHEM:NEW:COMPOUND:2025" name="D-Panthenol" comment="" chebi-id="CHEBI:27373" relevant="false">D-Panthenol</ne> 0.20
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.667" epochem-id="EPOCHEM:NEW:COMPOUND:260" name="Disodium EDTA" comment="" chebi-id="WO2007039057:514107" relevant="false">Disodium EDTA</ne> 0.10
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.208" epochem-id="EPOCHEM:NEW:COMPOUND:25" name="propylene glycol" comment="" chebi-id="CHEBI:16997" relevant="false">Propylene Glycol</ne> 4.00
<ne type="CHEMICAL" id="WO2007039057.HC.substance-names.30" epochem-id="EPOCHEM:NEW:SUBSTANCE:35" name="Polyacrylamide" comment="" chebi-id="WO2007039057:553195" relevant="false">Polyacrylamide</ne> &amp; <ne id="WO2007039057.HC.class-names.406" epochem-id="EPOCHEM:NEW:CLASS:341" name="C13-14 lsoparaffin" comment="" chebi-id="WO2007039057:930562" relevant="false" type="CLASS">C13-14 lsoparaffin</ne> &amp; <ne id="WO2007039057.HC.class-names.220" epochem-id="EPOCHEM:NEW:CLASS:84" name="Laureth" comment="" chebi-id="WO2007039057:192523" relevant="false" type="CLASS">Laureth</ne>-7 2.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.268" epochem-id="EPOCHEM:NEW:COMPOUND:132" name="9- hydroxy stearic acid" comment="" chebi-id="WO2007039057:377465" relevant="true">9-hydroxy stearic acid</ne> 0.50
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.722" epochem-id="EPOCHEM:NEW:COMPOUND:275" name="Retinol Acetate" comment="" chebi-id="WO2007039057:401402" relevant="false">Retinol Acetate</ne> 2.8 Ml 0.10
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.351" epochem-id="EPOCHEM:COMPOUND:4117" name="triethanolamine" comment="" chebi-id="CHEBI:28621" relevant="false">Triethanolamine</ne> q.s.
Example 5
Hair loss sera containing the ingredients indicated below can be prepared in a manner known per se
Formulation No 5
Ingredients % (w/w)
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.799" epochem-id="EPOCHEM:NEW:COMPOUND:9" name="Water" comment="" chebi-id="CHEBI:15377" relevant="false">Water</ne> Ad. 100
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.301" epochem-id="EPOCHEM:COMPOUND:4765" name="ethanol" comment="" chebi-id="CHEBI:16236" relevant="false">Ethanol</ne> 8.00 <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.677" epochem-id="EPOCHEM:NEW:COMPOUND:263" name="lsopropanol" comment="" chebi-id="WO2007039057:790628" relevant="false">lsopropanol</ne> 4.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.209" epochem-id="EPOCHEM:NEW:COMPOUND:25" name="propylene glycol" comment="" chebi-id="CHEBI:16997" relevant="false">Propylene Glycol</ne> 5.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.832" epochem-id="EPOCHEM:NEW:COMPOUND:2025" name="D-Panthenol" comment="" chebi-id="CHEBI:27373" relevant="false">D-Panthenol</ne> 0.20
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.684" epochem-id="EPOCHEM:NEW:COMPOUND:266" name="PEG-12 Dimethicone" comment="" chebi-id="WO2007039057:745283" relevant="false">PEG-12 Dimethicone</ne> 0.20
<ne type="LIGAND" id="WO2007039057.HC.ligand-names.330" epochem-id="EPOCHEM:NEW:LIGAND:335" name="PEG-40" comment="" chebi-id="WO2007039057:652711" relevant="false">PEG-40</ne> Hydrogenated Castor Oil 4.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.679" epochem-id="EPOCHEM:NEW:COMPOUND:264" name="Phytantriol" comment="" chebi-id="WO2007039057:49164" relevant="false">Phytantriol</ne> 0.05
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.681" epochem-id="EPOCHEM:NEW:COMPOUND:3" name="Vitamin E Acetate" comment="" chebi-id="WO2007039057:344931" relevant="false">Vitamin E Acetate</ne> 0.10
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.269" epochem-id="EPOCHEM:NEW:COMPOUND:132" name="9- hydroxy stearic acid" comment="" chebi-id="WO2007039057:377465" relevant="false">9-hydroxy stearic acid</ne> 0.50
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.748" epochem-id="EPOCHEM:NEW:COMPOUND:281" name="Retinol" comment="" chebi-id="WO2007039057:845039" relevant="false">Retinol</ne> 15D (<ne type="LIGAND" id="WO2007039057.HC.ligand-names.185" epochem-id="EPOCHEM:NEW:LIGAND:44" name="caprylic" comment="" chebi-id="WO2007039057:766489" relevant="false">Caprylic</ne>/<ne type="LIGAND" id="WO2007039057.HC.ligand-names.196" epochem-id="EPOCHEM:NEW:LIGAND:45" name="capric" comment="" chebi-id="WO2007039057:811964" relevant="false">Capric</ne> <ne id="WO2007039057.HC.class-names.425" epochem-id="EPOCHEM:NEW:CLASS:487" name="Triglyceride" comment="" chebi-id="CHEBI:17855" relevant="false" type="CLASS">Triglyceride</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.749" epochem-id="EPOCHEM:NEW:COMPOUND:281" name="Retinol" comment="" chebi-id="WO2007039057:845039" relevant="false">Retinol</ne>) 0.50
<ne type="FORMULA" id="WO2007039057.HC.formula-names.4" epochem-id="EPOCHEM:NEW:FORMULA:5" name="NaOH" comment="" chebi-id="CHEBI:32145" relevant="false">NaOH</ne> 10% q.s.
Example 6
Hair loss sera containing the ingredients indicated below can be prepared in a manner known per se
Formulation No 6
Ingredients % (w/w)
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.800" epochem-id="EPOCHEM:NEW:COMPOUND:9" name="Water" comment="" chebi-id="CHEBI:15377" relevant="false">Water</ne> Ad. 100
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.302" epochem-id="EPOCHEM:COMPOUND:4765" name="ethanol" comment="" chebi-id="CHEBI:16236" relevant="false">Ethanol</ne> 8.00 <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.678" epochem-id="EPOCHEM:NEW:COMPOUND:263" name="lsopropanol" comment="" chebi-id="WO2007039057:790628" relevant="false">lsopropanol</ne> 4.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.210" epochem-id="EPOCHEM:NEW:COMPOUND:25" name="propylene glycol" comment="" chebi-id="CHEBI:16997" relevant="false">Propylene Glycol</ne> 5.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.833" epochem-id="EPOCHEM:NEW:COMPOUND:2025" name="D-Panthenol" comment="" chebi-id="CHEBI:27373" relevant="false">D-Panthenol</ne> 0.20
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.683" epochem-id="EPOCHEM:NEW:COMPOUND:266" name="PEG-12 Dimethicone" comment="" chebi-id="WO2007039057:745283" relevant="false">PEG-12 Dimethicone</ne> 0.20
<ne type="LIGAND" id="WO2007039057.HC.ligand-names.331" epochem-id="EPOCHEM:NEW:LIGAND:335" name="PEG-40" comment="" chebi-id="WO2007039057:652711" relevant="false">PEG-40</ne> Hydrogenated Castor Oil 4.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.680" epochem-id="EPOCHEM:NEW:COMPOUND:264" name="Phytantriol" comment="" chebi-id="WO2007039057:49164" relevant="false">Phytantriol</ne> 0.05
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.109" epochem-id="EPOCHEM:NEW:COMPOUND:3" name="Vitamin E Acetate" comment="" chebi-id="WO2007039057:344931" relevant="false">Vitamin E</ne> <ne type="LIGAND" id="WO2007039057.HC.ligand-names.327" epochem-id="EPOCHEM:NEW:LIGAND:327" name="acetate" comment="" chebi-id="CHEBI:30089" relevant="false">Acetate</ne> 0.10
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.682" epochem-id="EPOCHEM:NEW:COMPOUND:265" name="9-hydroxyy stearic acid" comment="" chebi-id="WO2007039057:882440" relevant="false">9-hydroxyy stearic acid</ne> 0.50
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.723" epochem-id="EPOCHEM:NEW:COMPOUND:275" name="Retinol Acetate" comment="" chebi-id="WO2007039057:401402" relevant="false">Retinol Acetate</ne> 2.8 Ml 0.10
<ne type="FORMULA" id="WO2007039057.HC.formula-names.5" epochem-id="EPOCHEM:NEW:FORMULA:5" name="NaOH" comment="" chebi-id="CHEBI:32145" relevant="false">NaOH</ne> 10% q.s.
Example 7
A skin fortifier lotion containing the ingredients indicated below can be prepared in a manner known per se
Formulation No. 7
Ingredients % (w/w)
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.801" epochem-id="EPOCHEM:NEW:COMPOUND:9" name="Water" comment="" chebi-id="CHEBI:15377" relevant="false">Water</ne> Ad. 100
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.834" epochem-id="EPOCHEM:NEW:COMPOUND:2025" name="D-Panthenol" comment="" chebi-id="CHEBI:27373" relevant="false">D- Panthenol</ne> 0.05
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.764" epochem-id="EPOCHEM:NEW:COMPOUND:1340" name="Sodium Ascorbyl Phosphate" comment="" chebi-id="WO2007039057:296701" relevant="false">Sodium Ascorbyl Phosphate</ne> 0.20
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.211" epochem-id="EPOCHEM:NEW:COMPOUND:25" name="propylene glycol" comment="" chebi-id="CHEBI:16997" relevant="false">Propylene Glycol</ne> 5.00
<ne id="WO2007039057.HC.class-names.124" epochem-id="EPOCHEM:NEW:CLASS:39" name="acrylates" comment="" chebi-id="WO2007039057:571807" relevant="false" type="CLASS">Acrylates</ne>/<ne id="WO2007039057.HC.class-names.407" epochem-id="EPOCHEM:NEW:CLASS:340" name="C10- 30AlkylAcrylate" comment="" chebi-id="WO2007039057:925871" relevant="false" type="CLASS">C 10-30 Alkyl Acrylate</ne> Crosspolymer 0.50
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.869" epochem-id="EPOCHEM:NEW:COMPOUND:2027" name="Sodium Hydroxide" comment="" chebi-id="CHEBI:32145" relevant="false">Sodium Hydroxide</ne> 30% 0.40
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.668" epochem-id="EPOCHEM:NEW:COMPOUND:260" name="Disodium EDTA" comment="" chebi-id="WO2007039057:514107" relevant="false">Disodium EDTA</ne> 0.10
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.844" epochem-id="EPOCHEM:NEW:COMPOUND:2011" name="squalane" comment="" chebi-id="WO2007039057:290529" relevant="false">Squalane</ne> 2.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.573" epochem-id="EPOCHEM:NEW:COMPOUND:247" name="Phenoxyethanol" comment="" chebi-id="WO2007039057:872800" relevant="false">Phenoxyethanol</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.585" epochem-id="EPOCHEM:NEW:COMPOUND:248" name="Methylparaben" comment="" chebi-id="WO2007039057:179825" relevant="false">Methylparaben</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.597" epochem-id="EPOCHEM:NEW:COMPOUND:249" name="Ethylparaben" comment="" chebi-id="WO2007039057:489268" relevant="false">Ethylparaben</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.609" epochem-id="EPOCHEM:NEW:COMPOUND:250" name="Propylparaben" comment="" chebi-id="WO2007039057:368057" relevant="false">Propylparaben</ne> &amp; 0.80
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.621" epochem-id="EPOCHEM:NEW:COMPOUND:251" name="Butylparaben" comment="" chebi-id="WO2007039057:697925" relevant="false">Butylparaben</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.633" epochem-id="EPOCHEM:NEW:COMPOUND:252" name="lsopropylparaben" comment="" chebi-id="WO2007039057:443642" relevant="false">lsopropylparaben</ne>
Coco-Caprylate/Caprate 4.00
BHT 0.05
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.657" epochem-id="EPOCHEM:NEW:COMPOUND:257" name="Tocopheryl Acetate" comment="" chebi-id="WO2007039057:992777" relevant="false">Tocopheryl Acetate</ne> 0.10
<ne id="WO2007039057.HC.class-names.429" epochem-id="EPOCHEM:NEW:CLASS:969" name="Cyclomethicone" comment="" chebi-id="WO2007039057:784545" relevant="false" type="CLASS">Cyclomethicone</ne> 3.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.220" epochem-id="EPOCHEM:NEW:COMPOUND:98" name="glycerin" comment="" chebi-id="CHEBI:17754" relevant="false">Glycerin</ne> 3.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.270" epochem-id="EPOCHEM:NEW:COMPOUND:132" name="9- hydroxy stearic acid" comment="" chebi-id="WO2007039057:377465" relevant="true">9-hydroxy stearic acid</ne> 0.50
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.751" epochem-id="EPOCHEM:NEW:COMPOUND:281" name="Retinol" comment="" chebi-id="WO2007039057:845039" relevant="false">Retinol</ne> 15D (<ne type="LIGAND" id="WO2007039057.HC.ligand-names.186" epochem-id="EPOCHEM:NEW:LIGAND:44" name="caprylic" comment="" chebi-id="WO2007039057:766489" relevant="false">Caprylic</ne>/<ne type="LIGAND" id="WO2007039057.HC.ligand-names.197" epochem-id="EPOCHEM:NEW:LIGAND:45" name="capric" comment="" chebi-id="WO2007039057:811964" relevant="false">Capric</ne> <ne id="WO2007039057.HC.class-names.426" epochem-id="EPOCHEM:NEW:CLASS:487" name="Triglyceride" comment="" chebi-id="CHEBI:17855" relevant="false" type="CLASS">Triglyceride</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.752" epochem-id="EPOCHEM:NEW:COMPOUND:281" name="Retinol" comment="" chebi-id="WO2007039057:845039" relevant="false">Retinol</ne>) 0.50
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.870" epochem-id="EPOCHEM:NEW:COMPOUND:2027" name="Sodium Hydroxide" comment="" chebi-id="CHEBI:32145" relevant="false">Sodium Hydroxide</ne> 10% q.s.
Example 8
A skin fortifier lotion containing the ingredients indicated below can be prepared in a manner known per se
Formulation No. 8
Inqredients % (w/w)
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.802" epochem-id="EPOCHEM:NEW:COMPOUND:9" name="Water" comment="" chebi-id="CHEBI:15377" relevant="false">Water</ne> Ad. 100
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.835" epochem-id="EPOCHEM:NEW:COMPOUND:2025" name="D-Panthenol" comment="" chebi-id="CHEBI:27373" relevant="false">D- Panthenol</ne> 0.05
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.874" epochem-id="EPOCHEM:NEW:COMPOUND:1340" name="Sodium Ascorbyl Phosphate" comment="" chebi-id="WO2007039057:296701" relevant="false">Sodium Ascorbyl Phosphate</ne> 0.20
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.212" epochem-id="EPOCHEM:NEW:COMPOUND:25" name="propylene glycol" comment="" chebi-id="CHEBI:16997" relevant="false">Propylene Glycol</ne> 5.00
<ne id="WO2007039057.HC.class-names.125" epochem-id="EPOCHEM:NEW:CLASS:39" name="acrylates" comment="" chebi-id="WO2007039057:571807" relevant="false" type="CLASS">Acrylates</ne>/C 10-30 <ne type="LIGAND" id="WO2007039057.HC.ligand-names.343" epochem-id="EPOCHEM:NEW:LIGAND:543" name="Alkyl" comment="" chebi-id="WO2007039057:275769" relevant="false">Alkyl</ne> <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.197" epochem-id="EPOCHEM:COMPOUND:731" name="acrylate" comment="" chebi-id="CHEBI:37080" relevant="false">Acrylate</ne> Crosspolymer 0.50
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.871" epochem-id="EPOCHEM:NEW:COMPOUND:2027" name="Sodium Hydroxide" comment="" chebi-id="CHEBI:32145" relevant="false">Sodium Hydroxide</ne> 30% 0.40
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.669" epochem-id="EPOCHEM:NEW:COMPOUND:260" name="Disodium EDTA" comment="" chebi-id="WO2007039057:514107" relevant="false">Disodium EDTA</ne> 0.10
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.845" epochem-id="EPOCHEM:NEW:COMPOUND:2011" name="squalane" comment="" chebi-id="WO2007039057:290529" relevant="false">Squalane</ne> 2.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.574" epochem-id="EPOCHEM:NEW:COMPOUND:247" name="Phenoxyethanol" comment="" chebi-id="WO2007039057:872800" relevant="false">Phenoxyethanol</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.586" epochem-id="EPOCHEM:NEW:COMPOUND:248" name="Methylparaben" comment="" chebi-id="WO2007039057:179825" relevant="false">Methylparaben</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.598" epochem-id="EPOCHEM:NEW:COMPOUND:249" name="Ethylparaben" comment="" chebi-id="WO2007039057:489268" relevant="false">Ethylparaben</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.610" epochem-id="EPOCHEM:NEW:COMPOUND:250" name="Propylparaben" comment="" chebi-id="WO2007039057:368057" relevant="false">Propylparaben</ne> &amp; 0.80
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.622" epochem-id="EPOCHEM:NEW:COMPOUND:251" name="Butylparaben" comment="" chebi-id="WO2007039057:697925" relevant="false">Butylparaben</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.634" epochem-id="EPOCHEM:NEW:COMPOUND:252" name="lsopropylparaben" comment="" chebi-id="WO2007039057:443642" relevant="false">lsopropylparaben</ne>
Coco-Caprylate/Caprate 4.00
BHT 0.05
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.658" epochem-id="EPOCHEM:NEW:COMPOUND:257" name="Tocopheryl Acetate" comment="" chebi-id="WO2007039057:992777" relevant="false">Tocopheryl Acetate</ne> 0.10
<ne id="WO2007039057.HC.class-names.430" epochem-id="EPOCHEM:NEW:CLASS:969" name="Cyclomethicone" comment="" chebi-id="WO2007039057:784545" relevant="false" type="CLASS">Cyclomethicone</ne> 3.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.221" epochem-id="EPOCHEM:NEW:COMPOUND:98" name="glycerin" comment="" chebi-id="CHEBI:17754" relevant="false">Glycerin</ne> 3.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.271" epochem-id="EPOCHEM:NEW:COMPOUND:132" name="9- hydroxy stearic acid" comment="" chebi-id="WO2007039057:377465" relevant="true">9-hydroxy stearic acid</ne> 0.50
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.724" epochem-id="EPOCHEM:NEW:COMPOUND:275" name="Retinol Acetate" comment="" chebi-id="WO2007039057:401402" relevant="false">Retinol Acetate</ne> 2.8 Ml 0.10
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.872" epochem-id="EPOCHEM:NEW:COMPOUND:2027" name="Sodium Hydroxide" comment="" chebi-id="CHEBI:32145" relevant="false">Sodium Hydroxide</ne> 10% q.s.
Example 9
A formulation to treat age spots containing the ingredients indicated below can be prepared in a manner known per se
Formulation No. 9
Ingredients % (w[Lambda]v)
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.803" epochem-id="EPOCHEM:NEW:COMPOUND:9" name="Water" comment="" chebi-id="CHEBI:15377" relevant="false">Water</ne> Ad. 100
<ne type="CHEMICAL" id="WO2007039057.HC.substance-names.44" epochem-id="EPOCHEM:NEW:SUBSTANCE:281" name="Polyquaternium-10" comment="" chebi-id="WO2007039057:373869" relevant="false">Polyquaternium-10</ne> 0.10
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.836" epochem-id="EPOCHEM:NEW:COMPOUND:2025" name="D-Panthenol" comment="" chebi-id="CHEBI:27373" relevant="false">D- Panthenol</ne> 0.50
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.875" epochem-id="EPOCHEM:NEW:COMPOUND:1340" name="Sodium Ascorbyl Phosphate" comment="" chebi-id="WO2007039057:296701" relevant="false">Sodium Ascorbyl Phosphate</ne> 1.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.877" epochem-id="EPOCHEM:NEW:COMPOUND:2028" name="Niacinamid" comment="" chebi-id="WO2007039057:476025" relevant="false">Niacinamid</ne> 0.50
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.213" epochem-id="EPOCHEM:NEW:COMPOUND:25" name="propylene glycol" comment="" chebi-id="CHEBI:16997" relevant="false">Propylene Glycol</ne> 4.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.222" epochem-id="EPOCHEM:NEW:COMPOUND:98" name="glycerin" comment="" chebi-id="CHEBI:17754" relevant="false">Glycerin</ne> 3.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.701" epochem-id="EPOCHEM:NEW:COMPOUND:273" name="PEG-12" comment="" chebi-id="WO2007039057:527469" relevant="false">PEG-12</ne> <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.729" epochem-id="EPOCHEM:NEW:COMPOUND:276" name="Dimethicone" comment="" chebi-id="CHEBI:31498" relevant="false">Dimethicone</ne> 0.20
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.670" epochem-id="EPOCHEM:NEW:COMPOUND:260" name="Disodium EDTA" comment="" chebi-id="WO2007039057:514107" relevant="false">Disodium EDTA</ne> 0.10
<ne type="CHEMICAL" id="WO2007039057.HC.substance-names.37" epochem-id="EPOCHEM:NEW:SUBSTANCE:126" name="Polysorbate" comment="" chebi-id="WO2007039057:885715" relevant="false">Polysorbate</ne> 20 5.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.575" epochem-id="EPOCHEM:NEW:COMPOUND:247" name="Phenoxyethanol" comment="" chebi-id="WO2007039057:872800" relevant="false">Phenoxyethanol</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.587" epochem-id="EPOCHEM:NEW:COMPOUND:248" name="Methylparaben" comment="" chebi-id="WO2007039057:179825" relevant="false">Methylparaben</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.599" epochem-id="EPOCHEM:NEW:COMPOUND:249" name="Ethylparaben" comment="" chebi-id="WO2007039057:489268" relevant="false">Ethylparaben</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.611" epochem-id="EPOCHEM:NEW:COMPOUND:250" name="Propylparaben" comment="" chebi-id="WO2007039057:368057" relevant="false">Propylparaben</ne> &amp; 0.80
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.623" epochem-id="EPOCHEM:NEW:COMPOUND:251" name="Butylparaben" comment="" chebi-id="WO2007039057:697925" relevant="false">Butylparaben</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.635" epochem-id="EPOCHEM:NEW:COMPOUND:252" name="lsopropylparaben" comment="" chebi-id="WO2007039057:443642" relevant="false">lsopropylparaben</ne>
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.272" epochem-id="EPOCHEM:NEW:COMPOUND:132" name="9- hydroxy stearic acid" comment="" chebi-id="WO2007039057:377465" relevant="true">9-hydroxy stearic acid</ne> 0.50
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.754" epochem-id="EPOCHEM:NEW:COMPOUND:281" name="Retinol" comment="" chebi-id="WO2007039057:845039" relevant="false">Retinol</ne> 15D (<ne type="LIGAND" id="WO2007039057.HC.ligand-names.187" epochem-id="EPOCHEM:NEW:LIGAND:44" name="caprylic" comment="" chebi-id="WO2007039057:766489" relevant="false">Caprylic</ne>/<ne type="LIGAND" id="WO2007039057.HC.ligand-names.198" epochem-id="EPOCHEM:NEW:LIGAND:45" name="capric" comment="" chebi-id="WO2007039057:811964" relevant="false">Capric</ne> <ne id="WO2007039057.HC.class-names.427" epochem-id="EPOCHEM:NEW:CLASS:487" name="Triglyceride" comment="" chebi-id="CHEBI:17855" relevant="false" type="CLASS">Triglyceride</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.755" epochem-id="EPOCHEM:NEW:COMPOUND:281" name="Retinol" comment="" chebi-id="WO2007039057:845039" relevant="false">Retinol</ne>) 0.50
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.765" epochem-id="EPOCHEM:NEW:COMPOUND:2027" name="Sodium Hydroxide" comment="" chebi-id="CHEBI:32145" relevant="false">Sodium Hydroxide</ne> 10% q.s.
Example 10
A formulation to treat age spots containing the ingredients indicated below can be prepared in a manner known per se
Formulation No. 10
Inqredients % (w/w)
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.804" epochem-id="EPOCHEM:NEW:COMPOUND:9" name="Water" comment="" chebi-id="CHEBI:15377" relevant="false">Water</ne> Ad. 100.
<ne type="CHEMICAL" id="WO2007039057.HC.substance-names.45" epochem-id="EPOCHEM:NEW:SUBSTANCE:281" name="Polyquaternium-10" comment="" chebi-id="WO2007039057:373869" relevant="false">Polyquaternium-10</ne> 0.10
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.837" epochem-id="EPOCHEM:NEW:COMPOUND:2025" name="D-Panthenol" comment="" chebi-id="CHEBI:27373" relevant="false">D- Panthenol</ne> 0.50
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.876" epochem-id="EPOCHEM:NEW:COMPOUND:1340" name="Sodium Ascorbyl Phosphate" comment="" chebi-id="WO2007039057:296701" relevant="false">Sodium Ascorbyl Phosphate</ne> 1.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.878" epochem-id="EPOCHEM:NEW:COMPOUND:2028" name="Niacinamid" comment="" chebi-id="WO2007039057:476025" relevant="false">Niacinamid</ne> 0.50
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.214" epochem-id="EPOCHEM:NEW:COMPOUND:25" name="propylene glycol" comment="" chebi-id="CHEBI:16997" relevant="false">Propylene Glycol</ne> 4.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.223" epochem-id="EPOCHEM:NEW:COMPOUND:98" name="glycerin" comment="" chebi-id="CHEBI:17754" relevant="false">Glycerin</ne> 3.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.702" epochem-id="EPOCHEM:NEW:COMPOUND:273" name="PEG-12" comment="" chebi-id="WO2007039057:527469" relevant="false">PEG-12</ne> <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.730" epochem-id="EPOCHEM:NEW:COMPOUND:276" name="Dimethicone" comment="" chebi-id="CHEBI:31498" relevant="false">Dimethicone</ne> 0.20
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.671" epochem-id="EPOCHEM:NEW:COMPOUND:260" name="Disodium EDTA" comment="" chebi-id="WO2007039057:514107" relevant="false">Disodium EDTA</ne> 0.10
<ne type="CHEMICAL" id="WO2007039057.HC.substance-names.38" epochem-id="EPOCHEM:NEW:SUBSTANCE:126" name="Polysorbate" comment="" chebi-id="WO2007039057:885715" relevant="false">Polysorbate</ne> 20 5.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.576" epochem-id="EPOCHEM:NEW:COMPOUND:247" name="Phenoxyethanol" comment="" chebi-id="WO2007039057:872800" relevant="false">Phenoxyethanol</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.588" epochem-id="EPOCHEM:NEW:COMPOUND:248" name="Methylparaben" comment="" chebi-id="WO2007039057:179825" relevant="false">Methylparaben</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.600" epochem-id="EPOCHEM:NEW:COMPOUND:249" name="Ethylparaben" comment="" chebi-id="WO2007039057:489268" relevant="false">Ethylparaben</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.612" epochem-id="EPOCHEM:NEW:COMPOUND:250" name="Propylparaben" comment="" chebi-id="WO2007039057:368057" relevant="false">Propylparaben</ne> &amp; 0.80
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.624" epochem-id="EPOCHEM:NEW:COMPOUND:251" name="Butylparaben" comment="" chebi-id="WO2007039057:697925" relevant="false">Butylparaben</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.636" epochem-id="EPOCHEM:NEW:COMPOUND:252" name="lsopropylparaben" comment="" chebi-id="WO2007039057:443642" relevant="false">lsopropylparaben</ne>
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.273" epochem-id="EPOCHEM:NEW:COMPOUND:132" name="9- hydroxy stearic acid" comment="" chebi-id="WO2007039057:377465" relevant="false">9-hydroxy stearic acid</ne> 0.50
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.685" epochem-id="EPOCHEM:NEW:COMPOUND:275" name="Retinol Acetate" comment="" chebi-id="WO2007039057:401402" relevant="false">Retinol Acetate</ne> 2.8 Ml 0.10
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.873" epochem-id="EPOCHEM:NEW:COMPOUND:2027" name="Sodium Hydroxide" comment="" chebi-id="CHEBI:32145" relevant="false">Sodium Hydroxide</ne> 10% q.s.
Example 11
Anti-cellulite formulations containing the ingredients indicated below can be prepared in a manner known per se
Formulation No. 11
Inqredients % (w/w)
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.805" epochem-id="EPOCHEM:NEW:COMPOUND:9" name="Water" comment="" chebi-id="CHEBI:15377" relevant="false">Water</ne> Ad. 100
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.733" epochem-id="EPOCHEM:NEW:COMPOUND:277" name="Caffeine" comment="" chebi-id="CHEBI:27732" relevant="false">Caffeine</ne> 1.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.838" epochem-id="EPOCHEM:NEW:COMPOUND:2025" name="D-Panthenol" comment="" chebi-id="CHEBI:27373" relevant="false">D-Panthenol</ne> 0.50
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.224" epochem-id="EPOCHEM:NEW:COMPOUND:98" name="glycerin" comment="" chebi-id="CHEBI:17754" relevant="false">Glycerin</ne> 4.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.735" epochem-id="EPOCHEM:NEW:COMPOUND:278" name="Butylene Glycol" comment="" chebi-id="WO2007039057:776167" relevant="false">Butylene Glycol</ne> 2.00
<ne id="WO2007039057.HC.class-names.126" epochem-id="EPOCHEM:NEW:CLASS:39" name="acrylates" comment="" chebi-id="WO2007039057:571807" relevant="false" type="CLASS">Acrylates</ne>/<ne id="WO2007039057.HC.class-names.405" epochem-id="EPOCHEM:NEW:CLASS:340" name="C10- 30AlkylAcrylate" comment="" chebi-id="WO2007039057:925871" relevant="false" type="CLASS">C 10-30 Alkyl Acrylate</ne> Crosspolymer 0.20
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.737" epochem-id="EPOCHEM:NEW:COMPOUND:279" name="Disodium EDETA" comment="EDTA" chebi-id="WO2007039057:411403" relevant="false">Disodium EDETA</ne> 0.10
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.809" epochem-id="EPOCHEM:NEW:COMPOUND:1346" name="Arachidyl Alcohol" comment="" chebi-id="WO2007039057:949898" relevant="false">Arachidyl Alcohol</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.811" epochem-id="EPOCHEM:NEW:COMPOUND:1347" name="Behenyl Alcohol" comment="" chebi-id="CHEBI:31000" relevant="false">Behenyl Alcohol</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.813" epochem-id="EPOCHEM:NEW:COMPOUND:1348" name="Arachidyl Glucoside" comment="" chebi-id="WO2007039057:347563" relevant="false">Arachidyl Glucoside</ne> 5.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.846" epochem-id="EPOCHEM:NEW:COMPOUND:2011" name="squalane" comment="" chebi-id="WO2007039057:290529" relevant="false">Squalane</ne> 2.00
Mineral Oil 4.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.577" epochem-id="EPOCHEM:NEW:COMPOUND:247" name="Phenoxyethanol" comment="" chebi-id="WO2007039057:872800" relevant="false">Phenoxyethanol</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.589" epochem-id="EPOCHEM:NEW:COMPOUND:248" name="Methylparaben" comment="" chebi-id="WO2007039057:179825" relevant="false">Methylparaben</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.601" epochem-id="EPOCHEM:NEW:COMPOUND:249" name="Ethylparaben" comment="" chebi-id="WO2007039057:489268" relevant="false">Ethylparaben</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.613" epochem-id="EPOCHEM:NEW:COMPOUND:250" name="Propylparaben" comment="" chebi-id="WO2007039057:368057" relevant="false">Propylparaben</ne> &amp; 0.80
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.625" epochem-id="EPOCHEM:NEW:COMPOUND:251" name="Butylparaben" comment="" chebi-id="WO2007039057:697925" relevant="false">Butylparaben</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.637" epochem-id="EPOCHEM:NEW:COMPOUND:252" name="lsopropylparaben" comment="" chebi-id="WO2007039057:443642" relevant="false">lsopropylparaben</ne> <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.739" epochem-id="EPOCHEM:NEW:COMPOUND:280" name="lsononyl lsononanoate" comment="" chebi-id="WO2007039057:493766" relevant="false">lsononyl lsononanoate</ne> 4.00
BHT 0.05
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.647" epochem-id="EPOCHEM:NEW:COMPOUND:246" name="Cetyl Alcohol" comment="" chebi-id="CHEBI:16125" relevant="false">Cetyl Alcohol</ne> 2.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.731" epochem-id="EPOCHEM:NEW:COMPOUND:276" name="Dimethicone" comment="" chebi-id="CHEBI:31498" relevant="false">Dimethicone</ne> 0.50
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.659" epochem-id="EPOCHEM:NEW:COMPOUND:257" name="Tocopheryl Acetate" comment="" chebi-id="WO2007039057:992777" relevant="false">Tocopheryl Acetate</ne> 0.10
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.274" epochem-id="EPOCHEM:NEW:COMPOUND:132" name="9- hydroxy stearic acid" comment="" chebi-id="WO2007039057:377465" relevant="true">9-hydroxy stearic acid</ne> 0.50
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.757" epochem-id="EPOCHEM:NEW:COMPOUND:281" name="Retinol" comment="" chebi-id="WO2007039057:845039" relevant="false">Retinol</ne> 15D (<ne type="LIGAND" id="WO2007039057.HC.ligand-names.188" epochem-id="EPOCHEM:NEW:LIGAND:44" name="caprylic" comment="" chebi-id="WO2007039057:766489" relevant="false">Caprylic</ne>/<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.816" epochem-id="EPOCHEM:NEW:COMPOUND:255" name="CapricTriglyceride" comment="" chebi-id="WO2007039057:660099" relevant="false">Capric Triglyceride</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.758" epochem-id="EPOCHEM:NEW:COMPOUND:281" name="Retinol" comment="" chebi-id="WO2007039057:845039" relevant="false">Retinol</ne>) 0.50
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.352" epochem-id="EPOCHEM:COMPOUND:4117" name="triethanolamine" comment="" chebi-id="CHEBI:28621" relevant="false">Triethanolamine</ne> q.s.
Example 12
An anti-cellulite formulation containing the ingredients indicated below can be prepared in a manner known per se
Formulation No. 12
Inqredients % (w/w)
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.806" epochem-id="EPOCHEM:NEW:COMPOUND:9" name="Water" comment="" chebi-id="CHEBI:15377" relevant="false">Water</ne> Ad 100
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.734" epochem-id="EPOCHEM:NEW:COMPOUND:277" name="Caffeine" comment="" chebi-id="CHEBI:27732" relevant="false">Caffeine</ne> 1 00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.839" epochem-id="EPOCHEM:NEW:COMPOUND:2025" name="D-Panthenol" comment="" chebi-id="CHEBI:27373" relevant="false">D-Panthenol</ne> 0 50
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.225" epochem-id="EPOCHEM:NEW:COMPOUND:98" name="glycerin" comment="" chebi-id="CHEBI:17754" relevant="false">Glycerin</ne> 4 00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.736" epochem-id="EPOCHEM:NEW:COMPOUND:278" name="Butylene Glycol" comment="" chebi-id="WO2007039057:776167" relevant="false">Butylene Glycol</ne> 2 00
<ne id="WO2007039057.HC.class-names.127" epochem-id="EPOCHEM:NEW:CLASS:39" name="acrylates" comment="" chebi-id="WO2007039057:571807" relevant="false" type="CLASS">Acrylates</ne>/C 10-30 <ne type="LIGAND" id="WO2007039057.HC.ligand-names.344" epochem-id="EPOCHEM:NEW:LIGAND:543" name="Alkyl" comment="" chebi-id="WO2007039057:275769" relevant="false">Alkyl</ne> <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.199" epochem-id="EPOCHEM:COMPOUND:731" name="acrylate" comment="" chebi-id="CHEBI:37080" relevant="false">Acrylate</ne> Crosspolymer 0 20
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.738" epochem-id="EPOCHEM:NEW:COMPOUND:279" name="Disodium EDETA" comment="EDTA" chebi-id="WO2007039057:411403" relevant="false">Disodium EDETA</ne> 0 10
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.810" epochem-id="EPOCHEM:NEW:COMPOUND:1346" name="Arachidyl Alcohol" comment="" chebi-id="WO2007039057:949898" relevant="false">Arachidyl Alcohol</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.812" epochem-id="EPOCHEM:NEW:COMPOUND:1347" name="Behenyl Alcohol" comment="" chebi-id="CHEBI:31000" relevant="false">Behenyl Alcohol</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.814" epochem-id="EPOCHEM:NEW:COMPOUND:1348" name="Arachidyl Glucoside" comment="" chebi-id="WO2007039057:347563" relevant="false">Arachidyl Glucoside</ne> 5 00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.847" epochem-id="EPOCHEM:NEW:COMPOUND:2011" name="squalane" comment="" chebi-id="WO2007039057:290529" relevant="false">Squalane</ne> 2 00
Mineral Oil 4 00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.578" epochem-id="EPOCHEM:NEW:COMPOUND:247" name="Phenoxyethanol" comment="" chebi-id="WO2007039057:872800" relevant="false">Phenoxyethanol</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.590" epochem-id="EPOCHEM:NEW:COMPOUND:248" name="Methylparaben" comment="" chebi-id="WO2007039057:179825" relevant="false">Methylparaben</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.602" epochem-id="EPOCHEM:NEW:COMPOUND:249" name="Ethylparaben" comment="" chebi-id="WO2007039057:489268" relevant="false">Ethylparaben</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.614" epochem-id="EPOCHEM:NEW:COMPOUND:250" name="Propylparaben" comment="" chebi-id="WO2007039057:368057" relevant="false">Propylparaben</ne> &amp; 0 80
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.626" epochem-id="EPOCHEM:NEW:COMPOUND:251" name="Butylparaben" comment="" chebi-id="WO2007039057:697925" relevant="false">Butylparaben</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.638" epochem-id="EPOCHEM:NEW:COMPOUND:252" name="lsopropylparaben" comment="" chebi-id="WO2007039057:443642" relevant="false">lsopropylparaben</ne> <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.740" epochem-id="EPOCHEM:NEW:COMPOUND:280" name="lsononyl lsononanoate" comment="" chebi-id="WO2007039057:493766" relevant="false">lsononyl lsononanoate</ne> 4 00
BHT 0 05
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.648" epochem-id="EPOCHEM:NEW:COMPOUND:246" name="Cetyl Alcohol" comment="" chebi-id="CHEBI:16125" relevant="false">Cetyl Alcohol</ne> 2 00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.732" epochem-id="EPOCHEM:NEW:COMPOUND:276" name="Dimethicone" comment="" chebi-id="CHEBI:31498" relevant="false">Dimethicone</ne> 0 50
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.105" epochem-id="EPOCHEM:NEW:COMPOUND:10" name="tocopherol" comment="" chebi-id="CHEBI:27013" relevant="false">Tocopherol</ne> <ne type="LIGAND" id="WO2007039057.HC.ligand-names.328" epochem-id="EPOCHEM:NEW:LIGAND:327" name="acetate" comment="" chebi-id="CHEBI:30089" relevant="false">Acetate</ne> 0 10
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.275" epochem-id="EPOCHEM:NEW:COMPOUND:132" name="9- hydroxy stearic acid" comment="" chebi-id="WO2007039057:377465" relevant="true">9-hydroxy stearic acid</ne> 0 50
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.725" epochem-id="EPOCHEM:NEW:COMPOUND:275" name="Retinol Acetate" comment="" chebi-id="WO2007039057:401402" relevant="false">Retinol Acetate</ne> 2 8 Ml 0 10
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.353" epochem-id="EPOCHEM:COMPOUND:4117" name="triethanolamine" comment="" chebi-id="CHEBI:28621" relevant="false">Triethanolamine</ne> q s
Example 13
A skin repair formulation containing the ingredients indicated below can be prepared in a manner known per se
Formulation No. 13
Inqredients % (w/w)
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.689" epochem-id="EPOCHEM:NEW:COMPOUND:269" name="Polyglyceryl-2 Dipolyhydroxystearate" comment="" chebi-id="WO2007039057:897380" relevant="false">Polyglyceryl-2 Dipolyhydroxystearate</ne> 4.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.691" epochem-id="EPOCHEM:NEW:COMPOUND:270" name="Polyglyceryl-3 Diisostearate" comment="" chebi-id="WO2007039057:329828" relevant="false">Polyglyceryl-3 Diisostearate</ne> 2.00
Beeswax 2.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.879" epochem-id="EPOCHEM:NEW:COMPOUND:2029" name="Zinc Stearate" comment="" chebi-id="WO2007039057:430616" relevant="false">Zinc Stearate</ne> 2.00
<ne type="LIGAND" id="WO2007039057.HC.ligand-names.189" epochem-id="EPOCHEM:NEW:LIGAND:44" name="caprylic" comment="" chebi-id="WO2007039057:766489" relevant="false">Caprylic</ne>/<ne type="LIGAND" id="WO2007039057.HC.ligand-names.200" epochem-id="EPOCHEM:NEW:LIGAND:45" name="capric" comment="" chebi-id="WO2007039057:811964" relevant="false">Capric</ne> <ne id="WO2007039057.HC.class-names.428" epochem-id="EPOCHEM:NEW:CLASS:487" name="Triglyceride" comment="" chebi-id="CHEBI:17855" relevant="false" type="CLASS">Triglyceride</ne> 3.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.664" epochem-id="EPOCHEM:NEW:COMPOUND:259" name="Cetearyl lsononanoate" comment="" chebi-id="WO2007039057:190422" relevant="false">Cetearyl lsononanoate</ne> 8.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.662" epochem-id="EPOCHEM:NEW:COMPOUND:258" name="Dicaprylyl Ether" comment="" chebi-id="WO2007039057:68771" relevant="false">Dicaprylyl Ether</ne> 5.00
BHT 0.05
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.579" epochem-id="EPOCHEM:NEW:COMPOUND:247" name="Phenoxyethanol" comment="" chebi-id="WO2007039057:872800" relevant="false">Phenoxyethanol</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.591" epochem-id="EPOCHEM:NEW:COMPOUND:248" name="Methylparaben" comment="" chebi-id="WO2007039057:179825" relevant="false">Methylparaben</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.603" epochem-id="EPOCHEM:NEW:COMPOUND:249" name="Ethylparaben" comment="" chebi-id="WO2007039057:489268" relevant="false">Ethylparaben</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.615" epochem-id="EPOCHEM:NEW:COMPOUND:250" name="Propylparaben" comment="" chebi-id="WO2007039057:368057" relevant="false">Propylparaben</ne> &amp; 0.60
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.627" epochem-id="EPOCHEM:NEW:COMPOUND:251" name="Butylparaben" comment="" chebi-id="WO2007039057:697925" relevant="false">Butylparaben</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.639" epochem-id="EPOCHEM:NEW:COMPOUND:252" name="lsopropylparaben" comment="" chebi-id="WO2007039057:443642" relevant="false">lsopropylparaben</ne>
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.807" epochem-id="EPOCHEM:NEW:COMPOUND:9" name="Water" comment="" chebi-id="CHEBI:15377" relevant="false">Water</ne> Ad. 100
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.840" epochem-id="EPOCHEM:NEW:COMPOUND:2025" name="D-Panthenol" comment="" chebi-id="CHEBI:27373" relevant="false">D-Panthenol</ne> 0.20
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.672" epochem-id="EPOCHEM:NEW:COMPOUND:260" name="Disodium EDTA" comment="" chebi-id="WO2007039057:514107" relevant="false">Disodium EDTA</ne> 0.10
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.215" epochem-id="EPOCHEM:NEW:COMPOUND:25" name="propylene glycol" comment="" chebi-id="CHEBI:16997" relevant="false">Propylene Glycol</ne> 4.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.276" epochem-id="EPOCHEM:NEW:COMPOUND:132" name="9- hydroxy stearic acid" comment="" chebi-id="WO2007039057:377465" relevant="true">9-hydroxy stearic acid</ne> 0.55
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.760" epochem-id="EPOCHEM:NEW:COMPOUND:281" name="Retinol" comment="" chebi-id="WO2007039057:845039" relevant="false">Retinol</ne> 15D (<ne type="LIGAND" id="WO2007039057.HC.ligand-names.190" epochem-id="EPOCHEM:NEW:LIGAND:44" name="caprylic" comment="" chebi-id="WO2007039057:766489" relevant="false">Caprylic</ne>/<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.817" epochem-id="EPOCHEM:NEW:COMPOUND:255" name="CapricTriglyceride" comment="" chebi-id="WO2007039057:660099" relevant="false">Capric Triglyceride</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.761" epochem-id="EPOCHEM:NEW:COMPOUND:281" name="Retinol" comment="" chebi-id="WO2007039057:845039" relevant="false">Retinol</ne>) 0.50
Example 14
A skin repair formulation containing the ingredients indicated below can be prepared in a manner known per se
Formulation No. 14
Inqredients % (w/w)
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.690" epochem-id="EPOCHEM:NEW:COMPOUND:269" name="Polyglyceryl-2 Dipolyhydroxystearate" comment="" chebi-id="WO2007039057:897380" relevant="false">Polyglyceryl-2 Dipolyhydroxystearate</ne> 4.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.692" epochem-id="EPOCHEM:NEW:COMPOUND:270" name="Polyglyceryl-3 Diisostearate" comment="" chebi-id="WO2007039057:329828" relevant="false">Polyglyceryl-3 Diisostearate</ne> 2.00
Beeswax 2.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.880" epochem-id="EPOCHEM:NEW:COMPOUND:2029" name="Zinc Stearate" comment="" chebi-id="WO2007039057:430616" relevant="false">Zinc Stearate</ne> 2.00
<ne type="LIGAND" id="WO2007039057.HC.ligand-names.191" epochem-id="EPOCHEM:NEW:LIGAND:44" name="caprylic" comment="" chebi-id="WO2007039057:766489" relevant="false">Caprylic</ne>/<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.815" epochem-id="EPOCHEM:NEW:COMPOUND:255" name="CapricTriglyceride" comment="" chebi-id="WO2007039057:660099" relevant="false">Capric Triglyceride</ne> 3.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.665" epochem-id="EPOCHEM:NEW:COMPOUND:259" name="Cetearyl lsononanoate" comment="" chebi-id="WO2007039057:190422" relevant="false">Cetearyl lsononanoate</ne> 8.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.663" epochem-id="EPOCHEM:NEW:COMPOUND:258" name="Dicaprylyl Ether" comment="" chebi-id="WO2007039057:68771" relevant="false">Dicaprylyl Ether</ne> 5.00
BHT 0.05
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.580" epochem-id="EPOCHEM:NEW:COMPOUND:247" name="Phenoxyethanol" comment="" chebi-id="WO2007039057:872800" relevant="false">Phenoxyethanol</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.592" epochem-id="EPOCHEM:NEW:COMPOUND:248" name="Methylparaben" comment="" chebi-id="WO2007039057:179825" relevant="false">Methylparaben</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.604" epochem-id="EPOCHEM:NEW:COMPOUND:249" name="Ethylparaben" comment="" chebi-id="WO2007039057:489268" relevant="false">Ethylparaben</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.616" epochem-id="EPOCHEM:NEW:COMPOUND:250" name="Propylparaben" comment="" chebi-id="WO2007039057:368057" relevant="false">Propylparaben</ne> &amp; 0.60
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.628" epochem-id="EPOCHEM:NEW:COMPOUND:251" name="Butylparaben" comment="" chebi-id="WO2007039057:697925" relevant="false">Butylparaben</ne> &amp; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.640" epochem-id="EPOCHEM:NEW:COMPOUND:252" name="lsopropylparaben" comment="" chebi-id="WO2007039057:443642" relevant="false">lsopropylparaben</ne>
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.808" epochem-id="EPOCHEM:NEW:COMPOUND:9" name="Water" comment="" chebi-id="CHEBI:15377" relevant="false">Water</ne> Ad. 100
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.841" epochem-id="EPOCHEM:NEW:COMPOUND:2025" name="D-Panthenol" comment="" chebi-id="CHEBI:27373" relevant="false">D-Panthenol</ne> 0.20
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.673" epochem-id="EPOCHEM:NEW:COMPOUND:260" name="Disodium EDTA" comment="" chebi-id="WO2007039057:514107" relevant="false">Disodium EDTA</ne> 0.10
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.216" epochem-id="EPOCHEM:NEW:COMPOUND:25" name="propylene glycol" comment="" chebi-id="CHEBI:16997" relevant="false">Propylene Glycol</ne> 4.00
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.277" epochem-id="EPOCHEM:NEW:COMPOUND:132" name="9- hydroxy stearic acid" comment="" chebi-id="WO2007039057:377465" relevant="false">9-hydroxy stearic acid</ne> 0.50
<ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.726" epochem-id="EPOCHEM:NEW:COMPOUND:275" name="Retinol Acetate" comment="" chebi-id="WO2007039057:401402" relevant="false">Retinol Acetate</ne> 2.8 Ml 0.10
What is claimed is :
</P>
<P>1. A cosmetic or pharmaceutical composition comprising a <ne id="WO2007039057.HC.class-names.316" epochem-id="EPOCHEM:NEW:CLASS:319" name="fatty acid" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acid</ne> containing 6 to 18 <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.9" epochem-id="EPOCHEM:COMPOUND:6728" name="carbon" comment="" chebi-id="CHEBI:27594" relevant="false">carbon</ne> atoms, which carries one or two <ne type="LIGAND" id="WO2007039057.HC.ligand-names.250" epochem-id="EPOCHEM:NEW:LIGAND:68" name="hydroxy" comment="" chebi-id="CHEBI:43176" relevant="false">hydroxy</ne>, <ne type="LIGAND" id="WO2007039057.HC.ligand-names.3" epochem-id="EPOCHEM:NEW:LIGAND:2" name="alkoxy" comment="" chebi-id="CHEBI:22338" relevant="false">alkoxy</ne>, preferably <ne type="LIGAND" id="WO2007039057.HC.ligand-names.333" epochem-id="EPOCHEM:NEW:LIGAND:94" name="methoxy" comment="" chebi-id="WO2007039057:259368" relevant="false">methoxy</ne> or <ne type="LIGAND" id="WO2007039057.HC.ligand-names.11" epochem-id="EPOCHEM:NEW:LIGAND:4" name="ethoxy" comment="" chebi-id="CHEBI:42241" relevant="false">ethoxy</ne>, C2-C4-acylprotected <ne type="LIGAND" id="WO2007039057.HC.ligand-names.19" epochem-id="EPOCHEM:NEW:LIGAND:6" name="amino" comment="" chebi-id="CHEBI:46882" relevant="false">amino</ne>, preferably C2, or <ne type="LIGAND" id="WO2007039057.HC.ligand-names.25" epochem-id="EPOCHEM:NEW:LIGAND:8" name="oxo" comment="" chebi-id="CHEBI:46629" relevant="false">oxo</ne> group, or a salt, <ne id="WO2007039057.HC.class-names.353" epochem-id="EPOCHEM:NEW:CLASS:185" name="ester" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">ester</ne> or <ne id="WO2007039057.HC.class-names.288" epochem-id="EPOCHEM:NEW:CLASS:138" name="amide" comment="" chebi-id="CHEBI:29337" relevant="false" type="CLASS">amide</ne> of such <ne id="WO2007039057.HC.class-names.246" epochem-id="EPOCHEM:NEW:CLASS:85" name="acids" comment="" chebi-id="CHEBI:37527" relevant="false" type="CLASS">acids</ne> or a mixture of these <ne id="WO2007039057.HC.class-names.247" epochem-id="EPOCHEM:NEW:CLASS:85" name="acids" comment="" chebi-id="CHEBI:37527" relevant="false" type="CLASS">acids</ne>; and a carrier conventionally used in cosmetic or pharmaceutical compositions.
</P>
<P>2. The composition as in claim 1 , wherein the <ne id="WO2007039057.HC.class-names.251" epochem-id="EPOCHEM:NEW:CLASS:310" name="aliphatic fatty acid" comment="" chebi-id="WO2007039057:762442" relevant="false" type="CLASS">aliphatic fatty acid</ne> is a <ne id="WO2007039057.HC.class-names.253" epochem-id="EPOCHEM:NEW:CLASS:311" name="saturated straight- chain fatty acid" comment="" chebi-id="WO2007039057:324836" relevant="false" type="CLASS">saturated straight- chain fatty acid</ne> or <ne id="WO2007039057.HC.class-names.255" epochem-id="EPOCHEM:NEW:CLASS:312" name="[omega] - branched-chain fatty acid" comment="" chebi-id="WO2007039057:687913" relevant="false" type="CLASS">[omega]-branched-chain fatty acid</ne>.
</P>
<P>3. The composition as in claim 2 wherein the saturated straight-chain or <ne id="WO2007039057.HC.class-names.257" epochem-id="EPOCHEM:NEW:CLASS:313" name="[omega]- branched chain fatty acid" comment="" chebi-id="WO2007039057:772281" relevant="false" type="CLASS">[omega]- branched chain fatty acid</ne> is substituted between the positions 6 and 12.
</P>
<P>4. The composition as in claim 3 wherein the saturated straight-chain or [omega]- branched <ne id="WO2007039057.HC.class-names.321" epochem-id="EPOCHEM:NEW:CLASS:319" name="fatty acid" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acid</ne> is substituted by <ne type="LIGAND" id="WO2007039057.HC.ligand-names.251" epochem-id="EPOCHEM:NEW:LIGAND:68" name="hydroxy" comment="" chebi-id="CHEBI:43176" relevant="false">hydroxy</ne>.
</P>
<P>5. The composition as in claim 4 wherein the <ne id="WO2007039057.HC.class-names.322" epochem-id="EPOCHEM:NEW:CLASS:319" name="fatty acid" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acid</ne> is <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.278" epochem-id="EPOCHEM:NEW:COMPOUND:132" name="9- hydroxy stearic acid" comment="" chebi-id="WO2007039057:377465" relevant="false">9-hydroxy stearic acid</ne>.
</P>
<P>6. The composition as in any one of claims 1 to 5 comprising additionally a <ne id="WO2007039057.HC.class-names.68" epochem-id="EPOCHEM:NEW:CLASS:24" name="retinoid" comment="" chebi-id="CHEBI:26537" relevant="true" type="CLASS">retinoid</ne>.
</P>
<P>7. The composition as in any one of claims 1 to 6 wherein the <ne id="WO2007039057.HC.class-names.69" epochem-id="EPOCHEM:NEW:CLASS:24" name="retinoid" comment="" chebi-id="CHEBI:26537" relevant="true" type="CLASS">retinoid</ne> is <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.14" epochem-id="EPOCHEM:COMPOUND:881" name="retinoic acid" comment="" chebi-id="CHEBI:15367" relevant="true">retinoic acid</ne> or a derivative thereof.
</P>
<P>8. The composition as in any one of claims 1 to 6 wherein the <ne id="WO2007039057.HC.class-names.70" epochem-id="EPOCHEM:NEW:CLASS:24" name="retinoid" comment="" chebi-id="CHEBI:26537" relevant="true" type="CLASS">retinoid</ne> is <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.693" epochem-id="EPOCHEM:NEW:COMPOUND:271" name="retinyl acetate" comment="" chebi-id="WO2007039057:869397" relevant="true">retinyl acetate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.695" epochem-id="EPOCHEM:NEW:COMPOUND:272" name="phenylbutyrate" comment="" chebi-id="WO2007039057:384498" relevant="false">phenylbutyrate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.399" epochem-id="EPOCHEM:COMPOUND:420" name="propionate" comment="" chebi-id="CHEBI:17272" relevant="false">propionate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.705" epochem-id="EPOCHEM:COMPOUND:679" name="octanoate" comment="" chebi-id="CHEBI:25646" relevant="false">octanoate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.708" epochem-id="EPOCHEM:COMPOUND:535" name="laurate" comment="" chebi-id="CHEBI:18262" relevant="false">laurate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.713" epochem-id="EPOCHEM:COMPOUND:586" name="palmitate" comment="" chebi-id="CHEBI:29889" relevant="false">palmitate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.718" epochem-id="EPOCHEM:COMPOUND:699" name="oleate" comment="" chebi-id="CHEBI:30823" relevant="false">oleate</ne>, <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.720" epochem-id="EPOCHEM:COMPOUND:602" name="linoleate" comment="" chebi-id="CHEBI:30245" relevant="false">linoleate</ne>; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.704" epochem-id="EPOCHEM:NEW:COMPOUND:274" name="retinyl alkyl carbonate" comment="" chebi-id="WO2007039057:762347" relevant="false">retinyl alkyl carbonate</ne>; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.38" epochem-id="EPOCHEM:NEW:COMPOUND:30" name="retinoxytrimethylsilane" comment="" chebi-id="WO2007039057:901675" relevant="true">retinoxytrimethylsilane</ne>; <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.767" epochem-id="EPOCHEM:NEW:COMPOUND:1341" name="(all trans)-retinal" comment="" chebi-id="WO2007039057:847024" relevant="false">(all trans)-retinal</ne> or its <ne id="WO2007039057.HC.class-names.263" epochem-id="EPOCHEM:NEW:CLASS:314" name="acetals" comment="" chebi-id="WO2007039057:950244" relevant="false" type="CLASS">acetals</ne>; or <ne type="CHEMICAL" id="WO2007039057.HC.chemical-names.696" epochem-id="EPOCHEM:NEW:COMPOUND:31" name="methoxy PEG-12 retinamide" comment="" chebi-id="WO2007039057:287069" relevant="true">methoxy PEG-12 retinamide</ne>.
</P>
<P>9. The composition according to any of claims 1 to 8, wherein the amount of the <ne id="WO2007039057.HC.class-names.323" epochem-id="EPOCHEM:NEW:CLASS:319" name="fatty acid" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acid</ne> is from about 0.0001 to about 50 % by weight of the total composition.
</P>
<P>10. The composition according to any of claims 1 to 8, wherein the amount of the <ne id="WO2007039057.HC.class-names.324" epochem-id="EPOCHEM:NEW:CLASS:319" name="fatty acid" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acid</ne> is from about 0.001 to about 20 % by weight of the total composition.
</P>
<P>11. The composition according to any of claims 1 to 8, wherein the amount of the compound of the <ne id="WO2007039057.HC.class-names.325" epochem-id="EPOCHEM:NEW:CLASS:319" name="fatty acid" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acid</ne> is from about 0.01 to about 1 % by weight of the total composition.
</P>
<P>12. The composition according to any of claims 6 to 11 , wherein the amount of the <ne id="WO2007039057.HC.class-names.71" epochem-id="EPOCHEM:NEW:CLASS:24" name="retinoid" comment="" chebi-id="CHEBI:26537" relevant="true" type="CLASS">retinoid</ne> or derivative thereof is from about 0.001 to about 50 % by weight of the total composition.
</P>
<P>13. The composition according to any of claims 6 to 11 wherein the amount of the <ne id="WO2007039057.HC.class-names.72" epochem-id="EPOCHEM:NEW:CLASS:24" name="retinoid" comment="" chebi-id="CHEBI:26537" relevant="true" type="CLASS">retinoid</ne> or derivative thereof is from about 0.001 to about 20 % by weight of the total composition.
</P>
<P>14. The composition according to any of claims 6 to 11 , wherein the amount of the <ne id="WO2007039057.HC.class-names.73" epochem-id="EPOCHEM:NEW:CLASS:24" name="retinoid" comment="" chebi-id="CHEBI:26537" relevant="true" type="CLASS">retinoid</ne> or derivative thereof is from about 0.01 to about 1 % by weight of the total composition.
</P>
<P>15. The composition according to any of claims 6 to 14, wherein the ratio of the <ne id="WO2007039057.HC.class-names.326" epochem-id="EPOCHEM:NEW:CLASS:319" name="fatty acid" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acid</ne> to the <ne id="WO2007039057.HC.class-names.74" epochem-id="EPOCHEM:NEW:CLASS:24" name="retinoid" comment="" chebi-id="CHEBI:26537" relevant="true" type="CLASS">retinoid</ne> or derivative thereof is from about 1000 : 1 to about 1 : 1000 by weight.
</P>
<P>16. The composition according to any of claims 6 to 14, wherein the ratio of the <ne id="WO2007039057.HC.class-names.327" epochem-id="EPOCHEM:NEW:CLASS:319" name="fatty acid" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acid</ne> to the <ne id="WO2007039057.HC.class-names.75" epochem-id="EPOCHEM:NEW:CLASS:24" name="retinoid" comment="" chebi-id="CHEBI:26537" relevant="true" type="CLASS">retinoid</ne> or derivative thereof is from about 100 : 1 to about 1 : 100 by weight.
</P>
<P>17. The composition according to any of claims 6 to 14, wherein the ratio of the <ne id="WO2007039057.HC.class-names.328" epochem-id="EPOCHEM:NEW:CLASS:319" name="fatty acid" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acid</ne> to the <ne id="WO2007039057.HC.class-names.76" epochem-id="EPOCHEM:NEW:CLASS:24" name="retinoid" comment="" chebi-id="CHEBI:26537" relevant="true" type="CLASS">retinoid</ne> or derivative thereof is from about 30 : 1 to about 1 : 30 by weight.
</P>
<P>18. A composition as in any one of claims 1 to 17, which is for prevention or treatment of symptoms caused by negative developments of the physiological homeostasis of healthy skin, promotion of hair growth, protection from hair loss, prevention and treatment of itchy or irritated skin.
</P>
<P>19. A composition as in any one of claims 1 to 17 which is for the prevention or treatment of pigmentation disorders and/or for providing an even skin tone.
</P>
<P>20. A composition as in any one of claims 1 to 5 and 9 to 11 which is for fortifying the pigmentation by enhancing the effect of a tanning active.
</P>
<P>21. A composition as in claim 1 to 17, which is for the treatment or prevention of wrinkles or dry skin or sensitive skin, for the promotion of hair growth, for the protection from hair loss, and for thickening the epidermis.
</P>
<P>22. A method of treatment or prevention of symptoms caused by negative developments of the physiological homeostasis of healthy skin as well as treatment or prevention of itchy or irritated skin and of promotion of hair growth and of protection from hair loss, which method comprises the step of topically administering to a person in need of such treatment or prevention an effective amount of a <ne id="WO2007039057.HC.class-names.329" epochem-id="EPOCHEM:NEW:CLASS:319" name="fatty acid" comment="" chebi-id="CHEBI:35366" relevant="false" type="CLASS">fatty acid</ne> or a salt, <ne id="WO2007039057.HC.class-names.354" epochem-id="EPOCHEM:NEW:CLASS:185" name="ester" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">ester</ne> or <ne id="WO2007039057.HC.class-names.289" epochem-id="EPOCHEM:NEW:CLASS:138" name="amide" comment="" chebi-id="CHEBI:29337" relevant="false" type="CLASS">amide</ne>, optionally in combination with a <ne id="WO2007039057.HC.class-names.77" epochem-id="EPOCHEM:NEW:CLASS:24" name="retinoid" comment="" chebi-id="CHEBI:26537" relevant="true" type="CLASS">retinoid</ne>.
</P></DIV>
<DIV><P>
</P></DIV>
</BODY>
</PAPER>
